Processing 00000000.tx.1: Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats Hossein Fakhrai-Rad+, Andrej Nikoshkov+, Ashraf Kamel2, Maria Fernstrm1, Juleen R. 

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "identified as a candidate diabetes susceptibility gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0919453:Susceptibility Gene [Gene or Genome]
   774   C1332838:Candidate Gene [Gene or Genome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0017337:Gene [Gene or Genome]
   748   C0205396:Identified [Qualitative Concept]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "in GK rats Hossein Fakhrai-Rad+,"

Phrase: "Andrej Nikoshkov+,"

Phrase: "Ashraf Kamel2,"

Phrase: "Maria Fernstrm1,"

Phrase: "Juleen R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: Zierath1, Svante Norgren2, Holger Luthman and Joakim Galli Karolinska Institutet, Center for Molecular Medicine, Department of Molecular Medicine, Karolinska Hospital, L602, S-171 76 Stockholm, Sweden, 1Karolinska Institutet, Department of Clinical Physiology, Karolinska Hospital, S-171 76 Stockholm, Sweden and 2Karolinska Institutet, Department of Pediatrics, Pediatric Endocrine Research Unit, Huddinge University Hospital, B62, S-141 86 Stockholm, Sweden Received 5 May 2000; 

Phrase: "Zierath1,"

Phrase: "Svante Norgren2,"

Phrase: "Holger Luthman"

Phrase: "and"

Phrase: "Joakim Galli Karolinska Institutet,"

Phrase: "Center for Molecular Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "Department of Molecular Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Karolinska Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "L602,"

Phrase: "S-"

Phrase: "171 76 Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "1Karolinska Institutet,"

Phrase: "Department of Clinical Physiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C0587460:Clinical physiology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Karolinska Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "S-"

Phrase: "171 76 Stockholm,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "and"

Phrase: "2Karolinska Institutet,"

Phrase: "Department of Pediatrics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587482:department pediatrics [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Pediatric Endocrine Research Unit,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C1552763:Pediatric unit [Intellectual Product]
   902   C1718195:Pediatric unit [Health Care Related Organization]
   812   C0439148:Unit [Quantitative Concept]
   812   C1519795:Unit [Quantitative Concept]
   812   C1704753:Unit [Manufactured Object]
   812   C1880519:Unit [Quantitative Concept]
   708   C1518935:Pediatric Research [Research Activity]

Phrase: "Huddinge University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "B62,"

Phrase: "S-"

Phrase: "141 86 Stockholm,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "5 May 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.3: Revised and Accepted 28 June 2000.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "28 June 2000."
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Genetic analysis of the diabetic GK rat has revealed several diabetes susceptibility loci. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Genetic analysis of the diabetic GK rat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0679560:genetic analysis [Laboratory Procedure]
   778   C0796344:Genetic Analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "has"

Phrase: "revealed several diabetes susceptibility loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.5: Congenic strains have been established for the major diabetes locus, Niddm1, by transfer of GK alleles onto the genome of the normoglycemic F344 rat. 

Phrase: "Congenic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1516786:Congenic Strain [Animal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "have"

Phrase: "been"

Phrase: "established for the major diabetes locus,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0205164:Major [Qualitative Concept]
   753   C0443211:Established [Qualitative Concept]
   753   C1272684:Established [Qualitative Concept]
   753   C1708726:Locus [Gene or Genome]

Phrase: "Niddm1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417726:NIDDM1 [Gene or Genome]
  1000   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "by transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "of GK alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "onto the genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "of the normoglycemic F344 rat."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034703:Rat, F344 [Mammal]
           F344
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
Processing 00000000.tx.6: Niddm1 was dissected into two subloci, physically separated in the congenic strains Niddm1b and Niddm1i, each with at least one disease susceptibility gene. 

Phrase: "Niddm1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417726:NIDDM1 [Gene or Genome]
  1000   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "was"

Phrase: "dissected into two subloci,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205239:dissected [Functional Concept]
   770   C0205448:Two [Quantitative Concept]

Phrase: "physically"

Phrase: "separated in the congenic strains Niddm1b"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   773   C1516786:Congenic Strain [Animal]
   753   C0080194:Strains [Injury or Poisoning]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0456178:strains [Intellectual Product]
   753   C0687118:Separated [Functional Concept]
   719 E C1518614:Strain [Organism]
   719 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "Niddm1i,"

Phrase: "each with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1457900:Each [Quantitative Concept]

Phrase: "at least one disease susceptibility gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0919453:Susceptibility Gene [Gene or Genome]
   825   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.7: Here we have mapped Niddm1b to 1 cM by genetic and pathophysiological characterization of new congenic substrains for the locus. 

Phrase: "Here"

Phrase: "we"

Phrase: "have"

Phrase: "mapped Niddm1b to 1 cM"

Phrase: "by genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "pathophysiological characterization of new congenic substrains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "for the locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.8: The gene encoding insulin-degrading enzyme (Ide) was located to this 1 cM region, and the two amino acid substitutions (H18R and A890V) identified in the GK allele reduced insulin-degrading activity by 31% in transfected cells. 

Phrase: "The gene encoding insulin-degrading enzyme (Ide)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "located to this 1 cM region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "the two amino acid substitutions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   779   C1555721:Substitution [Idea or Concept]
   779   C1706204:Substitution [Activity]

Phrase: "(H18R"

Phrase: "and"

Phrase: "A890V"

Phrase: ")"

Phrase: "identified in the GK allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002085:Allele [Gene or Genome]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "insulin-degrading activity by 31%"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.9: However, when the H18R and A890V variants were studied separately, no effects were observed, demonstrating a synergistic effect of the two variants on insulin degradation. 

Phrase: "However,"

Phrase: "when"

Phrase: "the H18R"

Phrase: "and"

Phrase: "A890V variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "separately,"

Phrase: "no effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "demonstrating"

Phrase: "a synergistic effect of the two variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
   748   C2986495:Synergistic [Qualitative Concept]

Phrase: "on insulin degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.10: No effect on insulin degradation was observed in cell lysates, indicating that the effect is coupled to receptor-mediated internalization of insulin. 

Phrase: "No effect on insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in cell lysates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "indicating"

Phrase: "that"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "coupled to receptor-mediated internalization of insulin."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   800   C3271694:insulin receptor internalization [Phenomenon or Process]
   774   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   774   C0599281:receptor internalization [Phenomenon or Process]
   774   C1334133:INSULIN RECEPTOR [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0871786:internalization [Mental Process]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1948027:Coupled [Functional Concept]
   714 E C0010222:couple [Family Group]
Processing 00000000.tx.11: Congenic rats with the Ide GK allele displayed post-prandial hyperglycemia, reduced lipogenesis in fat cells, blunted insulin-stimulated glucose transmembrane uptake and reduced insulin degradation in isolated muscle. 

Phrase: "Congenic rats with the Ide GK allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "post-prandial hyperglycemia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020456:Hyperglycaemia [Disease or Syndrome]
   734   C0376674:Post-prandial [Temporal Concept]

Phrase: "reduced lipogenesis in fat cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596843:lipogenesis [Molecular Function]
   760   C1563744:Lipogenesis [Organism Function]

Phrase: "blunted insulin-stimulated glucose transmembrane uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C1159527:glucose uptake [Cell Function]
   799   C0243144:Uptake [Physiologic Function]
   799   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "reduced insulin degradation in isolated muscle."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.12: Analysis of additional rat strains demonstrated that the dysfunctional Ide allele was unique to GK. 

Phrase: "Analysis of additional rat strains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the dysfunctional Ide allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002085:Allele [Gene or Genome]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "unique to GK."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710548:Unique [Qualitative Concept]
Processing 00000000.tx.13: These data point to an important role for Ide in the diabetic phenotype in GK.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "point to an important role"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035820:Role [Social Behavior]
   760   C1552961:Point [Quantitative Concept]
   760   C1705810:Role [Conceptual Entity]
   760   C2347617:point [Quantitative Concept]

Phrase: "for Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the diabetic phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "in GK."
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Type 2 diabetes, or non-insulin-dependent diabetes mellitus (NIDDM), is an accelerating health burden in urbanized societies with aging populations. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "non-insulin-dependent diabetes mellitus (NIDDM),"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "an accelerating health burden in urbanized societies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2828008:Burden [Idea or Concept]

Phrase: "with aging populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.15: The disease is associated with physical inactivity, dyslipidemia, obesity and other components of the metabolic syndrome. 

Phrase: "The disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "associated with physical inactivity,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0031809:Physical [Health Care Activity]
   770   C0205485:Physical [Functional Concept]
   770   C1509143:Physical [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "dyslipidemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242339:Dyslipidaemia [Disease or Syndrome]

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "other components of the metabolic syndrome."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.16: A continuously increasing number of people worldwide are affected and are therefore at risk for myocardial infarction, stroke, end-stage kidney disease, vision defects and neurological problems. 

Phrase: "A continuously"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "number of people worldwide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "are"

Phrase: "therefore at risk for myocardial infarction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: "stroke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "end-stage kidney disease,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C0022661:End-Stage Kidney Disease [Disease or Syndrome]
  1000   C2316810:End Stage Kidney Disease [Disease or Syndrome,Finding]
   923   C0679247:end stage disease [Disease or Syndrome]
           Terminal Disease
   861   C0022658:Kidney disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0022646:Kidney [Body Part, Organ, or Organ Component]
   812   C0227665:kidney [Body Part, Organ, or Organ Component]
   812   C1278978:Kidney [Body Part, Organ, or Organ Component]
   812   C1514845:KIDNEY [Tissue]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   719 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "vision defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "neurological problems."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0221571:neurological problems [Finding]
   861   C1546466:Problems [Idea or Concept]
   827 E C0033213:Problem [Finding]
Processing 00000000.tx.17: It is generally considered that the disease in most cases results from a combination of impaired insulin action in target tissues and a reduced capacity to secrete insulin from the pancreatic B cells. 

Phrase: "It"

Phrase: "is"

Phrase: "generally"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "that"

Phrase: "the disease in most cases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "results from a combination of impaired insulin action"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205195:Combination [Qualitative Concept]
   744   C0221099:Impaired [Functional Concept]
   744   C0441472:Action [Functional Concept]
   744   C0684336:Impaired [Pathologic Function]
   744   C1274040:Result [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1546471:Result [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1947911:Combination [Physical Object]
   744   C2825142:Result [Finding]
   744   C3266814:Action [Activity]

Phrase: "in target tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0040300:Tissues [Tissue]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "a reduced capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "insulin from the pancreatic B cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0030281:Insulin Cell [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.18: The etiology is multifactorial with an appreciable genetic basis, although environmental factors are also of critical importance for the development of overt disease (16). 

Phrase: "The etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "is"

Phrase: "multifactorial with an appreciable genetic basis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1837655:Multifactorial [Finding]

Phrase: "although"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "also of critical importance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "for the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of overt disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.19: In the vast majority of type 2 diabetes patients, the genetic basis and the pathophysiological mechanisms behind the disease are still unclear. 

Phrase: "In the vast majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680220:majority [Social Behavior]

Phrase: "of type 2 diabetes patients,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   708   C1320657:type diabetes [Finding]

Phrase: "the genetic basis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "and"

Phrase: "the pathophysiological mechanisms behind the disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "still unclear."
Processing 00000000.tx.20: Genetic dissection of type 2 diabetes in humans is compromised by genetic heterogeneity, multigenicity and environmental variation. 

Phrase: "Genetic dissection of type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "is"

Phrase: "compromised by genetic heterogeneity,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   833   C0242960:Genetic Heterogeneity [Organism Attribute]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0019409:Heterogeneity [Qualitative Concept]
   770   C0314603:Genetic [Functional Concept]
   737   C2945640:compromise [Finding]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "multigenicity"

Phrase: "and"

Phrase: "environmental variation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.21: However, mutations in several genes linked to monogenic forms of type 2 diabetes have been identified in recent years (712). 

Phrase: "However,"

Phrase: "mutations in several genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "linked to monogenic forms of type 2 diabetes"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   778   C3463805:Type of Form [Intellectual Product]
           form type
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332307:Type [Qualitative Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C1547052:*Type [Quantitative Concept]
   711   C1517892:Link [Intellectual Product]
   711 E C1522492:Form [Functional Concept]
   711   C1704666:Link [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "identified in recent years"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C0332185:Recent [Temporal Concept]
   770   C0439234:years [Temporal Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "(712"

Phrase: ")."
Processing 00000000.tx.22: One way to circumvent the complexity in the human population is to genetically dissect well-defined animal models of multifactorial diseases. 

Phrase: "One way to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "circumvent"

Phrase: "the complexity in the human population"

Phrase: "is"

Phrase: "to genetically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "well-defined animal models of multifactorial diseases."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   817   C0012644:Animal Model of Disease [Experimental Model of Disease]
           Animal Disease Models
   778   C0599779:Models, Animal [Animal]
   774   C0003047:Animal Diseases [Disease or Syndrome]
   757   C0683033:disease models [Intellectual Product]
   757   C0684309:disease models [Experimental Model of Disease]
   748   C0003062:Animal [Animal]
   748   C3161035:Models [Intellectual Product]
Processing 00000000.tx.23: Such dissections of rat and mouse models for the metabolic syndrome have successfully revealed loci for glucose intolerance and diabetes (1320). 

Phrase: "Such dissections of rat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012737:Dissections [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models for the metabolic syndrome"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0524620:Metabolic syndrome [Disease or Syndrome]
   797   C1704565:Metabolic Model [Intellectual Product]
   760   C0039082:Syndrome [Disease or Syndrome]
   760   C0311400:Metabolic [Functional Concept]
   760   C1524026:Metabolic [Cell Function]
   760   C2707259:Metabolic [Clinical Attribute]
   760   C3161035:Model [Intellectual Product]

Phrase: "have"

Phrase: "successfully revealed loci for glucose intolerance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(1320"

Phrase: ")."
Processing 00000000.tx.24: The inbred GK rat is an extensively studied model of type 2 diabetes that displays the key features of the disease, such as defects in both insulin action and secretion as well as late complications (21,22). 

Phrase: "The inbred GK rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: "is"

Phrase: "an extensively studied model of type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "that"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "the key features of the disease,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "such as defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243067:defects [Functional Concept]
   966 E C1457869:Defect [Functional Concept]
   966 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in both insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "as well as"

Phrase: "late complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.25: The genetic analysis of the GK rat revealed several loci for diabetes-associated phenotypes (13,14). 

Phrase: "The genetic analysis of the GK rat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0679560:genetic analysis [Laboratory Procedure]
   778   C0796344:Genetic Analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "several loci for diabetes-associated phenotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1708726:Locus [Gene or Genome]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.26: We identified three genome-wide significant quantitative trait loci (QTL) (Niddm1, Niddm2 and Niddm3) affecting glucose homeostasis, one locus controlling body weight (Weight1) and an additional 10 loci with less significant influences on diabetes-associated phenotypes (13). 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "three genome-wide significant quantitative trait loci (QTL)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0597336:Quantitative Trait Loci [Gene or Genome]
   795   C0392762:Quantitative [Quantitative Concept]
   795   C0599883:Trait [Organism Attribute]
   762   C1708726:Locus [Gene or Genome]

Phrase: "(Niddm1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417726:NIDDM1 [Gene or Genome]
  1000   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "Niddm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417727:NIDDM2 [Gene or Genome]
  1000   C1832387:NIDDM2 [Disease or Syndrome]

Phrase: "and"

Phrase: "Niddm3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1863594:NIDDM3 [Disease or Syndrome]

Phrase: ")"

Phrase: "affecting glucose homeostasis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1326961:glucose homeostasis [Physiologic Function]
   827   C0019868:Homeostasis [Biologic Function]

Phrase: "one locus controlling body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   840   C0005910:Body Weight [Organism Attribute]
           weight
   840   C1305866:body weight [Diagnostic Procedure]
           weight
   804   C0043100:Weight [Quantitative Concept]
   804   C0242821:body [Human]
   804   C0460148:Body [Anatomical Structure]
   804   C1268086:Body [Anatomical Structure]
   804   C1705104:Weight [Idea or Concept]
   721 E C1995017:Bodies [Cell Component]

Phrase: "(Weight1"

Phrase: ")"

Phrase: "and"

Phrase: "an additional 10 loci with less significant influences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1708726:Locus [Gene or Genome]

Phrase: "on diabetes-associated phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.27: The major QTL, Niddm1, located on chromosome 1, explained 31% of the genetic variation of post-prandial glycemia and influenced insulin levels and body weight. 

Phrase: "The major QTL,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0597336:Quantitative Trait Loci [Gene or Genome]
   812   C0392762:Quantitative [Quantitative Concept]
   812   C0599883:Trait [Organism Attribute]
   779   C1708726:Locus [Gene or Genome]

Phrase: "Niddm1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417726:NIDDM1 [Gene or Genome]
  1000   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "located on chromosome 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008651:Chromosome 1 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "explained"

Phrase: "31% of the genetic variation of post-prandial glycemia"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0042333:Genetic Variation [Natural Phenomenon or Process]
   764   C0376674:Post-prandial [Temporal Concept]
   742   C0005802:glycemia [Carbohydrate]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0205419:Variation [Qualitative Concept]
   742   C0314603:Genetic [Functional Concept]
   742   C0450355:31 [Intellectual Product]
   742   C0687676:Post [Temporal Concept]
   742   C1704687:Post [Manufactured Object]

Phrase: "and"

Phrase: "influenced insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "body weight."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.28: The Niddm1 locus has been dissected further by analysis of congenic strains established by transferring Niddm1 GK alleles onto the genome of the normoglycemic F344 rat (23). 

Phrase: "The Niddm1 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: "further by analysis of congenic strains"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   773   C1516786:Congenic Strain [Animal]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0080194:Strains [Injury or Poisoning]
   753   C0456178:strains [Intellectual Product]
   753   C0936012:Analysis [Research Activity]
   753   C1517331:Further [Spatial Concept]
   753   C1524024:analysis [Functional Concept]
   719 E C0205108:far [Spatial Concept]
   719 E C1518614:Strain [Organism]
   719 E C2987481:Strain [Mental Process]

Phrase: "established by transferring Niddm1 GK alleles"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0002085:Alleles [Gene or Genome]
   753   C0443211:Established [Qualitative Concept]
   753   C1272684:Established [Qualitative Concept]
   753   C1417726:NIDDM1 [Gene or Genome]
   753   C1540850:Transferring [Activity]
   753   C1832544:NIDDM1 [Disease or Syndrome]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "onto the genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "of the normoglycemic F344 rat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034703:Rat, F344 [Mammal]
           F344
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.29: This made possible the dissection of Niddm1 into two genetic entities defined by the two non-overlapping congenic strains Niddm1b and Niddm1i, each displaying a distinct diabetic phenotype. 

Phrase: "This made possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "the dissection of Niddm1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "into two genetic entities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1551338:Entity [Entity]

Phrase: "defined by the two non-overlapping congenic strains Niddm1b"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C1516786:Congenic Strain [Animal]
   742   C0080194:Strains [Injury or Poisoning]
   742   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   742   C0205448:Two [Quantitative Concept]
   742   C0456178:strains [Intellectual Product]
   742   C1518422:Non [Functional Concept]
   742   C1704788:Defined [Conceptual Entity]
   742   C1948020:Overlapping [Conceptual Entity]
   742   C3539106:Defined [Intellectual Product]
   708 E C1518614:Strain [Organism]
   708 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "Niddm1i,"

Phrase: "each"

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a distinct diabetic phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.30: Here we describe the submapping of the Niddm1b locus to a small genetic region of 1 cM defined by new congenic strains. 

Phrase: "Here"

Phrase: "we"

Phrase: "describe"

Phrase: "the submapping of the Niddm1b locus"

Phrase: "to a small genetic region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   859   C0446509:Genital region [Body Location or Region]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of 1 cM"

Phrase: "defined by new congenic strains."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C1516786:Congenic Strain [Animal]
   760   C0080194:Strains [Injury or Poisoning]
   760   C0205314:New [Temporal Concept]
   760   C0456178:strains [Intellectual Product]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726 E C1518614:Strain [Organism]
   726 E C2987481:Strain [Mental Process]
Processing 00000000.tx.31: The gene encoding insulin-degrading enzyme (Ide) was mapped within this region, and a GK-specific allelic variant of Ide was identified. 

Phrase: "The gene encoding insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "mapped within this region,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   737   C0024779:Map [Manufactured Object]
   737   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "a GK-specific allelic variant of Ide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:Variant [Qualitative Concept]

Phrase: "was"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.32: Furthermore, in vitro expression analysis showed reduced insulin degradation by the GK variant, and isolated muscle from a congenic strain with the Ide GK allele demonstrated decreased insulin degradation and blunted insulin-stimulated glucose transport.  

Phrase: "Furthermore,"

Phrase: "in vitro expression analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "reduced insulin degradation by the GK variant,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "isolated muscle from a congenic strain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0080194:Muscle strain [Injury or Poisoning]
   753   C0026845:Muscle [Tissue]

Phrase: "with the Ide GK allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002085:Allele [Gene or Genome]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "demonstrated"

Phrase: "decreased insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "blunted insulin-stimulated glucose transport."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0178666:glucose transport [Cell Function]
   804   C0005528:Transport, NOS [Cell Function]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C1317949:Transport [Manufactured Object]
   804   C3495449:transport [Medical Device]
Processing 00000000.tx.33: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Analysis of diabetes-related phenotypes in Niddm1b substrains Substrains of Niddm1b were established as described in Materials and Methods. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Analysis of diabetes-related phenotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in Niddm1b substrains Substrains"

Phrase: "of Niddm1b"

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.34: Since an intraperitoneal glucose tolerance test (IPGTT) was used to identify Niddm1 as well as to define the Niddm1b and Niddm1i subloci, the same test was applied to characterize the new congenic sublines for Niddm1b (Fig. 1). 

Phrase: "Since"

Phrase: "an intraperitoneal glucose tolerance test (IPGTT)"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   923   C0017741:Glucose tolerance test [Diagnostic Procedure]
   875   C0337438:glucose test [Laboratory Procedure]
   875   C0595310:GLUCOSE TEST [Medical Device]
   861   C0178665:Glucose tolerance [Physiologic Function]
   861   C0201777:Tolerance test [Laboratory Procedure]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:test [Intellectual Product]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "Niddm1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417726:NIDDM1 [Gene or Genome]
  1000   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "as well as"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the Niddm1b"

Phrase: "and"

Phrase: "Niddm1i subloci,"

Phrase: "the same test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the new congenic sublines for Niddm1b"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.35: To map the susceptibility gene within Niddm1b, male rats from the congenic strains (Niddm1e, Niddm1f and Niddm1c) were subjected to an IPGTT at 95 days of age with F344 as control. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "the susceptibility gene within Niddm1b,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0919453:Susceptibility Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "male rats from the congenic strains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1514734:Rat Strains [Mammal]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]

Phrase: "(Niddm1e,"

Phrase: "Niddm1f"

Phrase: "and"

Phrase: "Niddm1c"

Phrase: ")"

Phrase: "were"

Phrase: "subjected to an IPGTT"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   814   C0017741:Glucose tolerance test [Diagnostic Procedure]
   778   C0178665:Glucose tolerance [Physiologic Function]
   778   C0201777:Tolerance test [Laboratory Procedure]
   774   C0337438:glucose test [Laboratory Procedure]
   774   C0595310:GLUCOSE TEST [Medical Device]
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0220929:tolerance [Mental Process]
   748   C0231197:Tolerance [Physiologic Function]
   748   C0392366:test [Intellectual Product]
   748   C0442120:Intraperitoneal [Spatial Concept]
   748   C1704410:Tolerance [Qualitative Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "at 95 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "with F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "as control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.36: Similarly to Niddm1b (23), post-prandial glucose levels in both Niddm1e and Niddm1f were significantly higher compared with F344 (Table 1). 

Phrase: "Similarly to Niddm1b"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "post-prandial glucose levels in both Niddm1e"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   778   C0428548:glucose levels [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   745 E C0337438:glucose level [Laboratory Procedure]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "Niddm1f"

Phrase: "were"

Phrase: "significantly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "compared with F344"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.37: The most pronounced difference was observed at 30 min after glucose injection, when the glucose levels were 21% higher in both Niddm1e and Niddm1f. 

Phrase: "The most pronounced difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed at 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "after glucose injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "when"

Phrase: "the glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "21% higher in both Niddm1e"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "Niddm1f."
Processing 00000000.tx.38: The basal and 30 min insulin levels were also significantly higher than in F344. 

Phrase: "The basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "30 min insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "also significantly higher than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in F344."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]
Processing 00000000.tx.39: The glucose and insulin values in Niddm1c were almost indistinguishable from those in F344, and therefore the differences between Niddm1c and Niddm1e or Niddm1f will be the same as between F344 and Niddm1e or Niddm1f. 

Phrase: "The glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin values in Niddm1c"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "almost indistinguishable from those in F344,"

Phrase: "and"

Phrase: "therefore"

Phrase: "the differences between Niddm1c"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "Niddm1e"

Phrase: "or"

Phrase: "Niddm1f"

Phrase: "will"

Phrase: "be"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as between F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034703:F344 [Mammal]

Phrase: "and"

Phrase: "Niddm1e"

Phrase: "or"

Phrase: "Niddm1f."
Processing 00000000.tx.40: View larger version (34K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.41: Genetic map of the Niddm1 region of rat chromosome 1 and the congenic strains. 

Phrase: "Genetic map of the Niddm1 region of rat chromosome 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0814036:genetic map [Intellectual Product]
           chromosome map
   757   C1424473:MAP-1 [Gene or Genome]
   757   C3258107:Region of origin [Finding]
   739   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   739   C0024779:Map [Manufactured Object]
   739   C0314603:Genetic [Functional Concept]
   739   C1706473:Map [Conceptual Entity]
   716   C0446509:Genital region [Body Location or Region]

Phrase: "and"

Phrase: "the congenic strains."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1516786:Congenic Strain [Animal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]
Processing 00000000.tx.42: The extents of GK-derived genomic intervals are displayed as black bars for the congenic strains: Niddm1b, Niddm1c, Niddmf, Niddm1e and Niddm1g. 

Phrase: "The extents of GK-derived genomic intervals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439792:Extents [Spatial Concept]

Phrase: "are"

Phrase: "displayed as black bars"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0439541:Black [Qualitative Concept]
   770   C0870432:displayed [Functional Concept]
   770   C1707156:BARS [Gene or Genome]
   770   C3274014:BARS [Intellectual Product]
   770   C3541345:BARS [Intellectual Product]
   737 E C1705417:Display [Manufactured Object]

Phrase: "for the congenic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1516786:Congenic Strain [Animal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: ":"

Phrase: "Niddm1b,"

Phrase: "Niddm1c,"

Phrase: "Niddmf,"

Phrase: "Niddm1e"

Phrase: "and"

Phrase: "Niddm1g."
Processing 00000000.tx.43: White bars indicate genomic intervals spanning the crossover points between GK- and F344-derived alleles, as defined by the closest flanking markers. 

Phrase: "White bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "indicate"

Phrase: "genomic intervals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1272706:intervals [Temporal Concept]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the crossover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010366:cross over [Genetic Function]
  1000   C0150097:CROSS-OVER [Research Activity]

Phrase: "points between GK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552961:Point [Quantitative Concept]
   790   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "F344-derived alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "as"

Phrase: "defined by the closest flanking markers."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0230171:flanking [Body Location or Region]
   753   C1522666:Closest [Spatial Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]
   719   C0005516:Marker [Clinical Attribute]
   719 E C0587267:Close [Functional Concept]
Processing 00000000.tx.44: The GK-derived chromosome regions are 28  1 cM in Niddm1b, 23  1 cM in Niddm1c, 7.6  1 cM in Niddm1f, 3.7  2 cM in Niddm1e and 17  2 cM in Niddm1g.  

Phrase: "The GK-derived chromosome regions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   844   C1953345:Chromosome region [Cell]
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "28  1 cM in Niddm1b,"

Phrase: "23  1 cM in Niddm1c,"

Phrase: "7.6  1 cM in Niddm1f,"

Phrase: "3.7  2 cM in Niddm1e"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   814   C0649800:CM 2-3 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "17  2 cM in Niddm1g."
Processing 00000000.tx.45: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.46: Diabetes-associated phenotypes in Niddm1c, Niddm1e, Niddm1f and F344 at age 95 days  Following the IPGTT at 95 days, the animals were treated with a high fat diet to challenge the metabolism further. 

Phrase: "Diabetes-associated phenotypes in Niddm1c,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0031437:Phenotypes [Organism Attribute]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "Niddm1e,"

Phrase: "Niddm1f"

Phrase: "and"

Phrase: "F344 at age 95 days"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034703:F344 [Mammal]

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the IPGTT at 95 days,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C0017741:Glucose tolerance test [Diagnostic Procedure]
   770   C0178665:Glucose tolerance [Physiologic Function]
   770   C0201777:Tolerance test [Laboratory Procedure]
   767   C0337438:glucose test [Laboratory Procedure]
   767   C0595310:GLUCOSE TEST [Medical Device]
   744   C0013220:Tolerance [Finding]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0020963:Tolerance [Pathologic Function]
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0220929:tolerance [Mental Process]
   744   C0231197:Tolerance [Physiologic Function]
   744   C0392366:test [Intellectual Product]
   744   C1704410:Tolerance [Qualitative Concept]

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "treated with a high fat diet"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   833   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   790   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0012155:Diet [Food]
   753   C0205250:High [Qualitative Concept]
   753   C0424612:FAT [Organism Attribute]
   753   C1299351:High [Qualitative Concept]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C2700149:HIGH [Intellectual Product]
   753   C2983588:DIET [Food]
   748 E C0012171:Dietary Fat [Food]
   748 E C1527016:Dietary Fat [Research Activity]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "to challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0798503:Challenge [Clinical Attribute]
  1000   C0805586:Challenge [Health Care Activity]
  1000   C3274764:Challenge [Conceptual Entity]

Phrase: "the metabolism further."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.47: The congenic strains exhibiting a diabetic phenotype at 95 days (Niddm1e and Niddm1f) and F344 control rats were treated with high fat diet from age 120 days and were subjected to an IPGTT at 225 days of age. 

Phrase: "The congenic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1516786:Congenic Strain [Animal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "a diabetic phenotype at 95 days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(Niddm1e"

Phrase: "and"

Phrase: "Niddm1f"

Phrase: ")"

Phrase: "and"

Phrase: "F344 control rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0034703:Rats, F344 [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "treated with high fat diet"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   862   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   806   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   762 E C0012171:Dietary Fat [Food]
   762 E C1527016:Dietary Fat [Research Activity]
   760   C0012155:Diet [Food]
   760   C0205250:High [Qualitative Concept]
   760   C0424612:FAT [Organism Attribute]
   760   C1299351:High [Qualitative Concept]
   760   C1442959:Diet [Organism Function]
   760   C1519433:DIET [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C2700149:HIGH [Intellectual Product]
   760   C2983588:DIET [Food]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "from age 120 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "were"

Phrase: "subjected to an IPGTT"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   814   C0017741:Glucose tolerance test [Diagnostic Procedure]
   778   C0178665:Glucose tolerance [Physiologic Function]
   778   C0201777:Tolerance test [Laboratory Procedure]
   774   C0337438:glucose test [Laboratory Procedure]
   774   C0595310:GLUCOSE TEST [Medical Device]
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0220929:tolerance [Mental Process]
   748   C0231197:Tolerance [Physiologic Function]
   748   C0392366:test [Intellectual Product]
   748   C0442120:Intraperitoneal [Spatial Concept]
   748   C1704410:Tolerance [Qualitative Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "at 225 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.48: Subsequently, basal levels of triglycerides, total cholesterol, high density lipoprotein (HDL) cholesterol and low density lipoprotein (LDL) cholesterol were determined, and the epididymal fat depots were weighed. 

Phrase: "Subsequently,"

Phrase: "basal levels of triglycerides,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   819   C0428475:levels triglycerides [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "total cholesterol,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0201950:Total Cholesterol [Laboratory Procedure]
  1000   C0543421:Total cholesterol [Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "high density lipoprotein (HDL) cholesterol"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0023822:High Density Lipoprotein Cholesterol [Biologically Active Substance,Lipid]
   923   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   902   C1522133:high cholesterol [Finding]
   861   C0065055:lipoprotein cholesterol [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205250:High [Qualitative Concept]
   812   C1299351:High [Qualitative Concept]
   812   C2700149:HIGH [Intellectual Product]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "low density lipoprotein (LDL) cholesterol"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0023824:Low Density Lipoprotein Cholesterol [Biologically Active Substance,Steroid]
   923   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   902   C0860920:Low cholesterol [Finding]
   861   C0065055:lipoprotein cholesterol [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205251:low [Qualitative Concept]
   812   C1299352:Low [Qualitative Concept]
   812   C1550472:low [Idea or Concept]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: ","

Phrase: "and"

Phrase: "the epididymal fat depots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424612:FAT [Organism Attribute]

Phrase: "were"

Phrase: "weighed."
Processing 00000000.tx.49: At 225 days of age, the post-prandial glucose levels were again significantly higher in Niddm1e and Niddm1f compared with F344 (Table 2). 

Phrase: "At 225 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "the post-prandial glucose levels"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "again significantly higher in Niddm1e"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "Niddm1f"

Phrase: "compared with F344"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.50: In comparison with the IPGTT at 95 days (Table 1), the differences in blood glucose were more pronounced at the later time points during the test (Table 2). 

Phrase: "In comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with the IPGTT"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   923   C0017741:Glucose tolerance test [Diagnostic Procedure]
   875   C0337438:glucose test [Laboratory Procedure]
   875   C0595310:GLUCOSE TEST [Medical Device]
   861   C0178665:Glucose tolerance [Physiologic Function]
   861   C0201777:Tolerance test [Laboratory Procedure]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:test [Intellectual Product]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "at 95 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the differences in blood glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced at the later time points"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
   719   C0205087:Late [Temporal Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "during the test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.51: At 90 min after injection, the glucose levels in both congenics were 30% higher than those in F344. 

Phrase: "At 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "after injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "the glucose levels in both congenics"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0428548:glucose levels [Laboratory or Test Result]
   756 E C0337438:glucose level [Laboratory Procedure]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "30% higher than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in F344."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]
Processing 00000000.tx.52: The basal insulin levels were significantly higher in the congenics, whereas the insulin levels after glucose injection were not significantly different between the two congenics and control F344. 

Phrase: "The basal insulin levels"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205112:Basal [Spatial Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher in the congenics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "whereas"

Phrase: "the insulin levels after glucose injection"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   790   C0202098:insulin levels [Laboratory Procedure]
   790   C0428405:insulin levels [Laboratory or Test Result]
   783   C0199782:Insulin injection [Therapeutic or Preventive Procedure]
   783   C0428548:glucose levels [Laboratory or Test Result]
   783   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   767 E C0337438:glucose level [Laboratory Procedure]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not significantly different between the two congenics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "control F344."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034703:F344 [Mammal]
Processing 00000000.tx.53: At 225 days of age, both increased body weight and epididymal fat weight were observed in Niddm1e. 

Phrase: "At 225 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "both increased body weight"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0043094:Increased body weight [Finding]
           Increased weight
   901   C0005910:Body Weight [Organism Attribute]
           weight
   901   C1305866:body weight [Diagnostic Procedure]
           weight
   827   C0043100:Weight [Quantitative Concept]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1705104:Weight [Idea or Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "epididymal fat weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1705104:Weight [Idea or Concept]

Phrase: "were"

Phrase: "observed in Niddm1e."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.54: The only statistically significant difference in lipid levels, compared with F344, was decreased HDL cholesterol in Niddm1e. 

Phrase: "The only statistically significant difference in lipid levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "compared with F344,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "HDL cholesterol in Niddm1e."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0023822:High Density Lipoprotein Cholesterol [Biologically Active Substance,Lipid]
   833   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   790   C0065055:lipoprotein cholesterol [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   783   C1522133:high cholesterol [Finding]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0178587:density [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.55: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.56: Diabetes-associated phenotypes in Niddm1e, Niddm1f and F344 at age 225 days  In Niddm1b, we previously determined insulin-stimulated glucose incorporation into lipids of isolated adipocytes from the epididymal fat depot in male rats (23). 

Phrase: "Diabetes-associated phenotypes in Niddm1e,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0031437:Phenotypes [Organism Attribute]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "Niddm1f"

Phrase: "and"

Phrase: "F344 at age 225 days"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034703:F344 [Mammal]

Phrase: "In Niddm1b,"

Phrase: "we previously determined insulin-stimulated glucose incorporation into lipids of isolated adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0243126:incorporation [Functional Concept]

Phrase: "from the epididymal fat depot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424612:FAT [Organism Attribute]

Phrase: "in male rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.57: The Niddm1b substrains Niddm1e and Niddm1f were subjected to the same test. 

Phrase: "The Niddm1b substrains Niddm1e"

Phrase: "and"

Phrase: "Niddm1f"

Phrase: "were"

Phrase: "subjected to the same test."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0445247:Same [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.58: As in Niddm1b, both basal and maximal insulin-stimulated lipogenesis were reduced in Niddm1e and Niddm1f compared with F344 (Fig. 2). 

Phrase: "As in Niddm1b,"

Phrase: "both basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "maximal insulin-stimulated lipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0596843:lipogenesis [Molecular Function]
   812   C1563744:Lipogenesis [Organism Function]

Phrase: "were"

Phrase: "reduced in Niddm1e"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "Niddm1f"

Phrase: "compared with F344"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.59: Based on the phenotype data, we conclude that the Niddm1b diabetes susceptibility gene(s) is located in the 3.7 cM GK interval of Niddm1e. 

Phrase: "Based on the phenotype data,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   781   C0242356:data base [Intellectual Product]
   781   C0993637:Data Base [Intellectual Product]
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1511726:Data [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3245479:data [Medical Device]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the Niddm1b diabetes susceptibility gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919453:Susceptibility Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "(s) is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "located in the 3.7 cM GK interval of Niddm1e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1272706:Interval [Temporal Concept]
   739   C1552654:Interval [Idea or Concept]
   739   C1552713:Interval [Intellectual Product]
Processing 00000000.tx.60: View larger version (13K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.61: Insulin stimulation of glucose incorporation into lipids (lipogenesis) in adipocytes isolated from epididymal fat. 

Phrase: "Insulin stimulation of glucose incorporation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "into lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "(lipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596843:lipogenesis [Molecular Function]
  1000   C1563744:Lipogenesis [Organism Function]

Phrase: ")"

Phrase: "in adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "isolated from epididymal fat."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0014533:Epididymal [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C0424612:FAT [Organism Attribute]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.62: Adipocytes were isolated from 2-month-old male F344 (n = 6), Niddm1f (n = 5) and Niddm1e rats (n = 4) and incubated with insulin (020 000 U/ml) for 2 h. 

Phrase: "Adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "isolated from 2-month-old male F344"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   748   C0024554:Male [Finding]
   748   C0034703:F344 [Mammal]
   748   C0086582:male [Population Group]
   748   C0205409:Isolated [Functional Concept]
   748   C0439231:month [Temporal Concept]
   748   C0439507:/month [Temporal Concept]
   748   C0580836:Old [Temporal Concept]
   748   C1548221:Isolated [Idea or Concept]
   748   C1706180:Male [Qualitative Concept]
   748   C1706428:Male [Qualitative Concept]
   748   C1706429:Male [Organism Attribute]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Niddm1f"

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Niddm1e rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "incubated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(020 000 U/ml) for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0439340:U/ml [Quantitative Concept]
   778   C1880521:U/mL [Quantitative Concept]
   778   C2945590:U/mL [Quantitative Concept]
   774   C0439391:mL/h [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.63: (a) Lipogenesis in the absence of insulin (basal conditions) was higher in F344 than in Niddm1f (P = 0.0001) and Niddm1e (P = 0.002); 

Phrase: "(a) Lipogenesis in the absence of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0596843:lipogenesis [Molecular Function]
   748   C1563744:Lipogenesis [Organism Function]

Phrase: "(basal conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: ")"

Phrase: "was"

Phrase: "higher in F344"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "than"

Phrase: "in Niddm1f"

Phrase: "(P = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "Niddm1e"

Phrase: "(P = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.64: (b) maximal insulin-induced lipogenesis was higher in F344 than in Niddm1f (P = 0.00001) and Niddm1e (P = 0.003). 

Phrase: "(b) maximal insulin-induced lipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0596843:lipogenesis [Molecular Function]
   804   C1563744:Lipogenesis [Organism Function]

Phrase: "was"

Phrase: "higher in F344"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "than"

Phrase: "in Niddm1f"

Phrase: "(P = 0.00001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "Niddm1e"

Phrase: "(P = 0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.65: Results are shown as means  SEM.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as means  SEM."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.66: DNA sequence and expression analysis of Ide Candidate genes were identified by employing genetic mapping data for human and mouse. 

Phrase: "DNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "expression analysis of Ide Candidate genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   782   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   782   C2717880:Candidate Gene Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "identified by employing genetic mapping data"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   790   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
   773 E C0814036:genetic map [Intellectual Product]
   756   C3641102:Data Origin [Idea or Concept]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0205396:Identified [Qualitative Concept]
   753   C0314603:Genetic [Functional Concept]
   753   C0557351:employing [Finding]
   753   C1283195:Mapping [Activity]
   753   C1511726:Data [Idea or Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C3245479:data [Medical Device]
   719 E C0024779:Map [Manufactured Object]
   719 E C0457083:Employ [Functional Concept]
   719 E C1706473:Map [Conceptual Entity]

Phrase: "for human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.67: Synteny is conserved between the Niddm1 region on rat chromosome 1, human chromosomes 9 and 10 and mouse chromosome 19 (23). 

Phrase: "Synteny"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314656:Synteny [Molecular Function]

Phrase: "is"

Phrase: "conserved between the Niddm1 region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C1417726:NIDDM1 [Gene or Genome]
   760   C1832544:NIDDM1 [Disease or Syndrome]

Phrase: "on rat chromosome 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1514732:Rat-1 [Cell]
   901   C0008651:Chromosome 1 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: "human chromosomes 9"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0008643:Chromosomes, Human [Cell Component]
   884   C0008672:Chromosome 9 [Cell Component]
   827   C0008633:Chromosomes [Cell Component]
   827   C0086418:Human [Human]

Phrase: "and"

Phrase: "10"

Phrase: "and"

Phrase: "mouse chromosome 19"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008661:Chromosome 19 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.68: The most interesting candidate was the gene encoding insulin-degrading enzyme (IDE), mapped to chromosome 10q24 in the human and chromosome 19 in the mouse. 

Phrase: "The most interesting candidate"

Phrase: "was"

Phrase: "the gene encoding insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "mapped to chromosome 10q24"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C0814036:chromosome map [Intellectual Product]
   770   C0008633:Chromosome [Cell Component]
   770   C1520284:10q24 [Cell Component]
   737   C0024779:Map [Manufactured Object]
   737   C1706473:Map [Conceptual Entity]

Phrase: "in the human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "chromosome 19 in the mouse."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0008661:Chromosome 19 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
Processing 00000000.tx.69: The Ide gene was genetically mapped on rat chromosome 1 within the GK interval of Niddm1e (Fig. 1). 

Phrase: "The Ide gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1337112:Insulin Gene [Gene or Genome]
   861   C1333402:Enzyme Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "genetically"

Phrase: "mapped on rat chromosome 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0008651:Chromosome 1 [Cell Component]
   797   C1514732:Rat-1 [Cell]
   781   C0814036:chromosome map [Intellectual Product]
   781   C1424473:MAP-1 [Gene or Genome]
   760   C0008633:Chromosome [Cell Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   726   C0024779:Map [Manufactured Object]
   726   C1706473:Map [Conceptual Entity]

Phrase: "within the GK interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: "of Niddm1e"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.70: To investigate the hypothesis that changes in the IDE protein could explain the phenotype of Niddm1e, the cDNA sequence of IDE was determined in both GK and F344. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that changes in the IDE protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "could"

Phrase: "explain"

Phrase: "the phenotype of Niddm1e,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]

Phrase: "the cDNA sequence of IDE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "determined in both GK"

Phrase: "and"

Phrase: "F344."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]
Processing 00000000.tx.71: Sequencing the complete translated region of the gene revealed three nucleotide differences between GK and F344 in the coding region, one in the 5' end (codon 18) and two in the 3' end (codons 890 and 934). 

Phrase: "Sequencing"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162326:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]

Phrase: "the complete translated region of the gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "three nucleotide differences between GK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "F344 in the coding region,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034703:F344 [Mammal]

Phrase: "one in the 5' end (codon 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "two in the 3' end (codons 890"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205448:Two [Quantitative Concept]

Phrase: "and"

Phrase: "934"

Phrase: ")."
Processing 00000000.tx.72: Two of these resulted in amino acid substitutions, a CACCGC transition at codon 18 (H18R) and a GCGGTG transition at codon 890 (A890V). 

Phrase: "Two of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "resulted in amino acid substitutions,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C1555721:Substitution [Idea or Concept]
   726   C1706204:Substitution [Activity]
   726   C2825142:Result [Finding]

Phrase: "a CACCGC transition at codon 18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0599156:Transition [Cell or Molecular Dysfunction]
   753   C2700061:Transition [Activity]

Phrase: "(H18R"

Phrase: ")"

Phrase: "and"

Phrase: "a GCGGTG transition at codon 890"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0599156:Transition [Cell or Molecular Dysfunction]
   753   C2700061:Transition [Activity]

Phrase: "(A890V"

Phrase: ")."
Processing 00000000.tx.73: The third variant was silent, a transition at codon 934 (GATGAC). 

Phrase: "The third variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "was"

Phrase: "silent,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443304:Silent [Qualitative Concept]
   928 E C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "a transition at codon 934"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0599156:Transition [Cell or Molecular Dysfunction]
   760   C2700061:Transition [Activity]

Phrase: "(GATGAC"

Phrase: ")."
Processing 00000000.tx.74: The presence of the GK allele of Ide in Niddm1e was confirmed by sequencing. 

Phrase: "The presence of the GK allele of Ide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in Niddm1e"

Phrase: "was"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.75: Additionally, the IDE cDNA sequences were determined in 11 other rat strains. 

Phrase: "Additionally,"

Phrase: "the IDE cDNA sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "determined in 11"

Phrase: "other rat strains."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1514734:Rat Strains [Mammal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]
Processing 00000000.tx.76: The A890V variation was unique for GK, whereas H18R was found also in five other strains, and the silent 934 codon variation in 3 of the 11 strains (Table 3). 

Phrase: "The A890V variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "was"

Phrase: "unique for GK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710548:Unique [Qualitative Concept]

Phrase: "whereas"

Phrase: "H18R"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "also in five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205451:Five [Quantitative Concept]

Phrase: "other strains,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0080194:Strains [Injury or Poisoning]
  1000   C0456178:strains [Intellectual Product]
   966 E C1518614:Strain [Organism]
   966 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "the silent 934 codon variation in 3 of the 11 strains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205419:Variation [Qualitative Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.77: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.78: Sequence variants in the Ide gene of various rat strains  To study the effect of the GK variant of IDE, the insulin-degrading activity was determined in an in vitro expression system. 

Phrase: "Sequence variants in the Ide gene of various rat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205419:variants [Qualitative Concept]

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effect of the GK variant of IDE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "the insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "determined in an in vitro expression system."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0021135:In Vitro [Intellectual Product]
   774   C1533691:in vitro [Qualitative Concept]
           vitro
   774   C2827718:In Vitro [Functional Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
Processing 00000000.tx.79: IDE was overexpressed in transfected COS-1 cells, and the ability of living and homogenized cells to hydrolyze insulin was recorded. 

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "was"

Phrase: "overexpressed in transfected COS-1 cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C1257857:COS-1 Cells [Cell]
   790   C0376702:COS-1 [Cell]
           COS Cells
   753   C0007634:Cells [Cell]
   753   C0454802:Cos [Geographic Area]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1514559:overexpress [Genetic Function]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the ability of living"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "homogenized cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "hydrolyze"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.80: Western blot analysis with anti-IDE antibodies confirmed expression of transfected IDE cDNAs (data not shown). 

Phrase: "Western blot analysis with anti-IDE antibodies"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "expression of transfected IDE cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1515563:cDNA Expression [Molecular Biology Research Technique]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.81: The two amino acid variants, H18R and A890V, in the GK allele were studied separately as well as in combination, and compared with the expressed F344 allele. 

Phrase: "The two amino acid variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "H18R"

Phrase: "and"

Phrase: "A890V,"

Phrase: "in the GK allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "separately"

Phrase: "as well as in combination,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205170:Well [Qualitative Concept]
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]
   760   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "compared with the expressed F344 allele."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002085:Allele [Gene or Genome]
   753   C0034703:F344 [Mammal]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.82: The insulin-degrading activity in intact cells transfected with the GK allele, containing both H18R and A890V, was decreased by 31% (P = 0.002) compared with F344 (Fig. 3). 

Phrase: "The insulin-degrading activity in intact cells"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C1145751:insulin activity [Molecular Function]
   757   C0030281:Insulin Cell [Cell]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "transfected with the GK allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "both H18R"

Phrase: "and"

Phrase: "A890V,"

Phrase: "was"

Phrase: "decreased by 31%"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C0450355:31 [Intellectual Product]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P = 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with F344"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.83: However, when the two variants were analyzed separately, no significant decrease in activity of either variant was observed. 

Phrase: "However,"

Phrase: "when"

Phrase: "the two variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "separately,"

Phrase: "no significant decrease in activity of either variant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.84: Thus, the data indicate a synergistic effect of the two amino acid substitutions. 

Phrase: "Thus,"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "a synergistic effect of the two amino acid substitutions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C0680963:substitution effect [Functional Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
   742   C2986495:Synergistic [Qualitative Concept]
Processing 00000000.tx.85: No allele-specific differences were found in enzyme activity analyzed in cell lysates. 

Phrase: "No allele-specific differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "found in enzyme activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0243102:enzyme activity [Molecular Function]
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C0150312:Found [Quantitative Concept]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737 E C0243095:Find [Finding]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "in cell lysates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
Processing 00000000.tx.86: We conclude that Ide is a likely candidate for the diabetes-associated phenotypes in Niddm1e. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a likely candidate for the diabetes-associated phenotypes"

Phrase: "in Niddm1e."
Processing 00000000.tx.87: View larger version (15K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.88: Enzyme activities of IDE variants in transfected intact COS-1 cells. 

Phrase: "Enzyme activities of IDE variants"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0243102:enzyme activity [Molecular Function]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "in transfected intact COS-1 cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   884   C1257857:COS-1 Cells [Cell]
   858   C0682538:intact cell [Cell]
   853   C0376702:COS Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.89: Activities are from COS-1 cells transfected with Ide alleles from GK, F344 and the individual GK variants, A890V and H18R. 

Phrase: "Activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "are from COS-1 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1257857:COS-1 Cells [Cell]
   806   C0376702:COS-1 [Cell]
           COS Cells
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C1551058:Are [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with Ide alleles"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0002085:Alleles [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "from GK,"

Phrase: "F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "and"

Phrase: "the individual GK variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "A890V"

Phrase: "and"

Phrase: "H18R."
Processing 00000000.tx.90: All values are from four separate transfections and are expressed as a percentage of F344 activity, which was defined arbitrarily as 100%. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are from four separate transfections"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]
   760   C0205450:Four [Quantitative Concept]
   760   C0443299:Separate [Spatial Concept]
   760   C1551058:Are [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "expressed as a percentage of F344 activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0034703:F344 [Mammal]
   748   C0205177:Activity [Functional Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "was"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "arbitrarily as 100%."
Processing 00000000.tx.91: Within each experiment, the background COS-1 insulin-degrading activity was subtracted from each individual value, and activities were corrected for the total protein content. 

Phrase: "Within each experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the background COS-1 insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   839   C1145751:insulin activity [Molecular Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1561536:*Activity [Idea or Concept]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "subtracted from each individual value,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0027361:Individual [Population Group]
   760   C0237401:Individual [Human]
   760   C1522609:Value [Quantitative Concept]
   726   C1719767:Subtract [Intellectual Product]
   726   C2348589:Subtract [Phenomenon or Process]

Phrase: "and"

Phrase: "activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "corrected for the total protein content."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   858   C1439363:corrected for total protein [Functional Concept]
   790   C0555903:Total protein [Laboratory Procedure]
   790   C1261360:total protein [Laboratory or Test Result]
   783 E C0439177:Protein.total [Quantitative Concept]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205202:Corrected [Qualitative Concept]
   753   C0423896:Content [Mental Process]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0456205:Content [Conceptual Entity]
   719 E C2349182:Correct [Qualitative Concept]
Processing 00000000.tx.92: Significant differences compared with the F344-allele are indicated: **P = 0.002. 

Phrase: "Significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with the F344-allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0034703:F344 [Mammal]
   760   C1707455:Compared [Activity]

Phrase: "are"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ":"

Phrase: "*"

Phrase: "*P = 0.002."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.93: The actual values (means  SEM) for A890V, H18R and GK are 95  9, 89  8 and 69  6%, respectively.  

Phrase: "The actual values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "SEM) for A890V,"

Phrase: "H18R"

Phrase: "and"

Phrase: "GK"

Phrase: "are"

Phrase: "95  9,"

Phrase: "89  8"

Phrase: "and"

Phrase: "69  6%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "respectively."
Processing 00000000.tx.94: Fine mapping of the diabetes-associated phenotype To support further the notion that IDE affects the diabetes phenotype in GK, a new congenic strain (Niddm1g) was established and characterized (Fig. 1). 

Phrase: "Fine mapping of the diabetes-associated phenotype To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1283195:Mapping [Activity]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the notion"

Phrase: "that IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the diabetes phenotype in GK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]

Phrase: "a new congenic strain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1516786:Congenic Strain [Animal]
   827   C0080194:Strain [Injury or Poisoning]
   827   C0456178:strain [Intellectual Product]
   827   C1518614:Strain [Organism]
   827   C2987481:Strain [Mental Process]

Phrase: "(Niddm1g"

Phrase: ")"

Phrase: "was"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "and"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.95: Niddm1g covered 17 cM of GK alleles and overlapped both Niddm1e and Niddm1f except for 1 cM in which Ide was located. 

Phrase: "Niddm1g"

Phrase: "covered"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439844:Covered [Functional Concept]
  1000   C1999244:Covered [Functional Concept]
   966 E C0180153:cover [Medical Device]
   966 E C1707529:Cover [Medical Device]

Phrase: "17 cM of GK alleles"

Phrase: "and"

Phrase: "overlapped"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0185027:overlapped [Therapeutic or Preventive Procedure]
   966 E C1948020:Overlap [Conceptual Entity]

Phrase: "both Niddm1e"

Phrase: "and"

Phrase: "Niddm1f except for 1 cM"

Phrase: "in which Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "located."
Processing 00000000.tx.96: Thus, Niddm1g was predicted to contain the F344 alleles of Ide, which was confirmed by sequencing. 

Phrase: "Thus,"

Phrase: "Niddm1g"

Phrase: "was"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the F344 alleles of Ide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Alleles [Gene or Genome]

Phrase: "which"

Phrase: "was"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.97: Niddm1g together with Niddm1e and F344 as controls were subjected to an IPGTT. 

Phrase: "Niddm1g together with Niddm1e"

Phrase: "and"

Phrase: "F344 as controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034703:F344 [Mammal]

Phrase: "were"

Phrase: "subjected to an IPGTT."
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   814   C0017741:Glucose tolerance test [Diagnostic Procedure]
   778   C0178665:Glucose tolerance [Physiologic Function]
   778   C0201777:Tolerance test [Laboratory Procedure]
   774   C0337438:glucose test [Laboratory Procedure]
   774   C0595310:GLUCOSE TEST [Medical Device]
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0220929:tolerance [Mental Process]
   748   C0231197:Tolerance [Physiologic Function]
   748   C0392366:test [Intellectual Product]
   748   C0442120:Intraperitoneal [Spatial Concept]
   748   C1704410:Tolerance [Qualitative Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]
Processing 00000000.tx.98: The glucose levels of Niddm1g were not significantly different from those of F344, whereas the glucose levels of Niddm1e were significantly higher than those of Niddm1g as well as F344 (Fig. 4). 

Phrase: "The glucose levels of Niddm1g"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0428548:glucose levels [Laboratory or Test Result]
   773 E C0337438:glucose level [Laboratory Procedure]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not significantly different from those of F344,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "whereas"

Phrase: "the glucose levels of Niddm1e"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0428548:glucose levels [Laboratory or Test Result]
   773 E C0337438:glucose level [Laboratory Procedure]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher than those of Niddm1g"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "as well as"

Phrase: "F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.99: We conclude that the hyperglycemia phenotype is encoded by the GK haplotype in the 1 cM region that differs between Niddm1e and Niddm1g. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the hyperglycemia phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "encoded by the GK haplotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018591:Haplotype [Organism Attribute]
   760   C0679058:encoded [Mental Process]
   760   C2700640:Encoded [Activity]

Phrase: "in the 1 cM region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "differs between Niddm1e"

Phrase: "and"

Phrase: "Niddm1g."
Processing 00000000.tx.100: View larger version (20K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.101: Pathophysiological characterization of the Niddm1g congenic strain. 

Phrase: "Pathophysiological characterization of the Niddm1g congenic strain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]
Processing 00000000.tx.102: Male rats (140 days) from strains Niddm1e (n = 7), Niddm1g (n = 8) and F344 (n = 8) were subjected to IPGTT, and blood glucose levels were determined at the indicated time points. 

Phrase: "Male rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(140 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "from strains Niddm1e"

Phrase: "(n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Niddm1g"

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to IPGTT,"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   833   C0017741:Glucose tolerance test [Diagnostic Procedure]
   790   C0178665:Glucose tolerance [Physiologic Function]
   790   C0201777:Tolerance test [Laboratory Procedure]
   783   C0337438:glucose test [Laboratory Procedure]
   783   C0595310:GLUCOSE TEST [Medical Device]
   753   C0013220:Tolerance [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0020963:Tolerance [Pathologic Function]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0220929:tolerance [Mental Process]
   753   C0231197:Tolerance [Physiologic Function]
   753   C0392366:test [Intellectual Product]
   753   C0442120:Intraperitoneal [Spatial Concept]
   753   C1704410:Tolerance [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "determined at the indicated time points."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C1444656:Indicated [Finding]
   753   C3541383:Time [Temporal Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]
Processing 00000000.tx.103: The glucose levels were higher in Niddm1e than in F344 at 15 min (P = 0.01), 60 min (P = 0.01) and 90 min (P = 0.002). 

Phrase: "The glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "higher in Niddm1e"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "than"

Phrase: "in F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "at 15 min (P = 0.01"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "60 min (P = 0.01"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "90 min (P = 0.002"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0439083:>90 [Quantitative Concept]
   804   C0439087:<90 [Quantitative Concept]
   804   C0702093:/min [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.104: As compared with Niddm1g, the glucose levels in Niddm1e were higher at 60 min (P = 0.03) and 90 min (P = 0.02). 

Phrase: "As"

Phrase: "compared with Niddm1g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "the glucose levels in Niddm1e"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0428548:glucose levels [Laboratory or Test Result]
   773 E C0337438:glucose level [Laboratory Procedure]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "higher at 60 min (P = 0.03"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "90 min (P = 0.02"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0439083:>90 [Quantitative Concept]
   804   C0439087:<90 [Quantitative Concept]
   804   C0702093:/min [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.105: Results are shown as means  SEM.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as means  SEM."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.106: The effect of the GK allele in the 1 cM region was investigated further by assessment of insulin-induced glucose transport in isolated muscle of rats at age 3 months (Niddm1e, Niddm1g and F344). 

Phrase: "The effect of the GK allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in the 1 cM region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "further by assessment of insulin-induced glucose transport"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   770   C0178666:glucose transport [Cell Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205263:Induced [Functional Concept]
   744   C1261322:Assessment [Health Care Activity]
   744   C1317949:Transport [Manufactured Object]
   744   C1516048:Assessment [Activity]
   744   C1517331:Further [Spatial Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C3495449:transport [Medical Device]
   711 E C0205108:far [Spatial Concept]

Phrase: "in isolated muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "at age 3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510828:Age-Months [Organism Attribute]
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "(Niddm1e,"

Phrase: "Niddm1g"

Phrase: "and"

Phrase: "F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: ")."
Processing 00000000.tx.107: Glucose transport was determined in the extensor digitorum longus (EDL) muscle in response to increasing concentrations of insulin. 

Phrase: "Glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "determined in the extensor digitorum longus (EDL) muscle"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0224464:Extensor digitorum longus muscle [Body Part, Organ, or Organ Component]
           Extensor digitorum longus
   814   C1305067:Extensor digitorum longus [Body Part, Organ, or Organ Component]
   804   C0224268:Extensor digitorum muscle [Body Part, Organ, or Organ Component]
           Extensor digitorum
   778   C1304999:Extensor digitorum [Body Part, Organ, or Organ Component]
   774   C0682594:Extensor muscle [Tissue]
   748   C0026845:Muscle [Tissue]
   748   C1184148:Extensor [Body Location or Region]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.108: Compared with both Niddm1g and F344, muscles from Niddm1e had significantly lower insulin-stimulated glucose transport, demonstrating severely reduced insulin action (Fig. 5a). 

Phrase: "Compared with both Niddm1g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "F344,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "muscles from Niddm1e"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026845:Muscles [Tissue]
   790   C1995013:Muscles [Body Part, Organ, or Organ Component]
   706 E C0442025:Muscular [Spatial Concept]

Phrase: "had"

Phrase: "significantly lower insulin-stimulated glucose transport,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0178666:glucose transport [Cell Function]
   799   C0005528:Transport, NOS [Cell Function]
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   799   C1317949:Transport [Manufactured Object]
   799   C3495449:transport [Medical Device]

Phrase: "demonstrating"

Phrase: "severely reduced insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0441472:Action [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C3266814:Action [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 5a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.109: However, the basal glucose transport in Niddm1e muscles was increased by 50% (P = 0.05) compared with F344, indicating that non-insulin-stimulated glucose uptake is increased compensatorily in the muscles of Niddm1e. 

Phrase: "However,"

Phrase: "the basal glucose transport in Niddm1e muscles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0178666:glucose transport [Cell Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1317949:Transport [Manufactured Object]
   748   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "increased by 50%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(P = 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with F344,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "indicating"

Phrase: "that non-insulin-stimulated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1159527:glucose uptake [Cell Function]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "compensatorily in the muscles of Niddm1e."
Processing 00000000.tx.110: No significant difference was observed between F344 and Niddm1g for either basal or insulin-induced glucose transport. 

Phrase: "No significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed between F344"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "Niddm1g for either basal"

Phrase: "or"

Phrase: "insulin-induced glucose transport."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0178666:glucose transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
Processing 00000000.tx.111: View larger version (15K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.112: Glucose transport and insulin degradation in muscle. 

Phrase: "Glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "insulin degradation in muscle."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.113: Insulin-stimulated 3-O-methylglucose transport in isolated EDL muscle and insulin-degrading activities in isolated epitrochlearis muscles of male F344 (n = 6), Niddm1e (n = 6) and Niddm1g (n = 6) rats. 

Phrase: "Insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "3-O-methylglucose transport in isolated EDL muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0005528:Transport, NOS [Cell Function]
   739   C1317949:Transport [Manufactured Object]
   739   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "insulin-degrading activities in isolated epitrochlearis muscles of male F344"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   741   C1145751:insulin activity [Molecular Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0441655:Activities [Activity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   706 E C0205177:Activity [Functional Concept]
   706 E C0439167:% activity [Quantitative Concept]
   706 E C1561536:*Activity [Idea or Concept]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Niddm1e"

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Niddm1g"

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.114: (a) Insulin-stimulated glucose transport is expressed as fold increase over basal. 

Phrase: "(a) Insulin-stimulated glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0178666:glucose transport [Cell Function]
   804   C0005528:Transport, NOS [Cell Function]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C1317949:Transport [Manufactured Object]
   804   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "expressed as fold increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332462:Fold [Spatial Concept]
   770   C0442805:Increase [Functional Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "over basal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]
Processing 00000000.tx.115: The increase in glucose transport was significantly lower in muscle from Niddm1e at an insulin concentration of 0.6 nM (P = 0.04) in comparison with F344. 

Phrase: "The increase in glucose transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "significantly lower in muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "from Niddm1e"

Phrase: "at an insulin concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 0.6 nM (P = 0.04"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with F344."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]
Processing 00000000.tx.116: As compared with Niddm1g, the increase in muscle from Niddm1e was lower at 0.6 nM (P = 0.005) and 2.4 nM (P = 0.04) insulin. 

Phrase: "As"

Phrase: "compared with Niddm1g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "the increase in muscle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "from Niddm1e"

Phrase: "was"

Phrase: "lower at 0.6 nM (P = 0.005"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0441994:Lower [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "2.4 nM (P = 0.04"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.117: Results are shown as means  SEM. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as means  SEM."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.118: (b) Insulin-degrading activity is expressed as a percentage of F344 activity, arbitrarily defined as 100%. 

Phrase: "(b) Insulin-degrading activity"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   875   C1145751:insulin activity [Molecular Function]
   861   C0291665:B-insulin [Amino Acid, Peptide, or Protein]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1561536:*Activity [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "expressed as a percentage of F344 activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0034703:F344 [Mammal]
   748   C0205177:Activity [Functional Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "arbitrarily"

Phrase: "defined as 100%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.119: Activities were corrected for differences in muscle weight. 

Phrase: "Activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "corrected for differences"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205202:Corrected [Qualitative Concept]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   756 E C2349182:Correct [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in muscle weight."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.120: Significant difference compared with F344 are indicated: **P = 0.007. 

Phrase: "Significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with F344"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "are"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ":"

Phrase: "*"

Phrase: "*P = 0.007."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.121: The values for IDE activity in muscle from Niddm1e and Niddm1g are 79  4 and 91  3% (means  SEM), respectively.  

Phrase: "The values for IDE activity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0042295:Values [Qualitative Concept]
   745   C3645543:Active value [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "from Niddm1e"

Phrase: "and"

Phrase: "Niddm1g"

Phrase: "are"

Phrase: "79  4"

Phrase: "and"

Phrase: "91  3%"

Phrase: "(means  SEM"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.122: In isolated muscle from these strains, the insulin-degrading activity was also determined. 

Phrase: "In isolated muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "from these strains,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0080194:Strains [Injury or Poisoning]
  1000   C0456178:strains [Intellectual Product]
   966 E C1518614:Strain [Organism]
   966 E C2987481:Strain [Mental Process]

Phrase: "the insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "also"

Phrase: "determined."
Processing 00000000.tx.123: The epitrochlearis muscles were isolated from Niddm1e, Niddm1g and F344, and the abilities of the muscles to degrade insulin were determined. 

Phrase: "The epitrochlearis muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0026845:Muscles [Tissue]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "isolated from Niddm1e,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "Niddm1g"

Phrase: "and"

Phrase: "F344,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "and"

Phrase: "the abilities of the muscles to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Abilities [Organism Attribute]

Phrase: "degrade"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.124: The insulin-degrading activity in muscle from Niddm1e was significantly reduced by 21% (P = 0.007) compared with F344 (Fig. 5b). 

Phrase: "The insulin-degrading activity in muscle"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1561536:*Activity [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   748   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "from Niddm1e"

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced by 21%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "(P = 0.007"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with F344"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "(Fig. 5b"

Phrase: ")."
Processing 00000000.tx.125: No significant difference was observed between Niddm1g and F344.  

Phrase: "No significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed between Niddm1g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "F344."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]
Processing 00000000.tx.126: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We describe the establishment of congenic substrains for the diabetes susceptibility locus Niddm1b (23), and show that the diabetes phenotype is retained in the new congenic strain Niddm1e that only maintains 3.7 cM of the 28 cM GK region of Niddm1b. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "describe"

Phrase: "the establishment of congenic substrains"

Phrase: "for the diabetes susceptibility locus Niddm1b"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the diabetes phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "retained in the new congenic strain Niddm1e"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1516786:Congenic Strain [Animal]
   748   C0080194:Strain [Injury or Poisoning]
   748   C0205314:New [Temporal Concept]
   748   C0333118:Retained [Functional Concept]
   748   C0456178:strain [Intellectual Product]
   748   C1518614:Strain [Organism]
   748   C2987481:Strain [Mental Process]

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "maintains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "3.7 cM of the 28 cM GK region of Niddm1b."
Processing 00000000.tx.127: Similarly to the parental Niddm1b strain, Niddm1e displayed elevated post-prandial glucose levels, impaired basal and insulin-induced lipogenesis in isolated adipocytes, increased body weight, excess epididymal fat mass and elevated fasting and post-prandial insulin concentrations (Tables 1 and 2). 

Phrase: "Similarly to the parental Niddm1b strain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0030551:Parental [Family Group]
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C1518614:Strain [Organism]
   753   C2987481:Strain [Mental Process]

Phrase: "Niddm1e"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "post-prandial glucose levels,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-induced lipogenesis in isolated adipocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0596843:lipogenesis [Molecular Function]
   753   C1563744:Lipogenesis [Organism Function]

Phrase: "increased body weight,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0043094:Increased body weight [Finding]
           Increased weight
   901   C0005910:Body Weight [Organism Attribute]
           weight
   901   C1305866:body weight [Diagnostic Procedure]
           weight
   827   C0043100:Weight [Quantitative Concept]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1705104:Weight [Idea or Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "excess epididymal fat mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0239277:EPIDIDYMAL MASS [Finding]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "elevated fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015663:Fasting [Finding]
   861   C1550565:fasting [Intellectual Product]
   827 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "post-prandial insulin concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   886   C1546088:post concentration [Clinical Attribute]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(Tables 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.128: To challenge further the metabolism of the animals and to investigate the effects of high fat diet and age on the development of the diabetic phenotype, old rats (225 days) were subjected to an IPGTT after 3.5 months on a high fat diet (Table 2). 

Phrase: "To challenge further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "the metabolism of the animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effects of high fat diet"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "age on the development of the diabetic phenotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0001779:Age [Organism Attribute]
   731   C2733260:Developmental age [Organism Attribute]

Phrase: "old rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(225 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to an IPGTT"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   814   C0017741:Glucose tolerance test [Diagnostic Procedure]
   778   C0178665:Glucose tolerance [Physiologic Function]
   778   C0201777:Tolerance test [Laboratory Procedure]
   774   C0337438:glucose test [Laboratory Procedure]
   774   C0595310:GLUCOSE TEST [Medical Device]
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0220929:tolerance [Mental Process]
   748   C0231197:Tolerance [Physiologic Function]
   748   C0392366:test [Intellectual Product]
   748   C0442120:Intraperitoneal [Spatial Concept]
   748   C1704410:Tolerance [Qualitative Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "after 3.5 months"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1442461:3 Months [Temporal Concept]
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "on a high fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.129: At this age, F344 control rats also showed signs of impaired glucose tolerance. 

Phrase: "At this age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "F344 control rats also"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0034703:Rats, F344 [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "signs of impaired glucose tolerance."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0220912:signs [Functional Concept]
   760   C0220913:signs [Manufactured Object]
   760   C0311392:SIGNS [Finding]
   726 E C1547188:Sign [Idea or Concept]
Processing 00000000.tx.130: The post-prandial glucose levels in F344 were distinctly higher than at 95 days, and glucose levels were not normalized 90 min after glucose injection, as at 95 days. 

Phrase: "The post-prandial glucose levels in F344"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   778   C0428548:glucose levels [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   745 E C0337438:glucose level [Laboratory Procedure]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "distinctly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "at 95 days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "90 min after glucose injection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: "as at 95 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.131: This effect was even more pronounced in the congenic strains (Niddm1e and Niddm1f) that exhibited the most significant difference compared with F344 at the 90 min time point. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "even more"

Phrase: "pronounced in the congenic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1516786:Congenic Strain [Animal]
   760   C0080194:Strains [Injury or Poisoning]
   760   C0456178:strains [Intellectual Product]
   726 E C1518614:Strain [Organism]
   726 E C2987481:Strain [Mental Process]

Phrase: "(Niddm1e"

Phrase: "and"

Phrase: "Niddm1f"

Phrase: ")"

Phrase: "that"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "the most significant difference"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]
   734   C1299394:Most significant [Qualitative Concept]

Phrase: "compared with F344"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "at the 90 min time point."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2348792:Time Point [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.132: We conclude that increasing age and high fat diet significantly aggravated the diabetes-associated phenotypes in Niddm1e compared with F344, demonstrating that Niddm1e carries a diabetes susceptibility gene. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that increasing age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "high fat diet significantly"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   923   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   861   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   812   C0012155:Diet [Food]
   812   C0205250:High [Qualitative Concept]
   812   C0424612:FAT [Organism Attribute]
   812   C1299351:High [Qualitative Concept]
   812   C1442959:Diet [Organism Function]
   812   C1519433:DIET [Therapeutic or Preventive Procedure]
   812   C2700149:HIGH [Intellectual Product]
   812   C2983588:DIET [Food]
   741 E C2699635:DIETARY [Functional Concept]

Phrase: "aggravated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0436331:Aggravated [Finding]
  1000   C1444749:Aggravated [Qualitative Concept]

Phrase: "the diabetes-associated phenotypes in Niddm1e"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0031437:Phenotypes [Organism Attribute]
   719 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "compared with F344,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "demonstrating"

Phrase: "that Niddm1e"

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "a diabetes susceptibility gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0919453:Susceptibility Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.133: As in the parental Niddm1b strain, the phenotype of Niddm1e indicated that the primary defect is in insulin action rather than in insulin secretion. 

Phrase: "As in the parental Niddm1b strain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0030551:Parental [Family Group]
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C1518614:Strain [Organism]
   753   C2987481:Strain [Mental Process]

Phrase: "the phenotype of Niddm1e"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the primary defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is in insulin action"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0441472:Action [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3266814:Action [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "rather than in insulin secretion."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.134: In addition to high blood glucose levels, Niddm1e rats showed both reduced glucose incorporation into lipids in isolated adipocytes (Fig. 2) and blunted insulin-induced glucose transport in muscle (Fig. 5a). 

Phrase: "In addition to high blood glucose levels,"
Meta Candidates (Total=21; Excluded=11; Pruned=0; Remaining=10)
   923   C0020456:HIGH BLOOD GLUCOSE [Disease or Syndrome]
   923   C0428554:blood glucose levels [Laboratory or Test Result]
   875   C0860803:high glucose [Finding]
   861   C0005802:Blood Glucose [Carbohydrate]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0229664:Blood [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "Niddm1e rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "both reduced glucose incorporation into lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243126:incorporation [Functional Concept]

Phrase: "in isolated adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Adipocytes [Cell]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "blunted insulin-induced glucose transport in muscle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0178666:glucose transport [Cell Function]
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1317949:Transport [Manufactured Object]
   748   C3495449:transport [Medical Device]

Phrase: "(Fig. 5a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.135: Also, the basal in vivo hyperinsulinemia at 95 and 225 days indicated insulin resistance (Tables 1 and 2). 

Phrase: "Also,"

Phrase: "the basal in vivo hyperinsulinemia at 95"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "225 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Tables 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.136: At 95 days of age, the insulin levels at 30 min were elevated in Niddm1e compared with F344, indicating a compensatory insulin secretion at the prevailing insulin resistance. 

Phrase: "At 95 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "the insulin levels at 30 min"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0202098:insulin levels [Laboratory Procedure]
   790   C0428405:insulin levels [Laboratory or Test Result]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "elevated in Niddm1e"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "compared with F344,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "indicating"

Phrase: "a compensatory insulin secretion at the prevailing insulin resistance."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1256369:insulin secretion [Cell Function]
   762   C0021655:Insulin Resistance [Pathologic Function]
   762   C2700570:INSULIN RESISTANCE [Gene or Genome]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.137: At 225 days, the insulin levels after glucose injection in Niddm1e were not different compared with F344, despite increased glucose levels, suggesting that insulin secretion defects had developed, probably secondarily to insulin resistance. 

Phrase: "At 225 days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "the insulin levels after glucose injection"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   790   C0202098:insulin levels [Laboratory Procedure]
   790   C0428405:insulin levels [Laboratory or Test Result]
   783   C0199782:Insulin injection [Therapeutic or Preventive Procedure]
   783   C0428548:glucose levels [Laboratory or Test Result]
   783   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   767 E C0337438:glucose level [Laboratory Procedure]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in Niddm1e"

Phrase: "were"

Phrase: "not different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with F344,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034703:F344 [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "despite increased glucose levels,"
Meta Candidates (Total=17; Excluded=10; Pruned=0; Remaining=7)
   966   C0017747:Increased glucose level [Finding]
   901   C0428548:glucose levels [Laboratory or Test Result]
   901   C0860803:increased glucose [Finding]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0205217:Increased [Quantitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C0442805:Increased [Functional Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C1517378:Gain [Quantitative Concept]
   734 E C0439661:Acquired [Temporal Concept]
   734 E C0442808:Increasing [Functional Concept]
   734 E C1301820:Obtain [Functional Concept]
   734 E C1706701:Acquire [Activity]
   734 E C3245488:acquired [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin secretion defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "had"

Phrase: "developed"

Phrase: ","

Phrase: "probably secondarily to insulin resistance."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   762   C0332325:Resistant to [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C0750492:Probably [Idea or Concept]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.138: We thus conclude that the Niddm1b diabetes susceptibility locus is redefined to the 3.7 cM GK region remaining in the Niddm1e strain. 

Phrase: "We thus"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the Niddm1b diabetes susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708726:Locus [Gene or Genome]

Phrase: "is"

Phrase: "redefined to the 3.7 cM GK region remaining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C1527428:Remaining [Qualitative Concept]

Phrase: "in the Niddm1e strain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]
Processing 00000000.tx.139: In the GK-specific 3.7 cM region of Niddm1e, we mapped the Ide gene, an interesting candidate for the diabetes phenotype. 

Phrase: "In the GK-specific 3.7 cM region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0017446:Region [Geographic Area]
   799   C0205147:Region [Spatial Concept]
   727 E C0205276:Regional [Spatial Concept]
   727 E C1947913:Regional [Spatial Concept]

Phrase: "of Niddm1e,"

Phrase: "we"

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: "the Ide gene,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1337112:Insulin Gene [Gene or Genome]
   861   C1333402:Enzyme Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "an interesting candidate for the diabetes phenotype."
Processing 00000000.tx.140: IDE is a Zn2+-requiring metalloproteinase with a distinct Zn2+-binding site (24,25), and it is widely expressed throughout the body (26). 

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "is"

Phrase: "a Zn2+-requiring metalloproteinase with a distinct Zn2+-binding site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(24,"

Phrase: "25"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "widely"

Phrase: "expressed throughout the body"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242821:body [Human]
   770   C0460148:Body [Anatomical Structure]
   770   C1268086:Body [Anatomical Structure]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.141: Several studies support IDE as part of the primary enzymatic mechanism for initiating cellular insulin processing and degradation; 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "IDE as part of the primary enzymatic mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0328104:Ide [Fish]
   744   C1415875:IDE [Gene or Genome]
   744   C2826366:IDE [Idea or Concept]

Phrase: "for initiating cellular insulin processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1158354:insulin processing [Molecular Function]
   812   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: ";"
Processing 00000000.tx.142: it is likely that IDE has an important regulatory role in insulin action (27). 

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "has"

Phrase: "an important regulatory role in insulin action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.143: On binding to its receptor, insulin is internalized into endosomes where insulin degradation is initiated by IDE (28). 

Phrase: "On binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to its receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "internalized into endosomes where insulin degradation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0034850:Endosomes [Cell Component]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "is"

Phrase: "initiated by IDE (28"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0328104:Ide [Fish]
   770   C1415875:IDE [Gene or Genome]
   770   C2826366:IDE [Idea or Concept]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: ")."
Processing 00000000.tx.144: After dissociation, the insulin receptor is recycled to the plasma membrane. 

Phrase: "After dissociation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "recycled to the plasma membrane."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0282114:recycled [Human-caused Phenomenon or Process]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.145: Apart from endosomes, IDE is also present in the cell membrane, in the cytoplasm and in peroxisomes. 

Phrase: "Apart from endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "is"

Phrase: "also"

Phrase: "present in the cell membrane,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0007603:Cell Membrane [Cell Component]
   806   C3161472:Cell Membrane [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0025255:Membrane [Tissue]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1706182:Membrane [Manufactured Object]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and in peroxisomes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0752063:Peroxisomes [Cell Component]
   790   C1515981:And [Idea or Concept]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.146: Several additional peptides interact with IDE, e.g. glucagon, ANP, transforming growth factor- and insulin-like growth factor (IGF) II bind and are readily degraded. 

Phrase: "Several additional peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "interact with IDE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0328104:Ide [Fish]
   790   C1415875:IDE [Gene or Genome]
   790   C2826366:IDE [Idea or Concept]

Phrase: "e.g. glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "ANP,"

Phrase: "transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "insulin-like growth factor (IGF) II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "are"

Phrase: "readily"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.147: In addition, proinsulin, IGF-I and epidermal growth factor bind, but are poorly degraded by IDE (27). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "IGF-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: ","

Phrase: "but"

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "degraded by IDE (27"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0328104:Ide [Fish]
   770   C1415875:IDE [Gene or Genome]
   770   C1881707:DEGRADED [Phenomenon or Process]
   770   C2826366:IDE [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.148: IDE may also be involved in other types of cellular proteolysis and interacts with the proteasome, the major site for intracellular protein degradation (29). 

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "involved in other types of cellular proteolysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0007634:Cellular [Cell]
   748   C0178539:Cellular [Functional Concept]
   748   C0332307:Types [Qualitative Concept]
   748   C0597304:Proteolysis [Molecular Function]
   748   C1314939:Involved [Functional Concept]
   714 E C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "interacts with the proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "the major site for intracellular protein degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.149: Furthermore, IDE may have a regulatory role in steroid action and interacts with the receptors for glucocorticoid and androgen (30). 

Phrase: "Furthermore,"

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "may"

Phrase: "have"

Phrase: "a regulatory role in steroid action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "interacts with the receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "for glucocorticoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoid [Hormone,Steroid]

Phrase: "and"

Phrase: "androgen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002844:Androgen [Hormone,Pharmacologic Substance]
  1000   C3536949:Androgen [Pharmacologic Substance]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.150: The Ide cDNA was sequenced in GK and F344, in search of structural differences in the encoded protein that could mediate the diabetic phenotype in Niddm1e. 

Phrase: "The Ide cDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "sequenced in GK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0004793:Sequence [Nucleotide Sequence]
   756   C0162326:Sequence [Nucleotide Sequence]
   756   C0162327:Sequence [Nucleotide Sequence]
   756   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "F344,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "in search of structural differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "in the encoded protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "could"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the diabetic phenotype in Niddm1e."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.151: Three single nucleotide polymorphisms were identified; 

Phrase: "Three single nucleotide polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ";"
Processing 00000000.tx.152: two of these resulted in amino acid substitutions (H18R and A890V), whereas the third was silent (codon 934). 

Phrase: "two of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "resulted in amino acid substitutions"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C1555721:Substitution [Idea or Concept]
   726   C1706204:Substitution [Activity]
   726   C2825142:Result [Finding]

Phrase: "(H18R"

Phrase: "and"

Phrase: "A890V"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "was"

Phrase: "silent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443304:Silent [Qualitative Concept]
   928 E C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "(codon 934"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: ")."
Processing 00000000.tx.153: The Ide cDNA was sequenced in 11 additional rat strains to investigate the prevalence of the identified variants. 

Phrase: "The Ide cDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "sequenced in 11 additional rat"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1524062:Additional [Functional Concept]
   726   C0004793:Sequence [Nucleotide Sequence]
   726   C0162326:Sequence [Nucleotide Sequence]
   726   C0162327:Sequence [Nucleotide Sequence]
   726   C1519249:Sequence [Functional Concept]

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the prevalence of the identified variants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]
Processing 00000000.tx.154: A890V was unique for GK, whereas H18R and the variant at codon 934 were also present in other strains, supporting the argument that the A890V variant influences the diabetic phenotype in Niddm1e (Table 3). 

Phrase: "A890V"

Phrase: "was"

Phrase: "unique for GK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710548:Unique [Qualitative Concept]

Phrase: "whereas"

Phrase: "H18R"

Phrase: "and"

Phrase: "the variant at codon 934"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "present in other strains,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0080194:Strains [Injury or Poisoning]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C0456178:strains [Intellectual Product]
   737 E C1518614:Strain [Organism]
   737 E C2987481:Strain [Mental Process]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the argument"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680226:argument [Social Behavior]
  1000   C1704769:Argument [Conceptual Entity]

Phrase: "that"

Phrase: "the A890V variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "influences"

Phrase: "the diabetic phenotype in Niddm1e"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.155: Furthermore, A890 is conserved in Ide from rat, human and Drosophila, suggesting that this residue is important for enzymatic activity. 

Phrase: "Furthermore,"

Phrase: "A890"

Phrase: "is"

Phrase: "conserved in Ide"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "Drosophila,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "is"

Phrase: "important for enzymatic activity."
Processing 00000000.tx.156: The substitutions are not in residues that have been shown to be necessary for Zn binding or for catalytic activity (31). 

Phrase: "The substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555721:Substitution [Idea or Concept]
   966   C1706204:Substitution [Activity]

Phrase: "are"

Phrase: "not in residues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1518422:Not [Functional Concept]
   756   C1709915:Residue [Conceptual Entity]
   756   C1882936:RESIDUE [Phenomenon or Process]
   706 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "necessary for Zn binding"

Phrase: "or for catalytic activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0243102:catalytic activity [Molecular Function]
   833   C1264638:Catalytic activity [Functional Concept]
   833   C1547012:*Catalytic Activity [Quantitative Concept]
   770   C0007382:Catalytic [Natural Phenomenon or Process]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.157: However, the residues important for ligand binding are still unknown. 

Phrase: "However,"

Phrase: "the residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "important for ligand binding"

Phrase: "are"

Phrase: "still unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.158: In vitro expression of IDE revealed that the GK allele had a 31% reduced ability to degrade insulin in living cells. 

Phrase: "In vitro expression of IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the GK allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "had"

Phrase: "a 31% reduced ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0085732:Ability [Organism Attribute]
   741 E C1299581:Able [Finding]

Phrase: "degrade"

Phrase: "insulin in living cells."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   802   C0030281:Insulin Cell [Cell]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.159: However, when the H18R and A890V variants were studied separately, no significant effects were observed (Fig. 3). 

Phrase: "However,"

Phrase: "when"

Phrase: "the H18R"

Phrase: "and"

Phrase: "A890V variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "separately,"

Phrase: "no significant effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.160: This indicates that the two variants are interacting (synergism) to mediate the effect on insulin degradation. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the two variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "are"

Phrase: "interacting"

Phrase: "(synergism"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0599739:synergism [Molecular Function]
   928 E C2986495:Synergistic [Qualitative Concept]
   900 E C0920877:Synergist [Organ or Tissue Function]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the effect on insulin degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.161: No effects of the GK variants on insulin degradation were observed in cell lysates of Ide-transfected COS cells, suggesting that the defect in IDE is coupled to receptor-mediated internalization of insulin or other activities that require intact cell structures. 

Phrase: "No effects of the GK variants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1301751:No effect [Qualitative Concept]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in cell lysates of Ide-transfected COS cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   743   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the defect in IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1457869:Defect [Functional Concept]
   770   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is"

Phrase: "coupled to receptor-mediated internalization of insulin"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   800   C3271694:insulin receptor internalization [Phenomenon or Process]
   774   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   774   C0599281:receptor internalization [Phenomenon or Process]
   774   C1334133:INSULIN RECEPTOR [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0871786:internalization [Mental Process]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1948027:Coupled [Functional Concept]
   714 E C0010222:couple [Family Group]

Phrase: "or"

Phrase: "other activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "require"

Phrase: "intact cell structures."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0243092:cell structures [Cell Component]
   901   C0682538:intact cell [Cell]
   867 E C0007634:Cell structure [Cell]
           Cell
   867 E C0935919:cell structure [Qualitative Concept]
   827   C0678594:structures [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.162: These data suggest that Ide is one of the genes contributing to the diabetes phenotype in GK rats and mediates the hyperglycemia and insulin resistance observed in Niddm1e, possibly through an impaired insulin-degrading capacity. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "one of the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "contributing to the diabetes phenotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1880177:Contributing [Activity]

Phrase: "in GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "observed in Niddm1e,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "possibly through an impaired insulin-degrading capacity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0221099:Impaired [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C1516240:Capacity [Quantitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2362652:Possibly [Qualitative Concept]
Processing 00000000.tx.163: This is supported by both genetic and pathophysiological data: (i)Niddm1g overlaps the major part of the GK region in Niddm1e except for 1 cM that includes Ide; 

Phrase: "This"

Phrase: "is"

Phrase: "supported by both genetic"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "and"

Phrase: "pathophysiological data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ":"

Phrase: "(i)Niddm1g"

Phrase: "overlaps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:overlap [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlap [Conceptual Entity]

Phrase: "the major part of the GK region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "in Niddm1e"

Phrase: "except for 1 cM"

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.164: (ii) the normoglycemic Niddm1g strain displayed post-prandial glucose levels indistinguishable from those observed in the F344 control rat (Fig. 4); 

Phrase: "(ii"

Phrase: ")"

Phrase: "the normoglycemic Niddm1g strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0080194:Strain [Injury or Poisoning]
   827   C0456178:strain [Intellectual Product]
   827   C1518614:Strain [Organism]
   827   C2987481:Strain [Mental Process]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "post-prandial glucose levels"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "indistinguishable from those"

Phrase: "observed in the F344 control rat"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0034703:Rat, F344 [Mammal]
           F344
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0243148:control [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.165: and (iii) the insulin-induced glucose transport is severely reduced in muscle from Niddm1e together with a 21% reduced ability to degrade insulin (Fig. 5). 

Phrase: "and ("

Phrase: "iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "the insulin-induced glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0178666:glucose transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "reduced in muscle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026845:Muscle [Tissue]
   790   C0392756:Reduced [Qualitative Concept]
   718 E C0442025:Muscular [Spatial Concept]

Phrase: "from Niddm1e"

Phrase: "together with a 21% reduced ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0085732:Ability [Organism Attribute]
   741 E C1299581:Able [Finding]

Phrase: "degrade"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.166: These phenotypes were not observed in the congenic strain Niddm1g, which carries F344 alleles of Ide. 

Phrase: "These phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031437:Phenotypes [Organism Attribute]
   966 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in the congenic strain Niddm1g,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1516786:Congenic Strain [Animal]
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C1441672:Observed [Functional Concept]
   753   C1518614:Strain [Organism]
   753   C2987481:Strain [Mental Process]

Phrase: "which"

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "F344 alleles of Ide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.167: Thus, the diabetes susceptibility locus is restricted to the 1 cM region that encompasses Ide, and which encodes several phenotypes related to IDE action, most conspicuously the reduced insulin-stimulated transmembrane transport of glucose in muscle. 

Phrase: "Thus,"

Phrase: "the diabetes susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "is"

Phrase: "restricted to the 1 cM region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0443288:Restricted [Functional Concept]

Phrase: "that"

Phrase: "encompasses"

Phrase: "Ide,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "several phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "related to IDE action,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0328104:Ide [Fish]
   770   C0439849:Related [Qualitative Concept]
   770   C0441472:Action [Functional Concept]
   770   C0445223:Related [Finding]
   770   C1415875:IDE [Gene or Genome]
   770   C2826366:IDE [Idea or Concept]
   770   C3266814:Action [Activity]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "most conspicuously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "the reduced insulin-stimulated transmembrane transport of glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1519624:Transmembrane Transport [Cell Function]
   767   C0178666:glucose transport [Cell Function]
   744   C0005528:Transport, NOS [Cell Function]
   744   C1317949:Transport [Manufactured Object]
   744   C3495449:transport [Medical Device]

Phrase: "in muscle."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.168: In this region of the rat genome, 1 cM in the (GK x F344) genetic map corresponds to only 0.5Mb of DNA, as deduced by comparison with the radiation hybrid map (32). 

Phrase: "In this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "of the rat genome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017428:Genome [Gene or Genome]
   861   C2338314:Genome [Conceptual Entity]

Phrase: "1 cM in the (GK x F344"

Phrase: ")"

Phrase: "genetic map"
Meta Candidates (Total=19; Excluded=14; Pruned=0; Remaining=5)
  1000   C0814036:genetic map [Intellectual Product]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0024779:Map [Manufactured Object]
   861   C0314603:Genetic [Functional Concept]
   861   C1706473:Map [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "corresponds"

Phrase: "to only 0.5Mb of DNA,"

Phrase: "as"

Phrase: "deduced by comparison with the radiation hybrid map"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C1253949:Radiation Hybrid Map [Intellectual Product]
   770   C0887811:Radiation Hybrid [Cell]
   744   C0020205:Hybrid [Organism]
   744   C0024779:Map [Manufactured Object]
   744   C0034519:Radiation [Natural Phenomenon or Process]
   744   C0560559:Radiation [Quantitative Concept]
   744   C0851346:Radiation [Natural Phenomenon or Process]
   744   C1522449:Radiation [Therapeutic or Preventive Procedure]
   744   C1524020:Radiation [Therapeutic or Preventive Procedure]
   744   C1524021:Radiation [Research Activity]
   744   C1706473:Map [Conceptual Entity]
   744   C1707455:Comparison [Activity]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.169: Several studies of diabetes in humans have shown decreased insulin clearance and degradation associated with insulin resistance. 

Phrase: "Several studies of diabetes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "insulin clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "associated with insulin resistance."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.170: This was observed in obese hyperinsulinemic individuals and in type 2 diabetes patients (3336), in non-diabetic insulin-resistant individuals (37) and in two different ethnic groups at high risk for diabetes (38,39). 

Phrase: "This"

Phrase: "was"

Phrase: "observed in obese hyperinsulinemic individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0028754:Obese [Disease or Syndrome]
   760   C1441672:Observed [Functional Concept]
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "and in type 2 diabetes patients"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0011860:Type 2 Diabetes [Disease or Syndrome]
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   767   C1550335:Patient type [Classification]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0332307:Type [Qualitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "(3336"

Phrase: ")"

Phrase: ","

Phrase: "in non-diabetic insulin-resistant individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0027361:Individual [Population Group]
   771   C0237401:Individual [Human]

Phrase: "(37"

Phrase: ")"

Phrase: "and in two different ethnic groups"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   756 E C1879937:Ethnic Group [Intellectual Product]
   753   C0205448:Two [Quantitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0680174:ethnic [Finding]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1515981:And [Idea or Concept]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   748   C0682076:ethnic difference [Finding]

Phrase: "at high risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0332167:High Risk [Qualitative Concept]
  1000   C3272283:High Risk [Finding]
   861   C0035647:Risk [Qualitative Concept]
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "for diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.171: In contrast, other studies have demonstrated an increased insulin clearance and degradation associated with diabetes (40,41). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "an increased insulin clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449297:Clearance [Qualitative Concept]
   827   C1382187:Clearance [Clinical Attribute]
   827   C2825073:Clearance [Natural Phenomenon or Process]
   734   C0020459:increased insulin [Disease or Syndrome]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "associated with diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.172: However, increased insulin degradation seems to be associated with insulin deficiency as such and, in both type 2 diabetes patients and in streptozotocin diabetic rats, increased degradation can be restored by insulin treatment (41,42). 

Phrase: "However,"

Phrase: "increased insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
   734   C0020459:increased insulin [Disease or Syndrome]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with insulin deficiency"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0011155:Deficiency [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1623416:deficiency [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "as such"

Phrase: "and"

Phrase: ","

Phrase: "in both type 2 diabetes patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   708   C1320657:type diabetes [Finding]

Phrase: "and in streptozotocin diabetic rats,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   760   C0241863:DIABETIC [Finding]
   760   C1515981:And [Idea or Concept]

Phrase: "increased degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "can"

Phrase: "be"

Phrase: "restored by insulin treatment"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.173: Increased insulin degradation in target tissues could therefore also be a secondary event in diabetes to compensate for impaired insulin secretion. 

Phrase: "Increased insulin degradation in target tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "could"

Phrase: "therefore also"

Phrase: "be"

Phrase: "a secondary event in diabetes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]

Phrase: "compensate for impaired insulin secretion."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0205432:compensate [Qualitative Concept]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.174: Furthermore, genetic linkage has been reported between type 2 diabetes and the distal region of chromosome 10q, close to the Ide gene in humans. 

Phrase: "Furthermore,"

Phrase: "genetic linkage"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
  1000   C0023745:genetic linkage [Molecular Function]
           linkage
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "reported between type 2 diabetes"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   781   C0585733:Report type [Intellectual Product]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1547052:*Type [Quantitative Concept]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "the distal region of chromosome 10q,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1953345:Region of chromosome [Cell]
           Chromosome region
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "close to the Ide gene"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C1333402:Enzyme Gene [Gene or Genome]
   774   C1337112:Insulin Gene [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0587267:Close [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.175: In a Mexican American population, evidence was found for a susceptibility locus on 10q that influenced both type 2 diabetes and age at onset of disease (43). 

Phrase: "In a Mexican American population,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   734   C0025884:Mexican American [Population Group]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "was"

Phrase: "found for a susceptibility locus"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0150312:Found [Quantitative Concept]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]
   760   C1708726:Locus [Gene or Genome]
   726 E C0243095:Find [Finding]

Phrase: "on 10q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520266:10q [Nucleotide Sequence]

Phrase: "that influenced"

Phrase: "both type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "age at onset of disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   797   C0277793:disease onset [Temporal Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.176: Weak linkage to type 2 diabetes was also observed in approximately the same region among Utah Caucasians (44). 

Phrase: "Weak linkage to type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023745:linkage [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "observed in approximately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332232:Approximately [Qualitative Concept]
   790   C1441672:Observed [Functional Concept]

Phrase: "the same region among Utah Caucasians"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.177: Moreover, a locus with suggestive evidence of linkage to leptin levels was found on 10q in French families (45). 

Phrase: "Moreover,"

Phrase: "a locus with suggestive evidence of linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]

Phrase: "to leptin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "found on 10q"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   790   C1520266:10q [Nucleotide Sequence]
   756 E C0243095:Find [Finding]

Phrase: "in French families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.178: Studies on the mechanisms of IDE that ultimately may lead to diabetes are in an early phase. 

Phrase: "Studies on the mechanisms of IDE"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0947630:studies [Laboratory Procedure]
   742   C2698671:MECHANISTIC STUDIES [Regulation or Law]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "that ultimately"

Phrase: "may"

Phrase: "lead to diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "are in an early phase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205390:Phase [Temporal Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.179: Presently, we can only speculate about the biochemical mechanisms through which IDE could mediate the insulin resistance phenotype observed in vivo in Niddm1e rats, in fat cells as well as the blunted insulin-stimulated glucose transport in muscle from Niddm1e. 

Phrase: "Presently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750528:presently [Idea or Concept]

Phrase: "we"

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "speculate about the biochemical mechanisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0678659:biochemical mechanisms [Molecular Function]
   760   C0205474:Biochemical [Functional Concept]
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "through which IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "could"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the insulin resistance phenotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
   734   C0021655:Insulin Resistance [Pathologic Function]
   734   C2700570:INSULIN RESISTANCE [Gene or Genome]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in vivo in Niddm1e rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "in fat cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0206131:Fat Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0424612:FAT [Organism Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as well as"

Phrase: "the blunted insulin-stimulated glucose transport in muscle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0178666:glucose transport [Cell Function]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C1317949:Transport [Manufactured Object]
   744   C3495449:transport [Medical Device]

Phrase: "from Niddm1e."
Processing 00000000.tx.180: However, previous studies of rats and humans have implied that both insulin receptor internalization and receptor recycling defects are associated with insulin resistance and diabetes (36,46,47). 

Phrase: "However,"

Phrase: "previous studies of rats"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "have"

Phrase: "implied"

Phrase: "that"

Phrase: "both insulin receptor internalization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C3271694:insulin receptor internalization [Phenomenon or Process]
   901   C0599281:receptor internalization [Phenomenon or Process]
   827   C0871786:internalization [Mental Process]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "receptor recycling defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]
   734   C0599282:receptor recycling [Cell Function]

Phrase: "are"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(36,"

Phrase: "46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.181: Possibly, a decreased intracellular degradation of insulin bound to its receptor would inhibit receptor-mediated signal transduction, by lowering the number of available receptors on the cell membrane and/or compromising the downstream signaling from the receptor. 

Phrase: "Possibly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "a decreased intracellular degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "bound to its receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332297:bound [Spatial Concept]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "would"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "receptor-mediated signal transduction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034782:Receptor-Mediated Signal Transduction [Cell Function,Molecular Function]
   861   C0037083:Signal Transduction [Cell Function]
   812   C1160185:transduction [Organism Function]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "by lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441994:lowering [Spatial Concept]
  1000   C2003888:Lowering [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "the number of available receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "on the cell membrane"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0007603:Cell Membrane [Cell Component]
  1000   C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1706182:Membrane [Manufactured Object]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and/or"

Phrase: "compromising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: "the downstream signaling from the receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1514762:Receptor Signaling [Molecular Function]
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]
Processing 00000000.tx.182: In addition to an effect on insulin receptor recycling and signaling, reduced IDE activity may also have a diabetogenic effect through its ability to degrade peptides sharing a hydrophobic motif (48), that has similarities to a motif common to amyloid-forming peptides (49). 

Phrase: "In addition to an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin receptor recycling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C3271703:insulin receptor recycling [Cell Function]
   901   C0599282:receptor recycling [Cell Function]
   827   C0282114:Recycling [Human-caused Phenomenon or Process]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]

Phrase: "reduced IDE activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0086439:Reduced Activity [Sign or Symptom]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "also"

Phrase: "have"

Phrase: "a diabetogenic effect through its ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "degrade"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Sharing [Social Behavior]

Phrase: "a hydrophobic motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "(48"

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "has"

Phrase: "similarities to a motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348205:Similarity [Qualitative Concept]

Phrase: "common to amyloid-forming peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.183: This notion may also be important for the susceptibility to diabetes and its complications, i.e. those affecting pancreas, large and small blood vessels and the basal membrane of the glomeruli of the kidney.  

Phrase: "This notion"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "important for the susceptibility"

Phrase: "to diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "its complications,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "those affecting pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "small blood vessels"
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   983   C0225988:small blood vessel [Body Part, Organ, or Organ Component]
           Small vessels, NOS
   913   C1282841:Small vessels [Body Part, Organ, or Organ Component]
   901   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   867 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   867 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   829 E C1558950:VASCULAR [Finding]
   829 E C1801960:Vascular [Qualitative Concept]
   808 E C0005767:Blood [Tissue]
   808 E C0005768:blood [Body Substance]
   808 E C0229664:Blood [Body Substance]
   808 E C0392895:Bloods [Population Group]
   790 E C0333275:Bloody [Qualitative Concept]
   755 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the basal membrane of the glomeruli of the kidney."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0025255:Membrane [Tissue]
   742   C0205112:Basal [Spatial Concept]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.184: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Rat breeding Inbred Fischer-344 rats were purchased from Charles River Laboratories (Wilmington, MA) and maintained by brothersister mating. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Rat breeding Inbred Fischer-344 rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034703:Rats, Inbred Fischer 344 [Mammal]
           Fischer Rats
           Fischer 344
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "purchased from Charles River Laboratories"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0337050:River [Natural Phenomenon or Process]
   760   C0869011:purchased [Activity]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "(Wilmington,"

Phrase: "MA)"

Phrase: "and"

Phrase: "maintained by brothersister mating."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1160186:mating [Cell Function]
   770   C1260875:mating [Organism Function]
   770   C1314677:Maintained [Functional Concept]
   770   C1748461:mating [Cell Function]
   737 E C0024501:Maintain [Activity]
Processing 00000000.tx.185: Rats had free access to tap water and chow and were maintained on a 12 h light and dark cycle (6:0018:00 h). 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "had"

Phrase: "free access to tap water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C2919405:Tap water [Inorganic Chemical,Pharmacologic Substance]
   804   C0034115:Tap [Health Care Activity]
   804   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   804   C0599638:WATER [Substance]
   804   C1550678:Water [Inorganic Chemical]
   733 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "and"

Phrase: "were"

Phrase: "maintained on a 12 h light"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1306462:Light [Functional Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1881376:Light [Qualitative Concept]
   719 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "dark cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511572:Cycle [Temporal Concept]

Phrase: "(6"

Phrase: ":"

Phrase: "0018"

Phrase: ":"

Phrase: "00 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.186: The high fat diet contained 2% cholesterol, 20% olive oil and 0.5% bile acid mixed in standard chow. 

Phrase: "The high fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "2% cholesterol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "20% olive oil"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0069449:olive oil [Lipid,Pharmacologic Substance]
   827   C0028908:Oil [Lipid]
   827   C0228539:Olive [Body Part, Organ, or Organ Component]
   827   C0262254:olive [Body Part, Organ, or Organ Component]
   827   C0349382:Olive [Food]
   827   C1517288:Oil [Food,Lipid]
   771 E C0996956:Olea [Plant]
   755 E C0234925:OILY [Finding]

Phrase: "and"

Phrase: "0.5% bile acid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0005390:Bile acid [Biologically Active Substance,Steroid]
   861   C2917673:Bile Acid [Pharmacologic Substance]
   833 E C0376167:Choleic Acid [Biologically Active Substance,Pharmacologic Substance,Steroid]
   812   C0001128:Acid [Chemical]
   812   C0005388:Bile [Body Substance]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "mixed in standard chow."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205430:Mixed [Functional Concept]
   770   C0324335:chow [Mammal]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.187: Rats were fed the high fat diet from the age of 120 days to killing. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "the high fat diet from the age of 120 days"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   782   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   760   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   739   C0012155:Diet [Food]
   739   C0205250:High [Qualitative Concept]
   739   C0424612:FAT [Organism Attribute]
   739   C1299351:High [Qualitative Concept]
   739   C1442959:Diet [Organism Function]
   739   C1519433:DIET [Therapeutic or Preventive Procedure]
   739   C2700149:HIGH [Intellectual Product]
   739   C2983588:DIET [Food]
   722 E C0012171:Dietary Fat [Food]
   722 E C1527016:Dietary Fat [Research Activity]

Phrase: "to killing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
Processing 00000000.tx.188: The congenic strains were bred by transferring the GK-derived genetic interval onto the F344 strain (23). 

Phrase: "The congenic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1516786:Congenic Strain [Animal]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "were"

Phrase: "bred by transferring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1540850:Transferring [Activity]
   756   C0006159:breed [Organism Function]
   756 E C0040671:Transfer [Mental Process]
   756   C1704650:Breed [Classification]
   756 E C1705822:Transfer [Activity]

Phrase: "the GK-derived genetic interval onto the F344 strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1272706:Interval [Temporal Concept]
   742   C1552654:Interval [Idea or Concept]
   742   C1552713:Interval [Intellectual Product]
   736   C0005605:Birth Interval [Temporal Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.189: The new sublines from Niddm1b (23) were established by backcrossing of Niddm1b rats to F344, and recombinants were identified within the Niddm1b region. 

Phrase: "The new sublines from Niddm1b"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "established by backcrossing of Niddm1b rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0443211:Established [Qualitative Concept]
   753   C0524616:Backcrossing [Organism Function]
   753   C1272684:Established [Qualitative Concept]

Phrase: "to F344,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "and"

Phrase: "recombinants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514798:Recombinants [Organism]

Phrase: "were"

Phrase: "identified within the Niddm1b region."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
Processing 00000000.tx.190: The Niddm1e, Niddm1f, Niddm1c and Niddm1g congenic strains were bred by 12 successive backcrosses to F344 followed by intercrosses to establish homozygous lines. 

Phrase: "The Niddm1e,"

Phrase: "Niddm1f,"

Phrase: "Niddm1c"

Phrase: "and"

Phrase: "Niddm1g congenic strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C1516786:Congenic Strain [Animal]
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]

Phrase: "were"

Phrase: "bred by 12 successive backcrosses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0006159:breed [Organism Function]
   726   C1704650:Breed [Classification]

Phrase: "to F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "followed by intercrosses to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "homozygous lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.191: IPGTT and lipid analysis The IPGTTs were performed in male rats, as previously described (23). 

Phrase: "IPGTT"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   923   C0017741:Glucose tolerance test [Diagnostic Procedure]
   875   C0337438:glucose test [Laboratory Procedure]
   875   C0595310:GLUCOSE TEST [Medical Device]
   861   C0178665:Glucose tolerance [Physiologic Function]
   861   C0201777:Tolerance test [Laboratory Procedure]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:test [Intellectual Product]
   812   C1704410:Tolerance [Qualitative Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "lipid analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "The IPGTTs"

Phrase: "were"

Phrase: "performed in male rats,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0024554:Male [Finding]
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0086582:male [Population Group]
   770   C0884358:Performed [Functional Concept]
   770   C1706180:Male [Qualitative Concept]
   770   C1706428:Male [Qualitative Concept]
   770   C1706429:Male [Organism Attribute]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.192: The serum insulin levels were determined with a rat-specific enzyme-linked immunosorbent assay (ELISA; Mercodia AB, Uppsala, Sweden). 

Phrase: "The serum insulin levels"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   966   C0428357:Serum insulin level [Laboratory Procedure]
           Serum insulin
   966   C1261415:serum insulin level [Laboratory or Test Result]
           serum insulin
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined with a rat-specific enzyme-linked immunosorbent assay"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   762   C2717977:Enzyme Assay [Laboratory Procedure]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0205369:Specific [Qualitative Concept]
   742   C0243073:assay [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1552740:specific [Intellectual Product]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]

Phrase: "(ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "; Mercodia AB,"

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")."
Processing 00000000.tx.193: The insulin values in micrograms per liter obtained from the ELISA analysis were converted to picomoles per liter by multiplying by a factor of 174. 

Phrase: "The insulin values in micrograms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "per liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475211:liter [Quantitative Concept]

Phrase: "obtained from the ELISA analysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0014441:ELISA [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1301820:Obtained [Functional Concept]
   760   C1524024:analysis [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "were"

Phrase: "converted to picomoles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   756   C0439192:picomole [Quantitative Concept]
   706 E C0439284:picomolar [Quantitative Concept]

Phrase: "per liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475211:liter [Quantitative Concept]

Phrase: "by multiplying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719797:Multiply [Functional Concept]
   966   C2911648:Multiply [Quantitative Concept]

Phrase: "by a factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "of 174."
Processing 00000000.tx.194: The serum levels of triglycerides, total cholesterol and HDL cholesterol were determined with Vitros TRIG Slides, Vitros CHOL Slides (Johnson & Johnson Clinical Diagnostics, Rochester, NY) and Liquid N-geneous HDL-c reagent kit (Biomed-RK, Jnkping, Sweden). 

Phrase: "The serum levels of triglycerides,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   824   C0542495:Serum triglyceride levels [Laboratory Procedure]
           Triglycerides - serum
   824   C1287372:Serum triglyceride levels [Laboratory or Test Result]
   797   C0428475:levels triglycerides [Laboratory or Test Result]
   760   C0229671:Serum [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "total cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0201950:Total Cholesterol [Laboratory Procedure]
  1000   C0543421:Total cholesterol [Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "HDL cholesterol"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0023822:High Density Lipoprotein Cholesterol [Biologically Active Substance,Lipid]
   923   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   902   C1522133:high cholesterol [Finding]
   861   C0065055:lipoprotein cholesterol [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205250:High [Qualitative Concept]
   812   C1299351:High [Qualitative Concept]
   812   C2700149:HIGH [Intellectual Product]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "were"

Phrase: "determined with Vitros TRIG Slides,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0202236:TRIG [Laboratory Procedure]
   760   C0444330:slides [Research Device]
   760   C1519533:TRIG [Professional or Occupational Group]
   726 E C1705201:Slide [Manufactured Object]

Phrase: "Vitros CHOL Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0444330:slides [Research Device]
   793 E C1705201:Slide [Manufactured Object]

Phrase: "(Johnson & Johnson Clinical Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0011900:Diagnostic [Finding]
   779   C0348026:Diagnostic [Functional Concept]

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "Liquid N-geneous HDL-c reagent kit (Biomed-RK,"

Phrase: "Jnkping,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")."
Processing 00000000.tx.195: Analysis of lipogenesis Male rats (75 days) were decapitated after carbon dioxide anesthesia, and the epididymal fat depots (12 g) were removed. 

Phrase: "Analysis of lipogenesis Male rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "(75 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "decapitated after carbon dioxide anesthesia,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007012:Carbon Dioxide [Biologically Active Substance,Inorganic Chemical]
   760   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   760   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   760   C0007009:Carbon [Element, Ion, or Isotope]
   760   C0678717:dioxide [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the epididymal fat depots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424612:FAT [Organism Attribute]

Phrase: "(12 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.196: Adipocytes were prepared as described (50). 

Phrase: "Adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "prepared as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.197: Studies of glucose incorporation into lipids (lipogenesis) were performed at a glucose concentration of 1 M, at which glucose transport into the cells is rate limiting (51). 

Phrase: "Studies of glucose incorporation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "into lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "(lipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596843:lipogenesis [Molecular Function]
  1000   C1563744:Lipogenesis [Organism Function]

Phrase: ")"

Phrase: "were"

Phrase: "performed at a glucose concentration of 1 M,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0427743:Glucose concentration [Laboratory Procedure]
   770   C1287281:Glucose concentration [Laboratory or Test Result]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0086045:Concentration [Mental Process]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0884358:Performed [Functional Concept]
   744   C1446561:Concentration [Quantitative Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at which glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "into the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "rate limiting"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0439801:limiting [Functional Concept]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]
   827 E C1549649:Limit [Idea or Concept]
   827 E C2349209:Limit [Conceptual Entity]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.198: The adipocytes were incubated at 2% (v/v) concentration in 0.5 ml of KrebsRinger phosphate buffer containing 40 mg/ml albumin (Sigma, Stockholm, Sweden), 0.2 M [3-3H]glucose (5 x 106 c.p.m.), 1.0 M unlabeled glucose and increasing concentrations of insulin. 

Phrase: "The adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 2%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "(v/v) concentration in 0.5 ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "of KrebsRinger phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "40 mg/ml albumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "0.2"

Phrase: "M ["

Phrase: "3-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(5 x 106 c.p."

Phrase: "m."

Phrase: ")"

Phrase: ","

Phrase: "1.0 M unlabeled glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "increasing concentrations of insulin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.199: The analysis was performed in triplicate at each insulin concentration at 37C for 2 h. 

Phrase: "The analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed in triplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at each insulin concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "at 37C"

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.200: Reactions were terminated by rapid chilling to 4C. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "terminated by rapid chilling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0085593:chilling [Sign or Symptom]
   770   C0439831:Rapid [Qualitative Concept]
   770   C1553404:terminated [Idea or Concept]
   770   C2348570:Terminated [Functional Concept]

Phrase: "to 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.201: Incorporation of glucose into lipids was determined as described (52). 

Phrase: "Incorporation of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243126:incorporation [Functional Concept]

Phrase: "into lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "was"

Phrase: "determined as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.202: Briefly, 45 l of 6.0 M H2SO4 and 4.0 ml of toluene with 2,5-diphenyloxazole were added to each vial, and the vials were left at room temperature overnight before liquid scintillation counting. 

Phrase: "Briefly,"

Phrase: "45 l of 6.0 M H2SO4"

Phrase: "and"

Phrase: "4.0 ml of toluene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "with 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyloxazole"

Phrase: "were"

Phrase: "added to each vial,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0184301:Phial [Medical Device]
   770   C1524062:Added [Functional Concept]
   770   C1533199:Vial [Quantitative Concept]
   770   C1706497:VIAL [Medical Device]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the vials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0184301:vials [Medical Device]
  1000   C1533199:Vials [Quantitative Concept]
   966 E C1706497:VIAL [Medical Device]

Phrase: "were"

Phrase: "left at room temperature overnight"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0205091:Left [Spatial Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C1547703:Room [Spatial Concept]
   760   C1552822:left [Functional Concept]

Phrase: "before liquid scintillation counting."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0036406:Scintillation Counting [Laboratory Procedure]
   827   C0302908:Liquid [Substance]
   827   C0678573:scintillation [Natural Phenomenon or Process]
   827   C1304698:Liquid [Finding]
   827   C1546699:Liquid NOS [Intellectual Product]
   827   C1561501:Liquid NOS [Substance]
   793   C0750480:Count [Activity]
   793   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.203: Lipogenesis was expressed per cell surface area in order to eliminate differences depending solely on adipocyte size (53). 

Phrase: "Lipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596843:lipogenesis [Molecular Function]
  1000   C1563744:Lipogenesis [Organism Function]

Phrase: "was"

Phrase: "expressed per cell surface area"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "eliminate"

Phrase: "differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "depending"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0725813:depend [Medical Device]

Phrase: "solely on adipocyte size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0206131:Adipocyte [Cell]
   770   C0456389:size [Spatial Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.204: The maximal insulin-induced lipogenesis was calculated as the difference between glucose incorporation at maximum minus the incorporation in the absence of insulin. 

Phrase: "The maximal insulin-induced lipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0596843:lipogenesis [Molecular Function]
   812   C1563744:Lipogenesis [Organism Function]

Phrase: "was"

Phrase: "calculated as the difference"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between glucose incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: "at maximum"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0806909:Maximum [Quantitative Concept]
  1000   C1552615:maximum [Quantitative Concept]
  1000   C2826546:MAXIMUM [Quantitative Concept]
   928 E C0205289:Maximal [Qualitative Concept]

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the incorporation in the absence of insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.205: Genotype analysis and localization of markers Rats were genotyped by PCR amplification of microsatellite markers essentially as previously described (54), with the exception that [-33P]ATP was used to label one of the primers in each pair. 

Phrase: "Genotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "localization of markers Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "were"

Phrase: "genotyped by PCR amplification of microsatellite markers essentially"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1519302:Microsatellite Markers [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           Microsatellite
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0677874:pCR [Finding]
   744   C1517480:Amplification [Molecular Biology Research Technique]
   744   C1521871:Amplification [Phenomenon or Process]
   744   C1705759:Amplification [Cell or Molecular Dysfunction]
   711   C0005516:Marker [Clinical Attribute]
   711   C0017431:Genotype [Organism Attribute]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(54"

Phrase: ")"

Phrase: ","

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "that"

Phrase: "[-33P"

Phrase: "]ATP"

Phrase: "was"

Phrase: "used to label one of the primers"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   757   C1524063:Use of [Functional Concept]
   748   C0181496:Label [Manufactured Object]
   748   C0205447:One [Quantitative Concept]
   748   C1273517:used [Finding]
   748   C2827499:Label [Governmental or Regulatory Activity]
   714 E C0042153:use [Functional Concept]
   714   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "in each pair."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.206: For the genetic mapping of new markers, the 45 rats with the most extreme glucose values from our first F2 cross were genotyped (13), and markers were placed on the genetic map by employing the computer package Mapmaker/exp 3.0 (55). 

Phrase: "For the genetic mapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1283195:Mapping [Activity]

Phrase: "of new markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "the 45 rats with the most extreme glucose values"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]

Phrase: "from our first F2 cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828360:Cross [Conceptual Entity]

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "placed on the genetic map"
Meta Candidates (Total=17; Excluded=7; Pruned=0; Remaining=10)
   806   C0814036:genetic map [Intellectual Product]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0024779:Map [Manufactured Object]
   760   C0314603:Genetic [Functional Concept]
   760   C1706473:Map [Conceptual Entity]
   753   C0032040:Birth Place [Finding]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "by employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "the computer package Mapmaker/exp 3.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0009622:Computer [Manufactured Object]
   799   C0013194:Package [Medical Device]
   799   C1417055:EXP [Gene or Genome]
   799   C2700580:Package [Manufactured Object]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.207: Genetic mapping of Ide The Ide probe for hybridization was synthesised by RTPCR, using available rat cDNA sequences and gene-specific primers (56). 

Phrase: "Genetic mapping of Ide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1283195:Mapping [Activity]

Phrase: "The Ide probe for hybridization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0182400:Probe [Medical Device]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "synthesised by RTPCR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "available rat cDNA sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "gene-specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.208: For the reverse transcriptase reaction, total RNA was prepared from the whole body of a 1-day-old rat, as previously described (57). 

Phrase: "For the reverse transcriptase reaction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared from the whole body of a 1-day-old rat,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   756   C0444584:Whole body [Anatomical Structure]
   756   C1546549:Whole body [Intellectual Product]
   756   C1550677:Whole body [Body Substance]
   754   C1514732:Rat-1 [Cell]
   738   C0034693:Rat, NOS [Mammal]
   738   C0034721:Rat [Mammal]
   738   C0242821:body [Human]
   738   C0332173:/day [Temporal Concept]
   738   C0439228:day [Temporal Concept]
   738   C0439505:/day [Temporal Concept]
   738   C0444667:Whole [Quantitative Concept]
   738   C0460148:Body [Anatomical Structure]
   738   C0580836:Old [Temporal Concept]
   738   C1268086:Body [Anatomical Structure]
   704   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.209: A 6 g aliquot of RNA was transcribed in a total volume of 20 l using BRL Superscript II (Life Technologies, Tby, Sweden), as described by the manufacturer. 

Phrase: "A 6 g aliquot of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "transcribed in a total volume of 20 l"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0449468:Total Volume [Quantitative Concept]
           *Volume
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BRL Superscript II"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Tby,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1705426:Manufacturer [Population Group]
Processing 00000000.tx.210: Ide mRNA was reverse transcribed with primer 5'-AGCTGGTGGACAAACAGGAG-3', and 2 l of the reverse transcriptase reaction was introduced in the subsequent PCR amplification (primers: 5'-GTGAACCTGCTGATTAACTAAG-3' and 5'-AGCTGGTGGACAAACAGGAG-3'; 

Phrase: "Ide mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed with primer 5'-AGCTGGTGGACAAACAGGAG-3',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "2 l of the reverse transcriptase reaction"

Phrase: "was"

Phrase: "introduced in the subsequent PCR amplification"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0332282:Subsequent [Temporal Concept]
   753   C0677874:pCR [Finding]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]
   719   C1292748:introduce [Functional Concept]

Phrase: "(primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "5'-GTGAACCTGCTGATTAACTAAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-AGCTGGTGGACAAACAGGAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.211: PCR-profile: 94C for 4 min, 30 cycles consisting of 94C for 30 s, 55C for 1 min, 72C for 2 min, and a final extension for 7 min at 72C). 

Phrase: "PCR-profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: ":"

Phrase: "94C for 4 min,"

Phrase: "30 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "consisting of 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "for 30 s,"

Phrase: "55C for 1 min,"

Phrase: "72C for 2 min,"

Phrase: "and"

Phrase: "a final extension for 7 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231448:Extension [Functional Concept]
   753   C1880641:Extension [Conceptual Entity]

Phrase: "at 72C"

Phrase: ")."
Processing 00000000.tx.212: The Southern blot analysis was performed as described (58). 

Phrase: "The Southern blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
  1000   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1710133:Southern [Spatial Concept]

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.213: High molecular weight DNA was extracted from rat liver, and genomic DNA (10 g) was digested with the restriction endonuclease, size fractionated in 0.8% agarose gels and transferred to nylon membranes (Zeta-probe; Bio-Rad, Hercules, CA). 

Phrase: "High molecular weight DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "was"

Phrase: "extracted from rat liver,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   802   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "genomic DNA (10 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "digested with the restriction endonuclease,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0012906:Restriction Endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0443288:Restriction [Functional Concept]
   760   C0868946:digested [Physiologic Function]

Phrase: "size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "fractionated in 0.8% agarose gels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C1979893:Fractionated [Qualitative Concept]
   719 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred to nylon membranes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025255:Membranes [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0740034:Nylon [Biomedical or Dental Material]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(Zeta-probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "; Bio-Rad,"

Phrase: "Hercules,"

Phrase: "CA)."
Processing 00000000.tx.214: The restriction fragment length polymorphism (RFLP) probes were 32P-labeled by random priming (59). 

Phrase: "The restriction fragment length polymorphism (RFLP) probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0182400:Probes [Medical Device]
   771   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   771 E C1704681:Probe [Gene or Genome]
   771 E C2347609:Probe [Chemical Viewed Functionally]
   771 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "32P-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "labeled by random priming"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0034656:RANDOM [Research Activity]
   770   C0439605:Random [Qualitative Concept]
   770   C0871133:Priming [Functional Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.215: An HincII RFLP was identified that generated fragments of 2.7 kb in GK and 0.7 kb in F344. 

Phrase: "An HincII RFLP"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   937   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   804   C0032529:Polymorphism [Genetic Function]
   804   C0332255:fragment [Functional Concept]
   804   C0443288:Restriction [Functional Concept]
   804   C1444754:Length [Quantitative Concept]
   804   C1706316:LENGTH [Research Activity]
   804   C1708096:Fragment [Qualitative Concept]
   804   C1882417:Polymorphism [Qualitative Concept]
   733 E C0205166:Long [Qualitative Concept]
   733 E C1522425:Longest [Qualitative Concept]
   733 E C1706317:Long [Qualitative Concept]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that generated fragments of 2.7 kb"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "in GK"

Phrase: "and"

Phrase: "0.7 kb in F344."
Processing 00000000.tx.216: Sequencing of rat IDE cDNA A 3128 bp rat Ide cDNA fragment, amplified by RTPCR with gene-specific primers, was sequenced. 

Phrase: "Sequencing of rat IDE cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]

Phrase: "A 3128 bp rat Ide cDNA fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332255:fragment [Functional Concept]
   793   C1708096:Fragment [Qualitative Concept]

Phrase: "amplified by RTPCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "with gene-specific primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.217: A 6 g aliquot of total RNA prepared from rat liver was used in the 20 l reverse transcriptase reaction with cDNA primer 5'-CTGTTTGTCTCTCTAATTGC-3'. 

Phrase: "A 6 g aliquot of total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510844:Aliquot [Quantitative Concept]

Phrase: "prepared from rat liver"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   737   C1521827:Prepare [Functional Concept]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "used in the 20 l reverse transcriptase reaction"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1273517:used [Finding]
   744   C1555029:Reverse [Idea or Concept]
   744   C2257077:transcriptase [Genetic Function]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "with cDNA primer 5'-CTGTTTGTCTCTCTAATTGC-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.218: A 2 l aliquot of the reverse transcriptase reaction was introduced in the PCR, using Expand Long Template PCR System (Boehringer Mannheim, Mannheim, Germany) as described by the manufacturer (PCR primers: 5'-ATGCGGAACGGGCTCGTGTG-3' and 5'-AGCCAGAAACTACTCAAAGC-3'; 

Phrase: "A 2 l aliquot of the reverse transcriptase reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "introduced in the PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   737   C1292748:introduce [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "Long Template PCR System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Boehringer Mannheim,"

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "as"

Phrase: "described by the manufacturer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1705426:Manufacturer [Population Group]

Phrase: "(PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "5'-ATGCGGAACGGGCTCGTGTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-AGCCAGAAACTACTCAAAGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.219: PCR profile: 94C for 2min, 30 cycles consisting of 94C for 10 s, 54C for 30 s, 68C for 2.5 min, of which the last 20 cycles were elongated for 20 s at 68C for each cycle, and a final extension for 7 min at 68C). 

Phrase: "PCR profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: ":"

Phrase: "94C for 2min,"

Phrase: "30 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "consisting of 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "for 10 s,"

Phrase: "54C for 30 s,"

Phrase: "68C for 2.5 min, of which"

Phrase: "the last 20 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1511572:Cycle [Temporal Concept]

Phrase: "were"

Phrase: "elongated for 20 s"

Phrase: "at 68C"

Phrase: "for each cycle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "a final extension for 7 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231448:Extension [Functional Concept]
   753   C1880641:Extension [Conceptual Entity]

Phrase: "at 68C"

Phrase: ")."
Processing 00000000.tx.220: The DNA sequences of the RTPCR products were determined using an ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction kit and Ide-specific primers in an ABI PRISM 377 semi-automatic sequencer (Applied Biosystems, Foster City, CA). 

Phrase: "The DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sequences of the RTPCR products"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C1514468:Products [Entity]
   760   C1519249:Sequence [Functional Concept]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0812225:KIT [Medical Device]
   791   C1150635:KIT [Molecular Function]
   791   C1705212:Kit [Medical Device]
   791   C1705213:KIT [Medical Device]
   791   C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "Ide-specific primers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "in an ABI PRISM 377 semi-automatic sequencer"

Phrase: "(Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.221: Plasmid construction and COS-1 cell transfections Ide mRNA from GK and F344 was amplified by RTPCR essentially as described above with primers extended with restriction sites. 

Phrase: "Plasmid construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "COS-1 cell transfections Ide mRNA from GK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: "was"

Phrase: "amplified by RTPCR essentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "as"

Phrase: "described above with primers"

Phrase: "extended with restriction sites."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   799   C1882940:Restriction Site [Nucleotide Sequence]
   770   C0205145:Sites [Spatial Concept]
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]
   770   C0443288:Restriction [Functional Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.222: The resulting 3.1 kb cDNA product containing the complete translated region was ligated into the BglII and MluI restriction sites of the expression vector pCMV4 (D.W. Russel, University of Texas Southwestern Medical Center, Houston, TX) under control of the strong cytomegalovirus promotor. 

Phrase: "The resulting 3.1 kb cDNA product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1514468:product [Entity]
   799   C1704444:Product [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the complete translated region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "ligated into the BglII"

Phrase: "and"

Phrase: "MluI restriction sites of the expression vector pCMV4"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   754   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   744   C0443288:Restriction [Functional Concept]
   737   C1882940:Restriction Site [Nucleotide Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "(D.W. Russel,"

Phrase: "University of Texas Southwestern Medical Center,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   904   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   799   C0039711:Texas [Geographic Area]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]
   799   C1710136:Southwestern [Spatial Concept]

Phrase: "Houston,"

Phrase: "TX) under control of the strong cytomegalovirus promotor."
Processing 00000000.tx.223: The Ide cDNA inserts in the resulting constructs pCMV4-Ide(GK) and pCMV4-Ide(F344) were sequenced to exclude PCR artifacts. 

Phrase: "The Ide cDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "inserts in the resulting constructs pCMV4-Ide"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   790   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   762   C0332294:Resulting in [Functional Concept]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0441587:Insert [Health Care Activity]
   742   C0678226:resulting [Functional Concept]
   742   C0813036:Inserts [Medical Device]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1743766:Insert [Medical Device]
   742   C1883719:Insert [Functional Concept]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]
   708   C2827421:Construct [Classification]

Phrase: "(GK)"

Phrase: "and"

Phrase: "pCMV4-Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(F344"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034703:F344 [Mammal]

Phrase: ")"

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "PCR artifacts."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0085089:Artifacts [Human-caused Phenomenon or Process]
   861   C0699801:artifacts [Manufactured Object]
   827 E C1879740:ARTIFACT [Phenomenon or Process]
Processing 00000000.tx.224: Internal restriction sites were used to separate the GK sequence variants generating pCMV4-Ide(H18R) and pCMV4-Ide(A890V). 

Phrase: "Internal restriction sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "the GK sequence variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "generating"

Phrase: "pCMV4-Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(H18R"

Phrase: ")"

Phrase: "and"

Phrase: "pCMV4-Ide"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(A890V"

Phrase: ")."
Processing 00000000.tx.225: Approximately 6 x 106 COS-1 cells were transiently transfected by electoporation (Gene Pulser; Bio-Rad, Richmond, CA; 1200 V, 25 F) with 10 g of pCMV4-Ide plasmid together with 1 g of the -galactosidase vector pCH110 (Pharmacia, Uppsala, Sweden). 

Phrase: "Approximately 6 x 106 COS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   845   C1257857:COS-1 Cells [Cell]
   829   C0376702:COS Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected by electoporation"

Phrase: "(Gene Pulser"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709772:Pulser [Medical Device]

Phrase: "; Bio-Rad,"

Phrase: "Richmond,"

Phrase: "CA"

Phrase: "; 1200 V,"

Phrase: "25 F) with 10 g of pCMV4-Ide plasmid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0015435:F Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   738   C0439133:(f) [Intellectual Product]
   738   C1553038:[f] [Quantitative Concept]

Phrase: "together with 1 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of the -galactosidase vector pCH110"

Phrase: "(Pharmacia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")."
Processing 00000000.tx.226: Assay of insulin-degrading activity in COS-1 cells. 

Phrase: "Assay of insulin-degrading activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "in COS-1 cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.227: Transfected COS-1 cells were seeded in 6 cm Petri dishes and incubated for 36 h in Dulbeccos modified Eagles medium (DMEM) supplied with 10% calf serum. 

Phrase: "Transfected COS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C1257857:COS-1 Cells [Cell]
   875   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in 6 cm Petri dishes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C1322960:Petri dish [Medical Device]
   719   C0020498:DISH [Disease or Syndrome]
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]

Phrase: "and"

Phrase: "incubated for 36 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in Dulbeccos modified Eagles medium (DMEM)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   804   C0009458:Medium [Intellectual Product]
   804   C0150312:In [Quantitative Concept]
   804   C0325564:Eagles [Bird]
   804   C0332285:In [Spatial Concept]
   804   C0392747:Modified [Functional Concept]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C3244283:medium [Intellectual Product]
   771 E C1551720:Eagle [Population Group]

Phrase: "supplied with 10% calf serum."
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   760   C0229671:Serum [Body Substance]
   760   C0230445:Calf [Body Location or Region]
   760   C1305418:Calf [Body Part, Organ, or Organ Component]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1999230:Supplied [Activity]
   726 E C0243163:supply [Idea or Concept]
   726 E C0699914:supply [Quantitative Concept]
   726 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   726 E C1561604:supply [Functional Concept]
   726 E C1875802:SUPPLY [Medical Device]
   704 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.228: Subsequently, the cells were washed twice in phosphate-buffered saline (PBS), pre-incubated at 37C in 3 ml of DMEM supplemented with 1mg/ml bovine serum albumin (BSA) for 30 min, and finally incubated in 2 ml of DMEM containing 1 mg/ml BSA and 15000 c.p.m./ml of [125I]insulin. 

Phrase: "Subsequently,"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in phosphate-buffered saline (PBS),"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "pre-incubated at 37C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332152:Pre [Temporal Concept]
   770   C0740175:Pre [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2257086:PRE [Genetic Function]

Phrase: "in 3 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of DMEM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0009458:Medium [Intellectual Product]
   804   C0325564:Eagles [Bird]
   804   C0332285:Of [Spatial Concept]
   804   C0392747:Modified [Functional Concept]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C3244283:medium [Intellectual Product]
   771 E C1551720:Eagle [Population Group]

Phrase: "supplemented with 1mg/ml bovine serum albumin (BSA)"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   814   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   778   C0728877:serum albumin [Laboratory or Test Result]
   774 E C0523465:Albumin - serum [Laboratory Procedure]
   748   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007452:Bovine [Mammal]
   748   C0229671:Serum [Body Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C1140701:bovine [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "finally"

Phrase: "incubated in 2 ml of DMEM"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0009458:Medium [Intellectual Product]
   742   C0325564:Eagles [Bird]
   742   C0392747:Modified [Functional Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1705217:Medium [Substance]
   742   C3244283:medium [Intellectual Product]
   708 E C1551720:Eagle [Population Group]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mg/ml BSA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   827   C0728877:serum albumin [Laboratory or Test Result]
   799   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0007452:Bovine [Mammal]
   799   C0229671:Serum [Body Substance]
   799   C1140701:bovine [Mammal]
   799   C1546774:Serum [Intellectual Product]
   799   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "15000 c.p."

Phrase: "m./"

Phrase: "ml of [125I"

Phrase: "]insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.229: Triplicate aliquots of 100 l were removed at 30, 45 and 60 min after addition of insulin. 

Phrase: "Triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "aliquots of 100 l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "removed at 30,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "45"

Phrase: "and"

Phrase: "60 min after addition of insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]
Processing 00000000.tx.230: Undegraded insulin was precipitated for 30 min on ice with 1vol of 25% trichloroacetic acid (TCA). 

Phrase: "Undegraded insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "precipitated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "with 1vol"

Phrase: "of 25% trichloroacetic acid (TCA)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.231: The samples were centrifuged at 20 000 g for 20 min, the supernatant recovered, and the amount of degraded insulin measured by radioactive counting. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 20 000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: ","

Phrase: "and"

Phrase: "the amount of degraded insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "measured by radioactive counting."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0034553:radioactive [Natural Phenomenon or Process]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.232: Cells were washed twice further with PBS, incubated for 2 h in DMEM, trypsinized and washed three times in PBS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice further with PBS,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C1517331:Further [Spatial Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]
   719 E C0205108:far [Spatial Concept]

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in DMEM,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   804   C0009458:Medium [Intellectual Product]
   804   C0150312:In [Quantitative Concept]
   804   C0325564:Eagles [Bird]
   804   C0332285:In [Spatial Concept]
   804   C0392747:Modified [Functional Concept]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C3244283:medium [Intellectual Product]
   771 E C1551720:Eagle [Population Group]

Phrase: "trypsinized"

Phrase: "and"

Phrase: "washed three times in PBS."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.233: The cells (~3 x 106 cells per plate) were recovered for homogenization by sonication for 15 s in 300 l of 100 mM phosphate buffer (pH 7.4) containing 0.5 mg/ml BSA. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(~3 x 106 cells per plate"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C1166718:cells plate [Cell Component]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "recovered for homogenization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0521108:recovered [Qualitative Concept]
   756 E C2004454:recover [Organism Function]

Phrase: "by sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037680:Sonication [Research Activity]

Phrase: "for 15 s"

Phrase: "in 300 l"

Phrase: "of 100 mM phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5 mg/ml BSA."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   818   C0728877:serum albumin [Laboratory or Test Result]
   795   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0007452:Bovine [Mammal]
   795   C0229671:Serum [Body Substance]
   795   C1140701:bovine [Mammal]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]
Processing 00000000.tx.234: The homogenate was centrifuged at 350 g for 10 min, and the supernatant was collected for measurement of insulin degradation activity, protein concentration, -galactosidase activity (verifying the reproducibility of transformation efficiency) and western blot analysis. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged at 350 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439267:g% [Quantitative Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "collected for measurement of insulin degradation activity,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C3547574:insulin degradation [Molecular Function]
   774   C0202098:Insulin measurement [Laboratory Procedure]
   774   C1145751:insulin activity [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0242485:Measurement [Functional Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0699900:Degradation [Organism Function]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1561536:*Activity [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "protein concentration, -"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "galactosidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150051:galactosidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "verifying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1553511:Verifying [Intellectual Product]
   966 E C1711411:Verify [Functional Concept]

Phrase: "the reproducibility of transformation efficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514863:Reproducibility [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.235: Triplicate aliquots of cell lysates containing 1 g of protein were incubated for 15 min at 37C in 100 l of assay buffer containing 2000 c.p.m. of [125I]insulin, and the amount of degraded insulin was measured as described above. 

Phrase: "Triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "aliquots of cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 g of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   819   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   770   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "incubated for 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "in 100 l"

Phrase: "of assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2000 c.p.m. of [125I"

Phrase: "]insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the amount of degraded insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "measured as described above."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0444706:Measured [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.236: In all experiments, background COS-1 insulin-degrading activity (in cells transfected with pCMV plasmid) was 2025% of that in cells expressing F344 rat IDE. 

Phrase: "In all experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "background COS-1 insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   839   C1145751:insulin activity [Molecular Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1561536:*Activity [Idea or Concept]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with pCMV plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "was"

Phrase: "2025% of that"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "F344 rat IDE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0328104:Ide [Fish]
   827   C1415875:IDE [Gene or Genome]
   827   C2826366:IDE [Idea or Concept]
   734   C0034703:Rat, F344 [Mammal]
Processing 00000000.tx.237: The IDE protein was detected by immunoblotting according to standard procedures using IDE antibodies kindly provided by Dr M.R. 

Phrase: "The IDE protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected by immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "according to standard procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "IDE antibodies kindly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "provided by Dr"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.238: Rosner (University of Chicago, Chicago, IL). 

Phrase: "Rosner"

Phrase: "(University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.239: Muscle preparation Male rats (3 months old) were anesthetized with an intraperitoneal injection of pentobarbital sodium (5 mg/100 g body wt). 

Phrase: "Muscle preparation Male rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "(3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "old)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "were"

Phrase: "anesthetized with an intraperitoneal injection of pentobarbital sodium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   789   C0310165:SODIUM PENTOBARBITAL INJECTION [Clinical Drug]
   770   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   770   C0700349:Pentobarbital Sodium [Organic Chemical,Pharmacologic Substance]
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0442120:Intraperitoneal [Spatial Concept]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1720436:Anesthetized [Finding]
   744   C1828121:Injection [Functional Concept]

Phrase: "(5 mg/100 g body"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C0333746:MG body [Finding]
   804   C0242821:body [Human]
   804   C0460148:Body [Anatomical Structure]
   804   C1268086:Body [Anatomical Structure]
   721 E C1995017:Bodies [Cell Component]

Phrase: "wt)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]
Processing 00000000.tx.240: Isolated EDL and epitrochlearis muscles were incubated in vitro. 

Phrase: "Isolated EDL"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0224464:Extensor digitorum longus [Body Part, Organ, or Organ Component]
   923   C1305067:Extensor digitorum longus [Body Part, Organ, or Organ Component]
   861   C0224268:Extensor digitorum [Body Part, Organ, or Organ Component]
   861   C1304999:Extensor digitorum [Body Part, Organ, or Organ Component]
   812   C1184148:Extensor [Body Location or Region]

Phrase: "and"

Phrase: "epitrochlearis muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0026845:Muscles [Tissue]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.241: Each EDL muscle was split into two equal longitudinal portions before incubation. 

Phrase: "Each EDL muscle"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0224464:Extensor digitorum longus muscle [Body Part, Organ, or Organ Component]
           Extensor digitorum longus
   923   C0224268:Extensor digitorum muscle [Body Part, Organ, or Organ Component]
           Extensor digitorum
   923   C1305067:Extensor digitorum longus [Body Part, Organ, or Organ Component]
   902   C0682594:Extensor muscle [Tissue]
   861   C1304999:Extensor digitorum [Body Part, Organ, or Organ Component]
   812   C0026845:Muscle [Tissue]
   812   C1184148:Extensor [Body Location or Region]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "was"

Phrase: "split into two equal longitudinal portions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1534709:Split [Functional Concept]
   753   C1881714:SPLIT [Phenomenon or Process]

Phrase: "before incubation."
Processing 00000000.tx.242: Thus, four EDL muscle strips were prepared for each animal. 

Phrase: "Thus,"

Phrase: "four EDL muscle strips"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1321564:strips [Medical Device]
   734   C0224464:Extensor digitorum longus muscle [Body Part, Organ, or Organ Component]
   700   C0224268:Extensor digitorum muscle [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "prepared for each animal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003062:Animal [Animal]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.243: The procedure and suitability of the muscle preparation have been described previously (60,61). 

Phrase: "The procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "suitability of the muscle preparation"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(60,"

Phrase: "61"

Phrase: ")."
Processing 00000000.tx.244: All incubation media were prepared from a stock solution of pre-gassed (95% O2/5% CO2) KrebsHenseleit buffer (KHB), which contained 5 mM HEPES and 0.1% BSA (radioimmunoassay grade). 

Phrase: "All incubation media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "prepared from a stock solution of pre-gassed"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0037633:Solution [Substance]
   744   C0332152:Pre [Temporal Concept]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C0740175:Pre [Qualitative Concept]
   744   C1710198:Stock [Idea or Concept]
   744   C2257086:PRE [Genetic Function]
   711   C0017110:Gas [Chemical Viewed Structurally]
   711   C0596601:Gas [Sign or Symptom]
   711   C1521827:Prepare [Functional Concept]

Phrase: "(95% O2/5% CO2) KrebsHenseleit buffer (KHB),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "5 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "0.1% BSA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "(radioimmunoassay grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441800:Grade [Classification]
   861   C0919553:Grade [Classification]
   861   C3244287:grade [Finding]

Phrase: ")."
Processing 00000000.tx.245: The gas phase in the vials was maintained at 95% O2/5% CO2 throughout all incubations. 

Phrase: "The gas phase in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205390:Phase [Temporal Concept]

Phrase: "the vials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0184301:vials [Medical Device]
  1000   C1533199:Vials [Quantitative Concept]
   966 E C1706497:VIAL [Medical Device]

Phrase: "was"

Phrase: "maintained at 95% O2/5% CO2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1314677:Maintained [Functional Concept]
   753   C2347816:Co2+ [Element, Ion, or Isotope]
   719 E C0024501:Maintain [Activity]

Phrase: "throughout all incubations."
Processing 00000000.tx.246: Assessment of glucose transport activity in muscle Glucose transport was assessed in EDL muscle using the glucose analog 3-O-methylglucose as described (60). 

Phrase: "Assessment of glucose transport activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "in muscle Glucose transport"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0026845:Muscle [Tissue]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "was"

Phrase: "assessed in EDL muscle"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0224464:Extensor digitorum longus muscle [Body Part, Organ, or Organ Component]
           Extensor digitorum longus
   833   C1305067:Extensor digitorum longus [Body Part, Organ, or Organ Component]
   820   C0224268:Extensor digitorum muscle [Body Part, Organ, or Organ Component]
           Extensor digitorum
   790   C1304999:Extensor digitorum [Body Part, Organ, or Organ Component]
   783   C0449622:Muscle assessed [Functional Concept]
   783   C0682594:Extensor muscle [Tissue]
   753   C0026845:Muscle [Tissue]
   753   C1184148:Extensor [Body Location or Region]
   753   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the glucose analog 3-O-methylglucose as described"

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.247: EDL muscles were incubated at 30C for 30 min in KHB supplemented with 5 mM glucose and 15 mM mannitol. 

Phrase: "EDL muscles"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   966   C0224464:Extensor digitorum longus muscle [Body Part, Organ, or Organ Component]
           Extensor digitorum longus
   923   C1305067:Extensor digitorum longus [Body Part, Organ, or Organ Component]
   906   C0224268:Extensor digitorum muscle [Body Part, Organ, or Organ Component]
           Extensor digitorum
   902   C0682594:extensor muscles [Tissue]
   861   C1304999:Extensor digitorum [Body Part, Organ, or Organ Component]
   812   C0026845:Muscles [Tissue]
   812   C1184148:Extensor [Body Location or Region]
   812   C1995013:Muscles [Body Part, Organ, or Organ Component]
   729 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 30C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "in KHB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "supplemented with 5 mM glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "15 mM mannitol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.248: Muscles were then incubated for an additional 30 min in KHB (5 mM glucose and 15 mM mannitol) with or without insulin (0.6 or 2.4 nM). 

Phrase: "Muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026845:Muscles [Tissue]
  1000   C1995013:Muscles [Body Part, Organ, or Organ Component]
   916 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for an additional 30 min"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1524062:Additional [Functional Concept]

Phrase: "in KHB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "15 mM mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "with"

Phrase: "or without insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(0.6"

Phrase: "or"

Phrase: "2.4 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]
Processing 00000000.tx.249: Subsequently, muscles were incubated for 10 min in KHB (20 mM mannitol) with or without insulin as indicated above. 

Phrase: "Subsequently,"

Phrase: "muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026845:Muscles [Tissue]
  1000   C1995013:Muscles [Body Part, Organ, or Organ Component]
   916 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 10 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in KHB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(20 mM mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "with"

Phrase: "or without insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as indicated above."
Processing 00000000.tx.250: Thereafter, muscles were incubated in KHB containing 8 mM 3-O-methylglucose (2.5 Ci/mmol) and 12 mM [14C]mannitol (26.3 Ci/mmol) for 12 min (insulin-stimulated) or 20 min (basal). 

Phrase: "Thereafter,"

Phrase: "muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026845:Muscles [Tissue]
  1000   C1995013:Muscles [Body Part, Organ, or Organ Component]
   916 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "incubated in KHB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "8 mM 3-O-methylglucose"

Phrase: "(2.5 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439190:MMOLE [Quantitative Concept]

Phrase: "and"

Phrase: "12 mM [14C"

Phrase: "]mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "(26.3 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439190:MMOLE [Quantitative Concept]

Phrase: "for 12 min (insulin-stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "or"

Phrase: "20 min ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.251: Muscles were processed for glucose transport as described (60). 

Phrase: "Muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026845:Muscles [Tissue]
  1000   C1995013:Muscles [Body Part, Organ, or Organ Component]
   916 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "processed for glucose transport"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0178666:glucose transport [Cell Function]
   802   C1519628:Transport Process [Molecular Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1317949:Transport [Manufactured Object]
   770   C1522240:Processed [Phenomenon or Process]
   770   C3495449:transport [Medical Device]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.252: Results are reported as insulin-stimulated fold increase of glucose analog accumulated per milliliter of intracellular water per hour over basal. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "reported as insulin-stimulated fold increase of glucose analog"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   764   C0596619:glucose analog [Carbohydrate]
   762   C0020459:INSULIN INCREASE [Disease or Syndrome]
   762   C1719133:Glucose/Insulin [Quantitative Concept]
   762   C2825028:Insulin Analog [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0243071:Analog [Chemical Viewed Structurally]
   742   C0332462:Fold [Spatial Concept]
   742   C0442805:Increase [Functional Concept]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1880834:FOLD [Phenomenon or Process]
   742   C1948023:Stimulated [Natural Phenomenon or Process]
   742   C3496591:Reported [Clinical Attribute]
   708 E C3273238:Report [Intellectual Product]

Phrase: "accumulated per milliliter of intracellular water"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   820   C2698229:Milliliter of Water [Quantitative Concept]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0439242:milliliter [Quantitative Concept]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]

Phrase: "per hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439227:Hour [Temporal Concept]
  1000   C0564385:/hour [Quantitative Concept]

Phrase: "over basal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]
Processing 00000000.tx.253: Assay of insulin-degrading activity in muscle Determination of insulin degradation in intact muscle was performed essentially as previously described (40). 

Phrase: "Assay of insulin-degrading activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "in muscle Determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "of insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "in intact muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "essentially"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.254: Intact epitrochlearis muscles were washed in KHB (20 mM mannitol) at 37C for 20 min, three times. 

Phrase: "Intact epitrochlearis muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026845:Muscles [Tissue]
   827   C1995013:Muscles [Body Part, Organ, or Organ Component]
   743 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "washed in KHB"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "(20 mM mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "at 37C"

Phrase: "for 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "three times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.255: Muscles were then incubated in 1 ml of KHB containing 10 000 c.p.m./ml of [125I]insulin for 30 min at 37C. 

Phrase: "Muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0026845:Muscles [Tissue]
  1000   C1995013:Muscles [Body Part, Organ, or Organ Component]
   916 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated in 1 ml of KHB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 000 c.p."

Phrase: "m./"

Phrase: "ml of [125I"

Phrase: "]insulin for 30 min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "at 37C."
Processing 00000000.tx.256: At the end of the incubation, triplicate 150 l aliquots were removed and the amount of degraded insulin was measured by TCA precipitation (as described above).  

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation,"

Phrase: "triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "150 l aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the amount of degraded insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "measured by TCA precipitation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.257: ACKNOWLEDGEMENTS  We greatly appreciate the excellent assistance of Ms Marianne Olsson, Ms Lena Jacobsson, Dr Jorge Rincon and Xiao Mei Song. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We greatly"

Phrase: "appreciate"

Phrase: "the excellent assistance of Ms Marianne Olsson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0018896:Assistance [Social Behavior]

Phrase: "Ms Lena Jacobsson,"

Phrase: "Dr Jorge Rincon"

Phrase: "and"

Phrase: "Xiao Mei Song."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872005:Song [Intellectual Product]
Processing 00000000.tx.258: This work was supported by grants from the Swedish Medical Research Council, Swedish Strategic Funds, Swedish Diabetes Association, Swedish Medical Association and the following foundations: Gunvor och Josef Anr, Magnus Bergvall, Emil and Wera Cornell, Wera Ekstrm, Petrus och Augusta Hedlund, Lars Hiertas Minne, Sven Jerring, Novo Nordisk, Samariten, Gamla Tjnarinnor and Ulf Widengrens Minne.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Swedish Medical Research Council,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0079816:Medical Research [Research Activity]
   861   C1556038:Medical Research [Professional or Occupational Group]
   812   C0035168:research [Research Activity]
   812   C0205476:Medical [Functional Concept]
   812   C0242481:Research [Research Activity]
   812   C1551807:Council [Population Group]

Phrase: "Swedish Strategic Funds,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016820:Funds [Quantitative Concept]

Phrase: "Swedish Diabetes Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "Swedish Medical Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the following foundations"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundations [Organization]
   768 E C0002055:base [Inorganic Chemical]
   768 E C0178499:Base [Chemical Viewed Functionally]
   768 E C1626935:Bases [Quantitative Concept]
   768 E C1880279:Base [Biomedical or Dental Material]
   750 E C0205112:Basal [Spatial Concept]

Phrase: ":"

Phrase: "Gunvor och Josef Anr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2247189:ANR [Molecular Function]

Phrase: "Magnus Bergvall,"

Phrase: "Emil"

Phrase: "and"

Phrase: "Wera Cornell,"

Phrase: "Wera Ekstrm,"

Phrase: "Petrus och Augusta Hedlund,"

Phrase: "Lars Hiertas Minne,"

Phrase: "Sven Jerring,"

Phrase: "Novo Nordisk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331875:Novo Nordisk [Health Care Related Organization]

Phrase: "Samariten,"

Phrase: "Gamla Tjnarinnor"

Phrase: "and"

Phrase: "Ulf Widengrens Minne."
Processing 00000000.tx.259: FOOTNOTES  + These authors contributed equally to this work  To whom correspondence should be addressed. 

Phrase: "FOOTNOTES  +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.260: Tel: +46 70 484 87 90; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+46 70 484 87 90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439083:>90 [Quantitative Concept]
   804   C0439087:<90 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.261: Fax: +46 8 517 757 15; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+46 8 517 757 15"

Phrase: ";"
Processing 00000000.tx.262: Email: jga@gen.ks.se  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1 Pyke, D.A. and Nelson, P.G. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "jga@gen.ks.se"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Pyke,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nelson,"

Phrase: "P.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.263: (1976) Diabetes mellitus in identical twins. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Diabetes mellitus in identical twins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   760   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.264: In Cruetzfeldt, W., Kbberling, J. and Neel, J.V. 

Phrase: "In Cruetzfeldt,"

Phrase: "W.,"

Phrase: "Kbberling,"

Phrase: "J."

Phrase: "and"

Phrase: "Neel,"

Phrase: "J.V."
Processing 00000000.tx.265: (eds), The Genetics of Diabetes Mellitus. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "The Genetics of Diabetes Mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0596425:diabetes mellitus genetics [Occupation or Discipline]
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
Processing 00000000.tx.266: Springer-Verlag, Berlin, Germany, pp. 

Phrase: "Springer-Verlag,"

Phrase: "Berlin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "pp."
Processing 00000000.tx.267: 194205. 

Phrase: "194205."
Processing 00000000.tx.268: 2 Barnett, A.H., Eff, C., Leslie, R.D.G. and Pyke, D.A. 

Phrase: "2 Barnett,"

Phrase: "A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Eff"

Phrase: ","

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leslie,"

Phrase: "R.D.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Pyke,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.269: (1981) Diabetes in identical twins. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Diabetes in identical twins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.270: Diabetologia, 20, 8793.[ISI][Medline] 3 Kobberling, J. and Tillil, H. 

Phrase: "Diabetologia,"

Phrase: "20,"

Phrase: "8793."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 3 Kobberling,"

Phrase: "J."

Phrase: "and"

Phrase: "Tillil,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.271: (1982) Empirical risk figures for first degree relatives of non-insulin-dependent diabetics. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Empirical risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "figures for first degree relatives of non-insulin-dependent diabetics."
Meta Candidates (Total=24; Excluded=3; Pruned=0; Remaining=21)
   782   C1518469:First Degree Relatives [Quantitative Concept]
   760   C0444502:First degree [Qualitative Concept]
   757   C0421248:diabetics insulin [Finding]
   748 E C1517194:First Degree Relative [Family Group]
   741   C3242642:relative dependent [Finding]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0080103:Relatives [Family Group]
   739   C0205435:First [Quantitative Concept]
   739   C0241863:diabetics [Finding]
   739   C0441889:Degree [Qualitative Concept]
   739   C0449286:Degree [Quantitative Concept]
   739   C0542560:Degree [Intellectual Product]
   739   C0851827:Dependent [Qualitative Concept]
   739   C1279901:First [Qualitative Concept]
   739   C1518422:Non [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1561545:degree [Quantitative Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1701901:Dependent [Qualitative Concept]
   739   C2348088:Degree [Quantitative Concept]
   739   C3244310:dependent [Functional Concept]
   724   C1261139:Diabetic relative [Finding]
   706 E C0205345:Relative [Qualitative Concept]
   706 E C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.272: In Kobberling, J. and Tattersall, R. 

Phrase: "In Kobberling,"

Phrase: "J."

Phrase: "and"

Phrase: "Tattersall,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.273: (eds), The Genetics of Diabetes Mellitus. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "The Genetics of Diabetes Mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0596425:diabetes mellitus genetics [Occupation or Discipline]
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
Processing 00000000.tx.274: Academic Press, London, UK, pp. 

Phrase: "Academic Press,"

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK,"

Phrase: "pp."
Processing 00000000.tx.275: 201209. 

Phrase: "201209."
Processing 00000000.tx.276: 4 Newman, B., Selby, J.V., King, M.C., Slemenda, C., Fabsitz, R. and Friedman, G.D. 

Phrase: "4 Newman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Selby,"

Phrase: "J.V., King,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Slemenda,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fabsitz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Friedman,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.277: (1987) Concordance for type II (non-insulin-dependent) diabetes mellitus in male twins. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Concordance for type II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680240:concordance [Social Behavior]

Phrase: "(non-insulin-dependent) diabetes mellitus in male twins."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   869   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   869   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   833   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1518422:Non [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
Processing 00000000.tx.278: Diabetologia, 30, 763768.[ISI][Medline] 5 Medici, F., Hawa, M., Ianari, A., Pyke, D.A. and Leslie, R.D. 

Phrase: "Diabetologia,"

Phrase: "30,"

Phrase: "763768."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 5 Medici,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0031831:Physician [Professional or Occupational Group]
   789   C0804815:Physician [Clinical Attribute]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hawa,"

Phrase: "M."

Phrase: ","

Phrase: "Ianari,"

Phrase: "A.,"

Phrase: "Pyke,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Leslie,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.279: (1999) Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Concordance rate for type II diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0680240:concordance [Social Behavior]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "in monozygotic twins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0041432:Monozygotic twins [Family Group]
   861   C0041427:Twins [Family Group]
   827 E C0205173:Twin [Functional Concept]

Phrase: ":"

Phrase: "actuarial analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001296:Actuarial Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.280: Diabetologia, 42, 146150.[ISI][Medline] 6 Poulsen, P., Kyvik, K.O., Vaag, A. and Beck-Nielsen, H. 

Phrase: "Diabetologia,"

Phrase: "42,"

Phrase: "146150."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 6 Poulsen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kyvik,"

Phrase: "K.O.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Vaag,"

Phrase: "A."

Phrase: "and"

Phrase: "Beck-Nielsen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.281: (1999) Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerancea population-based twin study. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Heritability of type II"

Phrase: "(non-insulin-dependent) diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "abnormal glucose tolerancea population-based twin study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   852   C1709599:Population Based Study [Research Activity]
   845   C0681876:Population Study [Research Activity]
   818   C0282476:twin study [Research Activity]
   818   C1096782:Twin Study [Intellectual Product]
   795   C0557651:Study [Manufactured Object]
   795   C2603343:Study [Research Activity]
Processing 00000000.tx.282: Diabetologia, 42, 139145.[ISI][Medline] 7 van den Ouweland, J.M., Lemkes, H.H., Ruitenbeek, W., Sandkuijl, L.A., de Vijlder, M.F., Struyvenberg, P.A., van de Kamp, J.J. and Maassen, J.A. 

Phrase: "Diabetologia,"

Phrase: "42,"

Phrase: "139145."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 7 van den Ouweland,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0178587:DEN [Quantitative Concept]
   812   C0557775:Van [Manufactured Object]

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Lemkes,"

Phrase: "H.H.,"

Phrase: "Ruitenbeek,"

Phrase: "W.,"

Phrase: "Sandkuijl,"

Phrase: "L.A.,"

Phrase: "de Vijlder,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Struyvenberg,"

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "van de Kamp,"

Phrase: "J.J."

Phrase: "and"

Phrase: "Maassen,"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.283: (1992) Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mutation in mitochondrial tRNA(Leu)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2315666:Mitochondrial mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(UUR"

Phrase: ")"

Phrase: "gene in a large pedigree"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1416798:LARGE gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "with maternally transmitted type II diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   901   C2984301:Type II diabetes mellitus [Functional Concept]
   839   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441730:Type II [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "deafness."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0011053:Deafness [Disease or Syndrome]
  1000   C0018772:deafness [Finding]
  1000   C0581883:Deafness [Disease or Syndrome]
   928 E C0525064:DEAF [Patient or Disabled Group]
   928 E C1547302:Deaf [Intellectual Product]
Processing 00000000.tx.284: Nature Genet., 5, 6871. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6871."
Processing 00000000.tx.285: 8 Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G.I., Zouali, H., Lesage, S., Velho, G., Iris, F. and Passa, P.E.A. 

Phrase: "8 Vionnet,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Stoffel,"

Phrase: "M."

Phrase: ","

Phrase: "Takeda,"

Phrase: "J.,"

Phrase: "Yasuda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "G.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Zouali,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lesage,"

Phrase: "S."

Phrase: ","

Phrase: "Velho,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Iris,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022077:Iris [Body Part, Organ, or Organ Component]
  1000   C1001362:Iris [Plant]
  1000   C1278891:Iris [Body Part, Organ, or Organ Component]
  1000   C2314880:Iris [Eukaryote]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Passa,"

Phrase: "P.E.A."
Processing 00000000.tx.286: (1992) Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nonsense mutation in the glucokinase gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0544885:Mutation, Nonsense [Cell or Molecular Dysfunction]
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C0746939:nonsense [Idea or Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "early-onset non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   913   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   913   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   877   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   818   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   795   C0011847:Diabetes [Disease or Syndrome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0851827:Dependent [Qualitative Concept]
   795   C1518422:Non [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1701901:Dependent [Qualitative Concept]
   795   C3244310:dependent [Functional Concept]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.287: Nature, 356, 721722.[ISI][Medline] 9 Yamagata, K., Furuta, H., Oda, N., Kaisaki, P.J., Menzel, S., Cox, N.J., Fajans, S.S., Signorini, S., Stoffel, M. and Bell, G.I. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "356,"

Phrase: "721722."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 9 Yamagata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Furuta,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kaisaki,"

Phrase: "P.J.,"

Phrase: "Menzel,"

Phrase: "S."

Phrase: ","

Phrase: "Cox,"

Phrase: "N.J.,"

Phrase: "Fajans,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Signorini,"

Phrase: "S."

Phrase: ","

Phrase: "Stoffel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "G.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.288: (1996) Mutations in the hepatocyte nuclear factor-4 gene in maturity-onset diabetes of the young (MODY1). 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mutations in the hepatocyte nuclear factor-4 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.289: Nature, 384, 458460.[ISI][Medline] 10 Yamagata, K., Oda, N., Kaisaki, P.J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R.D., Lathrop, G.M., Boriraj, V.V. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "384,"

Phrase: "458460."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 10 Yamagata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kaisaki,"

Phrase: "P.J.,"

Phrase: "Menzel,"

Phrase: "S."

Phrase: ","

Phrase: "Furuta,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vaxillaire,"

Phrase: "M."

Phrase: ","

Phrase: "Southam,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cox,"

Phrase: "R.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lathrop,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Boriraj,"

Phrase: "V.V. et al."
Processing 00000000.tx.290: (1996) Mutations in the hepatocyte nuclear factor-1 gene in maturity-onset diabetes of the young (MODY3). 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mutations in the hepatocyte nuclear factor-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(MODY3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1838100:MODY3 [Disease or Syndrome]
  1000   C3273648:MODY3 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.291: Nature, 384, 455458.[ISI][Medline] 11 Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B.N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "384,"

Phrase: "455458."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 11 Horikawa,"

Phrase: "Y.,"

Phrase: "Iwasaki,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2758676:Hara [Fish]

Phrase: "M."

Phrase: ","

Phrase: "Furuta,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hinokio,"

Phrase: "Y.,"

Phrase: "Cockburn,"

Phrase: "B.N., Lindner,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamagata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ogata,"

Phrase: "M."

Phrase: ","

Phrase: "Tomonaga,"

Phrase: "O. et al."
Processing 00000000.tx.292: (1997) Mutation in hepatocyte nuclear factor-1 gene (TCF2) associated with MODY. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in hepatocyte nuclear factor-1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(TCF2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420636:TCF2 [Gene or Genome]
  1000   C2348633:TCF2 [Gene or Genome]

Phrase: ")"

Phrase: "associated with MODY."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C2984262:MODY [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.293: Nature Genet., 17, 384385.[ISI][Medline] 12 Stoffers, D.A., Ferrer, J., Clarke, W.L. and Habener, J.F. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "17,"

Phrase: "384385."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 12 Stoffers,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ferrer,"

Phrase: "J.,"

Phrase: "Clarke,"

Phrase: "W.L."

Phrase: "and"

Phrase: "Habener,"

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.294: (1997) Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Early-onset type-II diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   901   C2984301:Type II diabetes mellitus [Functional Concept]
   839   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441730:Type II [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "(MODY4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1826562:MODY4 [Gene or Genome]
  1000   C1833382:MODY4 [Disease or Syndrome]

Phrase: ")"

Phrase: "linked to IPF1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1826562:IPF1 [Gene or Genome]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]
Processing 00000000.tx.295: Nature Genet., 17, 138139.[ISI][Medline] 13 Galli, J., Li, L.S., Glaser, A., stenson, C.G., Jiao, H., Fakhrai-Rad, H., Jacob, H.J., Lander, E.S. and Luthman, H. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "17,"

Phrase: "138139."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 13 Galli,"

Phrase: "J.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Glaser,"

Phrase: "A.,"

Phrase: "stenson,"

Phrase: "C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Jiao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fakhrai-Rad,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jacob,"

Phrase: "H.J.,"

Phrase: "Lander,"

Phrase: "E.S."

Phrase: "and"

Phrase: "Luthman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.296: (1996) Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genetic analysis of non-insulin dependent diabetes mellitus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: "in the GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.297: Nature Genet., 12, 3137.[ISI][Medline] 14 Gauguier, D., Froguel, P., Parent, V., Bernard, C., Bihoreau, M., Portha, B., James, M.R., Penicaud, L., Lathrop, M. and Ktorza, A. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "3137."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 14 Gauguier,"

Phrase: "D."

Phrase: ","

Phrase: "Froguel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Parent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030551:parent [Family Group]
  1000   C2699423:Parent [Conceptual Entity]

Phrase: "V.,"

Phrase: "Bernard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bihoreau,"

Phrase: "M."

Phrase: ","

Phrase: "Portha,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "James,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Penicaud,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lathrop,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ktorza,"

Phrase: "A."
Processing 00000000.tx.298: (1996) Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Chromosomal mapping of genetic loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
           Chromosome Mapping
   760   C1283195:Mapping [Activity]

Phrase: "associated with non-insulin dependent diabetes"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   882   C0011860:Non-Insulin Dependent Diabetes [Disease or Syndrome]
   833   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1518422:Non [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the GK rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.299: Nature Genet., 12, 3843.[ISI][Medline] 15 Aitman, T.J., Gotoda, T., Evans, A.L., Imrie, H., Heath, K.E., Trembling, P.M., Truman, H., Wallace, C.A., Rahman, A., Dore, C. et al. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "3843."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 15 Aitman,"

Phrase: "T.J.,"

Phrase: "Gotoda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Evans,"

Phrase: "A.L., Imrie,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Heath,"

Phrase: "K.E.,"

Phrase: "Trembling,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0234369:Trembling [Sign or Symptom]
   928 E C0036973:Shivered [Finding]
   907 E C0040822:Trembled [Sign or Symptom]

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Truman,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "C."

Phrase: "A.,"

Phrase: "Rahman,"

Phrase: "A.,"

Phrase: "Dore,"

Phrase: "C. et al."
Processing 00000000.tx.300: (1997) Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Quantitative trait loci for cellular defects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0597336:Quantitative Trait Loci [Gene or Genome]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0599883:Trait [Organism Attribute]
   719   C1708726:Locus [Gene or Genome]

Phrase: "in glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "fatty acid metabolism in hypertensive rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0596563:Fatty Acid Metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.301: Nature Genet., 16, 197201.[ISI][Medline] 16 Chung, W.K., Zheng, M., Chua, M., Kershaw, E., Power-Kehoe, L., Tsuji, M., Wu-Peng, X.S., Williams, J., Chua, S.C.J. and Leibel, R.L. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "16,"

Phrase: "197201."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 16 Chung,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "M."

Phrase: ","

Phrase: "Chua,"

Phrase: "M."

Phrase: ","

Phrase: "Kershaw,"

Phrase: "E.,"

Phrase: "Power-Kehoe,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Tsuji,"

Phrase: "M."

Phrase: ","

Phrase: "Wu-Peng,"

Phrase: "X.S.,"

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "Chua,"

Phrase: "S.C.J."

Phrase: "and"

Phrase: "Leibel,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.302: (1997) Genetic modifiers of Leprfa associated with variability in insulin production and susceptibility to NIDDM. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genetic modifiers of Leprfa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0205349:Modifier [Qualitative Concept]
   737   C1514623:Modifier [Conceptual Entity]
   737   C1516451:Modifier [Chemical Viewed Functionally]
   737   C3542952:Modifier [Intellectual Product]

Phrase: "associated with variability"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C2827666:Variability [Conceptual Entity]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0439828:Variable [Qualitative Concept]

Phrase: "in insulin production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "susceptibility to NIDDM."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   738   C2827756:Non Susceptible [Laboratory or Test Result]
   731   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   731   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
Processing 00000000.tx.303: Genomics, 41, 332244.[ISI][Medline] 17 Kanemoto, N., Hishigaki, H., Miyakita, A., Oga, K., Okuno, S., Tsuji, A., Takagi, T., Takahashi, E., Nakamura, Y. and Watanabe, T.K. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "41,"

Phrase: "332244."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 17 Kanemoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hishigaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miyakita,"

Phrase: "A.,"

Phrase: "Oga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417143:OGA [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Okuno,"

Phrase: "S."

Phrase: ","

Phrase: "Tsuji,"

Phrase: "A.,"

Phrase: "Takagi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takahashi,"

Phrase: "E.,"

Phrase: "Nakamura,"

Phrase: "Y."

Phrase: "and"

Phrase: "Watanabe,"

Phrase: "T.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.304: (1998) Genetic dissection of OLETF, a rat model for non-insulin-dependent diabetes mellitus. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genetic dissection of OLETF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "a rat model for non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]
Processing 00000000.tx.305: Mamm. 

Phrase: "Mamm."
Processing 00000000.tx.306: Genome, 9, 419425.[ISI][Medline] 18 Aitman, T.J., Glazier, A.M., Wallace, C.A., Cooper, L.D., Norsworthy, P.J., Wahid, F.N., Al-Majali, K.M., Trembling, P.M., Mann, C.J., Shoulders, C.C. et al. 

Phrase: "Genome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "9,"

Phrase: "419425."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 18 Aitman,"

Phrase: "T.J.,"

Phrase: "Glazier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336386:Glazier [Professional or Occupational Group]

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "C."

Phrase: "A.,"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "L.D.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Norsworthy,"

Phrase: "P.J.,"

Phrase: "Wahid,"

Phrase: "F.N., Al-Majali,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Trembling,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0234369:Trembling [Sign or Symptom]
   928 E C0036973:Shivered [Finding]
   907 E C0040822:Trembled [Sign or Symptom]

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Mann,"

Phrase: "C.J.,"

Phrase: "Shoulders,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037004:Shoulders [Body Location or Region]
   966 E C1283792:Shoulder [Body Location or Region]

Phrase: "C.C. et al."
Processing 00000000.tx.307: (1999) Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Identification of Cd36"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "(Fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: ")"

Phrase: "as an insulin-resistance gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1337112:Insulin Gene [Gene or Genome]
   901   C2945710:resistance gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0021655:Insulin Resistance [Pathologic Function]
   734   C2700570:INSULIN RESISTANCE [Gene or Genome]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "defective fatty acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "glucose metabolism in hypertensive rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0596620:glucose metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.308: Nature Genet., 21, 7683.[ISI][Medline] 19 Hirayama, I., Yi, Z., Izumi, S., Arai, I., Suzuki, W., Nagamachi, Y., Kuwano, H., Takeuchi, T. and Izumi, T. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "21,"

Phrase: "7683."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 19 Hirayama,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yi,"

Phrase: "Z.,"

Phrase: "Izumi,"

Phrase: "S."

Phrase: ","

Phrase: "Arai,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "W.,"

Phrase: "Nagamachi,"

Phrase: "Y.,"

Phrase: "Kuwano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takeuchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Izumi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.309: (1999) Genetic analysis of obese diabetes in the TSOD mouse. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genetic analysis of obese diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0679560:genetic analysis [Laboratory Procedure]
   806   C0796344:Genetic Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in the TSOD mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.310: Diabetes, 48, 11831191.[Abstract] 20 Ueda, H., Ikegami, H., Kawaguchi, Y., Fujisawa, T., Yamato, E., Shibata, M. and Ogihara, T. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "48,"

Phrase: "11831191."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 20 Ueda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ikegami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kawaguchi,"

Phrase: "Y.,"

Phrase: "Fujisawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331815:Fujisawa [Health Care Related Organization]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamato,"

Phrase: "E.,"

Phrase: "Shibata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ogihara,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.311: (1999) Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genetic analysis of late-onset type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of human complex trait."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599883:Trait [Organism Attribute]
Processing 00000000.tx.312: Diabetes, 48, 11681174.[Abstract] 21 Goto, Y., Kakizaki, M. and Masaki, N. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "48,"

Phrase: "11681174."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 21 Goto,"

Phrase: "Y.,"

Phrase: "Kakizaki,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Masaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1461631:masaki [Plant]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.313: (1975) Spontaneous diabetes produced by selective breeding of normal Wistar rats. 

Phrase: "(1975"

Phrase: ")"

Phrase: "Spontaneous diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "produced by selective breeding of normal Wistar rats."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0034716:Rats, Wistar [Mammal]
   770   C0678952:selective breeding [Genetic Function]
   744   C0006159:Breeding [Organism Function]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C2347086:% Normal [Quantitative Concept]
   744   C2700262:Wistar [Mammal]
Processing 00000000.tx.314: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.315: Jap. 

Phrase: "Jap."
Processing 00000000.tx.316: Acad., 51, 8085.[ISI] 22 Suzuki, K.-I., Goto, Y. and Toyota, T. 

Phrase: "Acad.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]

Phrase: "51,"

Phrase: "8085."

Phrase: "[ISI] 22 Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0998924:suzuki [Fish]

Phrase: "K.-I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Goto,"

Phrase: "Y."

Phrase: "and"

Phrase: "Toyota,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.317: (1992) Spontaneously diabetic GK (Goto-Kakizaki) rats. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Spontaneously diabetic GK (Goto-Kakizaki) rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
Processing 00000000.tx.318: In Shafir, E. 

Phrase: "In Shafir,"

Phrase: "E."
Processing 00000000.tx.319: (ed.), Lessons from Animal Diabetes. 

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Lessons from Animal Diabetes."
Processing 00000000.tx.320: Smith-Gordon, London, UK, pp. 

Phrase: "Smith-Gordon,"

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK,"

Phrase: "pp."
Processing 00000000.tx.321: 107116. 

Phrase: "107116."
Processing 00000000.tx.322: 23 Galli, J., Fakhrai-Rad, H., Kamel, A., Marcus, C., Norgren, S. and Luthman, H. 

Phrase: "23 Galli,"

Phrase: "J.,"

Phrase: "Fakhrai-Rad,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kamel,"

Phrase: "A.,"

Phrase: "Marcus,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Norgren,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Luthman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.323: (1999) Pathophysiological and genetic characterization of the major diabetes locus in GK rats. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Pathophysiological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0031847:pathophysiology [Functional Concept]
   928   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "and"

Phrase: "genetic characterization of the major diabetes locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.324: Diabetes, 48, 24632470.[Abstract] 24 Ebrahim, A., Hamel, F.G., Bennett, R.G. and Duckworth, W.C. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "48,"

Phrase: "24632470."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24 Ebrahim,"

Phrase: "A.,"

Phrase: "Hamel,"

Phrase: "F.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bennett,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Duckworth,"

Phrase: "W.C."
Processing 00000000.tx.325: (1991) Identification of the metal associated with the insulin degrading enzyme. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Identification of the metal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "associated with the insulin degrading enzyme."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.326: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.327: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.328: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.329: Commun., 181, 13981406.[ISI][Medline] 25 Becker, A.B. and Roth, R.A. 

Phrase: "Commun.,"

Phrase: "181,"

Phrase: "13981406."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 25 Becker,"

Phrase: "A.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.330: (1992) An unusual active site identified in a family of zinc metalloendopeptidases. 

Phrase: "(1992"

Phrase: ")"

Phrase: "An unusual active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0205681:Active Site [Functional Concept]
   827   C0205145:Site [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "identified in a family of zinc metalloendopeptidases."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0015576:Family [Family Group]
   748   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205396:Identified [Qualitative Concept]
   748   C1442934:Metalloendopeptidases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1704727:Family [Conceptual Entity]
   748   C2348288:Zinc [Element, Ion, or Isotope]
Processing 00000000.tx.331: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.332: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.333: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.334: USA, 89, 38353839.[Abstract] 26 Bondy, C.A., Zhou, J., Chin, E., Reinhardt, R.R., Ding, L. and Roth, R.A. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "89,"

Phrase: "38353839."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 26 Bondy,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Zhou,"

Phrase: "J.,"

Phrase: "Chin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008114:Chin [Body Location or Region]
  1000   C1284862:Chin [Body Location or Region]

Phrase: "E.,"

Phrase: "Reinhardt,"

Phrase: "R.R.,"

Phrase: "Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.335: (1994) Cellular distribution of insulin-degrading enzyme gene expression. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cellular distribution of insulin-degrading enzyme gene expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.336: Comparison with insulin and insulin-like growth factor receptors. 

Phrase: "Comparison with insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "insulin-like growth factor receptors."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
  1000   C0140079:Insulin-Like Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   897   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   884   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   881 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.337: J. 

Phrase: "J."
Processing 00000000.tx.338: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.339: Invest., 93, 966973.[ISI][Medline] 27 Duckworth, W.C., Bennett, R.G. and Hamel, F.G. 

Phrase: "Invest.,"

Phrase: "93,"

Phrase: "966973."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 27 Duckworth,"

Phrase: "W.C., Bennett,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hamel,"

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.340: (1998) Insulin degradation: progress and potential. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.341: Endocr. 

Phrase: "Endocr."
Processing 00000000.tx.342: Rev., 19, 608624.[Abstract/Free FullText] 28 Hamel, F.G., Mahoney, M.J. and Duckworth, W.C. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "19,"

Phrase: "608624."

Phrase: "[Abstract/Free FullText"

Phrase: "] 28 Hamel,"

Phrase: "F.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Mahoney,"

Phrase: "M."

Phrase: "J."

Phrase: "and"

Phrase: "Duckworth,"

Phrase: "W.C."
Processing 00000000.tx.343: (1991) Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Degradation of intraendosomal insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "by insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "without acidification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522821:acidification [Cell Function]
  1000   C2987513:Acidification [Phenomenon or Process]
Processing 00000000.tx.344: Diabetes, 40, 436443.[Abstract] 29 Duckworth, W.C., Bennett, R.G. and Hamel, F.G. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "436443."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 29 Duckworth,"

Phrase: "W.C., Bennett,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hamel,"

Phrase: "F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.345: (1998) Insulin acts intracellularly on proteasomes through insulin-degrading enzyme. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "intracellularly on proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C1325620:proteasome [Cell Component]
   756 E C1752727:Proteasome [Molecular Function]

Phrase: "through insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.346: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.347: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.348: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.349: Commun., 244, 390394.[ISI][Medline] 30 Kupfer, S.R., Wilson, E.M. and French, F.S. 

Phrase: "Commun.,"

Phrase: "244,"

Phrase: "390394."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 30 Kupfer,"

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Wilson,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "French,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "F.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.350: (1994) Androgen and glucocorticoid receptors interact with insulin degrading enzyme. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Androgen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002844:Androgen [Hormone,Pharmacologic Substance]
  1000   C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucocorticoid receptors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "interact with insulin degrading enzyme."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.351: J. 

Phrase: "J."
Processing 00000000.tx.352: Biol. 

Phrase: "Biol."
Processing 00000000.tx.353: Chem., 269, 2062220628.[Abstract/Free FullText] 31 Perlman, R.K. and Rosner, M.R. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "2062220628."

Phrase: "[Abstract/Free FullText"

Phrase: "] 31 Perlman,"

Phrase: "R.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rosner,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.354: (1994) Identification of zinc ligands of the insulin-degrading enzyme. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Identification of zinc ligands of the insulin-degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0020792:Identification [Mental Process]
   742   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.355: J. 

Phrase: "J."
Processing 00000000.tx.356: Biol. 

Phrase: "Biol."
Processing 00000000.tx.357: Chem., 269, 3314033145.[Abstract/Free FullText] 32 Watanabe, T.K., Bihoreau, M.T., McCarthy, L.C., Kiguwa, S.L., Hishigaki, H., Tsuji, A., Browne, J., Yamasaki, Y., Mizoguchi-Miyakita, A., Oga, K. et al. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "3314033145."

Phrase: "[Abstract/Free FullText"

Phrase: "] 32 Watanabe,"

Phrase: "T.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bihoreau,"

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "McCarthy,"

Phrase: "L.C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Kiguwa,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Hishigaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tsuji,"

Phrase: "A.,"

Phrase: "Browne,"

Phrase: "J.,"

Phrase: "Yamasaki,"

Phrase: "Y.,"

Phrase: "Mizoguchi-Miyakita,"

Phrase: "A.,"

Phrase: "Oga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417143:OGA [Gene or Genome]

Phrase: "K. et al."
Processing 00000000.tx.358: (1999) A radiation hybrid map of the rat genome containing 5,255 markers. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A radiation hybrid map of the rat genome"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C1253949:Radiation Hybrid Map [Intellectual Product]
   770   C0887811:Radiation Hybrid [Cell]
   744   C0020205:Hybrid [Organism]
   744   C0024779:Map [Manufactured Object]
   744   C0034519:Radiation [Natural Phenomenon or Process]
   744   C0560559:Radiation [Quantitative Concept]
   744   C0851346:Radiation [Natural Phenomenon or Process]
   744   C1522449:Radiation [Therapeutic or Preventive Procedure]
   744   C1524020:Radiation [Therapeutic or Preventive Procedure]
   744   C1524021:Radiation [Research Activity]
   744   C1706473:Map [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5,255 markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.359: Nature Genet., 22, 2736.[ISI][Medline] 33 Meistas, M.T., Margolis, S. and Kowarski, A.A. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "22,"

Phrase: "2736."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 33 Meistas,"

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Margolis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kowarski,"

Phrase: "A."

Phrase: "A."
Processing 00000000.tx.360: (1983) Hyperinsulinemia of obesity is due to decreased clearance of insulin. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Hyperinsulinemia of obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "is due to decreased clearance of insulin."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2825073:Clearance [Natural Phenomenon or Process]
   748   C3146286:Due [Idea or Concept]
   714 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.361: Am. 

Phrase: "Am."
Processing 00000000.tx.362: J. 

Phrase: "J."
Processing 00000000.tx.363: Physiol., 245, E155E159.[Abstract/Free FullText] 34 Bonora, E., Zavaroni, I., Coscelli, C. and Butturini, U. 

Phrase: "Physiol.,"

Phrase: "245,"

Phrase: "E155E159."

Phrase: "[Abstract/Free FullText"

Phrase: "] 34 Bonora,"

Phrase: "E.,"

Phrase: "Zavaroni,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Coscelli,"

Phrase: "C."

Phrase: "and"

Phrase: "Butturini,"

Phrase: "U."
Processing 00000000.tx.364: (1983) Decreased hepatic insulin extraction in subjects with mild glucose intolerance. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "hepatic insulin extraction in subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]

Phrase: "with mild glucose intolerance."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C0872215:mild intolerance [Disease or Syndrome]
   901   C0271650:Glucose Intolerance [Disease or Syndrome]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0231199:Intolerance [Organism Function]
   827   C1744706:intolerance [Intellectual Product]
   827   C2355652:Intolerance [Organism Attribute]
   755 E C0231200:Intolerant [Functional Concept]
Processing 00000000.tx.365: Metabolism, 32, 438446.[ISI][Medline] 35 Jochen, A.L., Berhanu, P. and Olefsky, J.M. 

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "32,"

Phrase: "438446."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 35 Jochen,"

Phrase: "A.L., Berhanu,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Olefsky,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.366: (1986) Insulin internalization and degradation in adipocytes from normal and type II diabetic subjects. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Insulin internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "degradation in adipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "from normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "type II diabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]
Processing 00000000.tx.367: J. 

Phrase: "J."
Processing 00000000.tx.368: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.369: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.370: Metab., 62, 268274.[Abstract] 36 Trischitta, V., Brunetti, A., Chiavetta, A., Benzi, L., Papa, V. and Vigneri, R. 

Phrase: "Metab.,"

Phrase: "62,"

Phrase: "268274."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 36 Trischitta,"

Phrase: "V.,"

Phrase: "Brunetti,"

Phrase: "A.,"

Phrase: "Chiavetta,"

Phrase: "A.,"

Phrase: "Benzi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Papa,"

Phrase: "V."

Phrase: "and"

Phrase: "Vigneri,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.371: (1989) Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Defects in insulin-receptor internalization"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   879   C0271689:Insulin Receptor, Defect in [Disease or Syndrome]
           Insulin receptor defect
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "processing in monocytes of obese subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "obese NIDDM patients."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   860   C1829939:{Non-patient} [Clinical Attribute]
   845   C0581116:dependent patients [Functional Concept]
   795   C0030705:Patients [Patient or Disabled Group]
   747   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   747   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   710   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
Processing 00000000.tx.372: Diabetes, 38, 15791584.[Abstract] 37 Jones, C.N., Pei, D., Staris, P., Polonsky, K.S., Chen, Y.D. and Reaven, G.M. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "38,"

Phrase: "15791584."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 37 Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "C.N., Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0814202:PEI [Intellectual Product]
   827   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "D."

Phrase: ","

Phrase: "Staris,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Polonsky,"

Phrase: "K.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Y.D."

Phrase: "and"

Phrase: "Reaven,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: (1997) Alterations in the glucose-stimulated insulin secretory doseresponse curve and in insulin clearance in nondiabetic insulin-resistant individuals. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alterations in the glucose-stimulated insulin secretory doseresponse curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1515926:Alteration [Idea or Concept]

Phrase: "and in insulin clearance"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C1515981:And [Idea or Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2825073:Clearance [Natural Phenomenon or Process]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in nondiabetic insulin-resistant individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
Processing 00000000.tx.374: J. 

Phrase: "J."
Processing 00000000.tx.375: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.376: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.377: Metab., 82, 18341838.[Abstract/Free FullText] 38 Haffner, S.M., Stern, M.P., Watanabe, R.M. and Bergman, R.N. 

Phrase: "Metab.,"

Phrase: "82,"

Phrase: "18341838."

Phrase: "[Abstract/Free FullText"

Phrase: "] 38 Haffner,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Stern,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Watanabe,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bergman,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.378: (1992) Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Relationship of insulin clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "secretion to insulin sensitivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1256369:insulin secretion [Cell Function]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "in non-diabetic Mexican Americans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025884:Mexican Americans [Population Group]
   812   C0596070:americans [Population Group]
Processing 00000000.tx.379: Eur. 

Phrase: "Eur."
Processing 00000000.tx.380: J. 

Phrase: "J."
Processing 00000000.tx.381: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.382: Invest., 22, 147153. 

Phrase: "Invest.,"

Phrase: "22,"

Phrase: "147153."
Processing 00000000.tx.383: 39 Osei, K. and Schuster, D.P. 

Phrase: "39 Osei,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Schuster,"

Phrase: "D.P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.384: (1994) Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Ethnic differences in secretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0682076:ethnic differences [Finding]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "sensitivity,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "hepatic extraction of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]

Phrase: "in black and white Americans."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C0085756:Black American [Population Group]
   844   C0221786:White American [Population Group]
   812   C0596070:americans [Population Group]
   756   C1609177:Black and White [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.385: Diabet. 

Phrase: "Diabet."
Processing 00000000.tx.386: Med., 11, 755762.[ISI][Medline] 40 Duckworth, W.C., Gifford, D., Kitabchi, A.E., Runyan, K. and Solomon, S.S. 

Phrase: "Med.,"

Phrase: "11,"

Phrase: "755762."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 40 Duckworth,"

Phrase: "W.C., Gifford,"

Phrase: "D."

Phrase: ","

Phrase: "Kitabchi,"

Phrase: "A.E.,"

Phrase: "Runyan,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Solomon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551833:Solomon [Population Group]

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.387: (1979) Insulin binding and degradation by muscles from streptozotocin-diabetic rats. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Insulin binding"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1623517:insulin binding [Molecular Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "degradation by muscles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "from streptozotocin-diabetic rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.388: Diabetes, 28, 746748.[Abstract] 41 Standl, E. and Kolb, H.J. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "28,"

Phrase: "746748."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 41 Standl,"

Phrase: "E."

Phrase: "and"

Phrase: "Kolb,"

Phrase: "H.J."
Processing 00000000.tx.389: (1984) Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and type 2 (non-insulin-dependent) diabetic patients. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Insulin degrading enzyme activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C1145751:insulin activity [Molecular Function]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "and"

Phrase: "insulin binding of erythrocytes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1623517:insulin binding [Molecular Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in normal subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "type 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441730:Type 2 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(non-insulin-dependent) diabetic patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1829939:{Non-patient} [Clinical Attribute]
   853   C0581116:dependent patients [Functional Concept]
   804   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.390: Diabetologia, 27, 1722.[ISI][Medline] 42 Philippe, J., Halban, P.A., Gjinovci, A., Duckworth, W.C., Estreicher, J. and Renold, A.E. 

Phrase: "Diabetologia,"

Phrase: "27,"

Phrase: "1722."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 42 Philippe,"

Phrase: "J.,"

Phrase: "Halban,"

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Gjinovci,"

Phrase: "A.,"

Phrase: "Duckworth,"

Phrase: "W.C., Estreicher,"

Phrase: "J."

Phrase: "and"

Phrase: "Renold,"

Phrase: "A.E."
Processing 00000000.tx.391: (1981) Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Increased clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "degradation of [3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442460:3H [Temporal Concept]

Phrase: "]insulin in streptozotocin diabetic rats."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C0421248:diabetic insulin [Finding]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.392: J. 

Phrase: "J."
Processing 00000000.tx.393: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.394: Invest., 67, 673680.[ISI][Medline] 43 Duggirala, R., Blangero, J., Almasy, L., Dyer, T.D., Williams, K.L., Leach, R.J., OConnell, P. and Stern, M.P. 

Phrase: "Invest.,"

Phrase: "67,"

Phrase: "673680."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 43 Duggirala,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blangero,"

Phrase: "J.,"

Phrase: "Almasy,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dyer,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Williams,"

Phrase: "K.L.,"

Phrase: "Leach"

Phrase: ","

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "OConnell,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Stern,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.395: (1999) Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Linkage of type 2 diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0023745:linkage [Molecular Function]
   716   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
   716   C2984301:Type II diabetes mellitus [Functional Concept]

Phrase: "and of age at onset"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "to a genetic location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "on chromosome 10q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520266:10q [Nucleotide Sequence]

Phrase: "in Mexican Americans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025884:Mexican Americans [Population Group]
   861   C0596070:americans [Population Group]
Processing 00000000.tx.396: Am. 

Phrase: "Am."
Processing 00000000.tx.397: J. 

Phrase: "J."
Processing 00000000.tx.398: Hum. 

Phrase: "Hum."
Processing 00000000.tx.399: Genet., 64, 11271140.[ISI][Medline] 44 Elbein, S.C., Hoffman, M.D., Teng, K., Leppert, M.F. and Hasstedt, S.J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "64,"

Phrase: "11271140."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 44 Elbein,"

Phrase: "S.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Hoffman,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Teng,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Leppert,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Hasstedt,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.400: (1999) A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A genome-wide search for type 2 diabetes susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1552603:search [Intellectual Product]
   739   C1706202:Search [Activity]

Phrase: "in Utah Caucasians."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007457:Caucasians [Population Group]
   861   C0043157:Caucasians [Population Group]
Processing 00000000.tx.401: Diabetes, 48, 11751182.[Abstract] 45 Hager, J., Dina, C., Francke, S., Dubois, S., Houari, M., Vatin, V., Vaillant, E., Lorentz, N., Basdevant, A., Clement, K. et al. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "48,"

Phrase: "11751182."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 45 Hager,"

Phrase: "J.,"

Phrase: "Dina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1086404:Dina [Eukaryote]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Francke,"

Phrase: "S."

Phrase: ","

Phrase: "Dubois,"

Phrase: "S."

Phrase: ","

Phrase: "Houari,"

Phrase: "M."

Phrase: ","

Phrase: "Vatin,"

Phrase: "V.,"

Phrase: "Vaillant,"

Phrase: "E.,"

Phrase: "Lorentz,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Basdevant,"

Phrase: "A.,"

Phrase: "Clement,"

Phrase: "K. et al."
Processing 00000000.tx.402: (1998) A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A genome-wide scan for human obesity genes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0017429:Genome, Human [Gene or Genome]
   767   C1517519:Genome Scan [Molecular Biology Research Technique]
   744   C0017428:Genome [Gene or Genome]
   744   C0034606:Scan [Diagnostic Procedure]
   744   C0332464:Wide [Spatial Concept]
   744   C0441633:Scan [Diagnostic Procedure]
   744   C2338314:Genome [Conceptual Entity]
   744   C2826292:SCAN [Finding]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a major susceptibility locus on chromosome 10."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.403: Nature Genet., 20, 304308.[ISI][Medline] 46 Chen, Y.-D., Parillo, M., Jeng, C.Y. and Zhang, J.C. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "20,"

Phrase: "304308."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 46 Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "Y.-"

Phrase: "D."

Phrase: ","

Phrase: "Parillo,"

Phrase: "M."

Phrase: ","

Phrase: "Jeng,"

Phrase: "C.Y."

Phrase: "and"

Phrase: "Zhang,"

Phrase: "J.C."
Processing 00000000.tx.404: (1987) Defects in adipocytes glucose transport, insulin binding, insulin internalization, and insulin receptor recycling in an animal model of non-insulin-dependent diabetes mellitus. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Defects in adipocytes glucose transport,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0342750:Glucose transport defect [Disease or Syndrome]
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "insulin binding,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C1623517:insulin binding [Molecular Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin internalization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "insulin receptor recycling in an animal model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C3271703:insulin receptor recycling [Cell Function]
   778   C0599282:receptor recycling [Cell Function]
   748   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "of non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.405: Diabetes, 34, 55A. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "34,"

Phrase: "55A."
Processing 00000000.tx.406: 47 Trischitta, V. and Reaven, G.M. 

Phrase: "47 Trischitta,"

Phrase: "V."

Phrase: "and"

Phrase: "Reaven,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.407: (1988) Evidence of a defect in insulin-receptor recycling in adipocytes from older rats. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Evidence of a defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in insulin-receptor recycling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C3271703:insulin receptor recycling [Cell Function]
   901   C0599282:receptor recycling [Cell Function]
   827   C0282114:Recycling [Human-caused Phenomenon or Process]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "in adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "from older rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.408: Am. 

Phrase: "Am."
Processing 00000000.tx.409: J. 

Phrase: "J."
Processing 00000000.tx.410: Physiol., 254, E39E44.[Abstract/Free FullText] 48 Kurochkin, I.V. 

Phrase: "Physiol.,"

Phrase: "254,"

Phrase: "E39E44."

Phrase: "[Abstract/Free FullText"

Phrase: "] 48 Kurochkin,"

Phrase: "I.V."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.411: (1998) Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.412: FEBS Lett., 427, 153156.[ISI][Medline] 49 Turnell, W.G. and Finch, J.T. 

Phrase: "FEBS Lett.,"

Phrase: "427,"

Phrase: "153156."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 49 Turnell,"

Phrase: "W.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "J.T."
Processing 00000000.tx.413: (1992) Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Binding of the dye congo red"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to the amyloid protein pig insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a novel homology amongst amyloid-forming peptide sequences."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   750   C0162775:Sequence Homology [Quantitative Concept]
   744   C1334043:Homology [Gene or Genome]
   744   C2697616:Homology [Qualitative Concept]
   700 E C0162774:Sequence Homolog [Molecular Sequence]
Processing 00000000.tx.414: J. 

Phrase: "J."
Processing 00000000.tx.415: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.416: Biol., 227, 12051223.[ISI][Medline] 50 Kamel, A., Norgren, S., Ehren, H., Hildingsson, U. and Marcus, C. 

Phrase: "Biol.,"

Phrase: "227,"

Phrase: "12051223."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 50 Kamel,"

Phrase: "A.,"

Phrase: "Norgren,"

Phrase: "S."

Phrase: ","

Phrase: "Ehren,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hildingsson,"

Phrase: "U."

Phrase: "and"

Phrase: "Marcus,"

Phrase: "C."
Processing 00000000.tx.417: (1997) Antilipolytic effect of insulin and insulin receptor messenger RNA expression in adipocytes of infants, children, and adults. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Antilipolytic effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "insulin receptor messenger RNA expression in adipocytes of infants,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0040649:RNA Expression [Genetic Function]
   762   C0597360:receptor expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "children,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Children [Age Group]
  1000   C0680063:Children [Family Group]

Phrase: "and"

Phrase: "adults."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]
Processing 00000000.tx.418: Pediatr. 

Phrase: "Pediatr."
Processing 00000000.tx.419: Res., 41, 563567.[Abstract] 51 Arner, P. and Engfeldt, P. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "41,"

Phrase: "563567."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 51 Arner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Engfeldt,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.420: (1987) Fasting-mediated alteration studies in insulin action on lipolysis and lipogenesis in obese women. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Fasting-mediated alteration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "studies in insulin action"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   819   C2986485:Action Study [Research Activity]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0441472:Action [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2603343:Study [Research Activity]
   770   C3266814:Action [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "on lipolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023796:Lipolysis [Organism Function]

Phrase: "and"

Phrase: "lipogenesis in obese women."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596843:lipogenesis [Molecular Function]
   770   C1563744:Lipogenesis [Organism Function]
Processing 00000000.tx.421: Am. 

Phrase: "Am."
Processing 00000000.tx.422: J. 

Phrase: "J."
Processing 00000000.tx.423: Physiol., 253, 193201. 

Phrase: "Physiol.,"

Phrase: "253,"

Phrase: "193201."
Processing 00000000.tx.424: 52 Moody, A.J., Stan, M.A., Stan, M. and Gliemann, J. 

Phrase: "52 Moody, A.J.,"

Phrase: "Stan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2985331:STAN [Diagnostic Procedure]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2985331:STAN [Diagnostic Procedure]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Gliemann,"

Phrase: "J."
Processing 00000000.tx.425: (1974) A simple free fat cell bioassay for insulin. 

Phrase: "(1974"

Phrase: ")"

Phrase: "A simple free fat cell bioassay for insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0005507:Bioassay [Laboratory Procedure]
   744   C1704780:Bioassay [Conceptual Entity]
Processing 00000000.tx.426: Horm. 

Phrase: "Horm."
Processing 00000000.tx.427: Metab. 

Phrase: "Metab."
Processing 00000000.tx.428: Res., 6, 1216.[ISI][Medline] 53 Marcus, C., Karpe, B., Bolme, P., Sonnenfeld, T. and Arner, P. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "6,"

Phrase: "1216."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 53 Marcus,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Karpe,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bolme,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sonnenfeld,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Arner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.429: (1987) Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Changes in catecholamine-induced lipolysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007412:Catecholamine [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0023796:Lipolysis [Organism Function]
   760   C0205263:Induced [Functional Concept]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]
   760   C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "in isolated human fat cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   875   C0427861:Human cells [Laboratory or Test Result]
   861   C0206131:Fat Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0424612:FAT [Organism Attribute]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "during the first year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439234:year [Temporal Concept]
   861   C0439508:/year [Temporal Concept]

Phrase: "of life."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]
Processing 00000000.tx.430: J. 

Phrase: "J."
Processing 00000000.tx.431: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.432: Invest., 79, 18121818.[ISI][Medline] 54 Jacob, H.J., Lindpaintner, K., Lincoln, S.E., Kusumi, K., Bunker, R.K., Mao, Y.P., Ganten, D., Dzau, V.J. and Lander, E.S. 

Phrase: "Invest.,"

Phrase: "79,"

Phrase: "18121818."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 54 Jacob,"

Phrase: "H.J.,"

Phrase: "Lindpaintner,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: "E.,"

Phrase: "Kusumi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bunker,"

Phrase: "R.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mao,"

Phrase: "Y.P.,"

Phrase: "Ganten,"

Phrase: "D."

Phrase: ","

Phrase: "Dzau,"

Phrase: "V.J."

Phrase: "and"

Phrase: "Lander,"

Phrase: "E.S."
Processing 00000000.tx.433: (1991) Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Genetic mapping of a gene causing hypertension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0008630:genetic mapping [Laboratory Procedure,Molecular Biology Research Technique]
           Gene Mapping
   748   C1283195:Mapping [Activity]

Phrase: "in the stroke-prone spontaneously hypertensive rat."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0034705:Spontaneously hypertensive rat [Mammal]
   804   C0033422:Prone [Spatial Concept]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   804   C0038454:Stroke [Disease or Syndrome]
   804   C0857121:hypertensive [Finding]
Processing 00000000.tx.434: Cell, 67, 213224.[ISI][Medline] 55 Lander, E., Green, P., Abrahamson, J., Barlow, A., Daley, M., Lincoln, S. and Newburg, L. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "67,"

Phrase: "213224."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 55 Lander,"

Phrase: "E.,"

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Abrahamson,"

Phrase: "J.,"

Phrase: "Barlow,"

Phrase: "A.,"

Phrase: "Daley,"

Phrase: "M."

Phrase: ","

Phrase: "Lincoln,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Newburg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.435: (1987) Mapmaker: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Mapmaker"

Phrase: ":"

Phrase: "an interactive computer package for constructing primary genetic linkage maps of experimental"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0013194:Package [Medical Device]
   736   C2700580:Package [Manufactured Object]

Phrase: "and"

Phrase: "natural populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.436: Genomics, 1, 174181.[Medline] 56 Baumeister, H., Mller, D., Rehbein, M. and Richter, D. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "174181."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 56 Baumeister,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mller,"

Phrase: "D."

Phrase: ","

Phrase: "Rehbein,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Richter,"

Phrase: "D."
Processing 00000000.tx.437: (1993) The rat insulin-degrading enzyme: molecular cloning and characterization of tissue-specific transcripts. 

Phrase: "(1993"

Phrase: ")"

Phrase: "The rat insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of tissue-specific transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]
Processing 00000000.tx.438: FEBS Lett., 317, 250254.[ISI][Medline] 57 Chomczynski, P. and Sacchi, N. 

Phrase: "FEBS Lett.,"

Phrase: "317,"

Phrase: "250254."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 57 Chomczynski,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Sacchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.439: (1987) Single-step method of RNA isolation by acid guanidinium thiocyanatephenolchloroform extraction. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Single-step method of RNA isolation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "by acid guanidinium thiocyanatephenolchloroform extraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185115:Extraction [Therapeutic or Preventive Procedure]
   812   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.440: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.441: Biochem., 162, 156159.[ISI][Medline] 58 Sambrook, J., Fritsch, E.F. and Maniatis, T. 

Phrase: "Biochem.,"

Phrase: "162,"

Phrase: "156159."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 58 Sambrook,"

Phrase: "J.,"

Phrase: "Fritsch,"

Phrase: "E.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.442: (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Molecular Cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "A Laboratory Manual, 2nd edn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1419408:EDN [Gene or Genome]
Processing 00000000.tx.443: Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 

Phrase: "Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.444: 59 Feinberg, A.P. and Vogelstein, B. 

Phrase: "59 Feinberg,"

Phrase: "A.P."

Phrase: "and"

Phrase: "Vogelstein,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.445: (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. 

Phrase: "(1983"

Phrase: ")"

Phrase: "A technique for radiolabeling DNA restriction endonuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449851:Technique [Functional Concept]

Phrase: "fragments to high specific activity."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0205177:Activity [Functional Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0332255:fragment [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0486805:Fragments [Body Substance]
   760   C1299351:High [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   760   C1561536:*Activity [Idea or Concept]
   760   C1708096:Fragment [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.446: Anal. 

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.447: Biochem., 132, 613.[ISI][Medline] 60 Wallberg-Henriksson, H., Zetan, N. and Henriksson, J. 

Phrase: "Biochem.,"

Phrase: "132,"

Phrase: "613."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 60 Wallberg-Henriksson,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zetan,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Henriksson,"

Phrase: "J."
Processing 00000000.tx.448: (1987) Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Reversibility of decreased insulin-stimulated glucose transport capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449261:Reversibility [Temporal Concept]

Phrase: "in diabetic muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "with in vitro incubation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.449: Insulin is not required. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.450: J. 

Phrase: "J."
Processing 00000000.tx.451: Biol. 

Phrase: "Biol."
Processing 00000000.tx.452: Chem., 262, 76657671.[Abstract/Free FullText] 61 Henriksen, E.J. and Holloszy, J.O. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "262,"

Phrase: "76657671."

Phrase: "[Abstract/Free FullText"

Phrase: "] 61 Henriksen,"

Phrase: "E.J."

Phrase: "and"

Phrase: "Holloszy,"

Phrase: "J.O."
Processing 00000000.tx.453: (1991) Effect of diffusion distance on measurement of rat skeletal muscle glucose transport in vitro. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Effect of diffusion distance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of rat skeletal muscle glucose transport"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   884   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   840   C0178666:glucose transport [Cell Function]
   840   C0242692:Muscle, Skeletal [Tissue]
   840   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   804   C0005528:Transport, NOS [Cell Function]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0026845:Muscle [Tissue]
   804   C0037253:skeletal [Body System]
   804   C0521324:Skeletal [Spatial Concept]
   804   C1317949:Transport [Manufactured Object]
   804   C3495449:transport [Medical Device]
   733 E C0442025:Muscular [Spatial Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.454: Acta Physiol. 

Phrase: "Acta Physiol."
Processing 00000000.tx.455: Scand., 143, 381386.[ISI][Medline]

Phrase: "Scand.,"

Phrase: "143,"

Phrase: "381386."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

